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ABSTRACT
A feasible approach to the restoration of injured bone tissue is the use of tissue
engineering strategies to deliver mesenchymal stem cells (MSCs) to the site of
regenration in degradable, in-situ gelling, bio-active hydrogels. Although inert
Polyethylene glycol (PEG) hydrogels provide flexibility in controlling the cell
microenvironment, their use for in vivo applications in tissue regeneration is limited by
their persistence (nondegradability) in the site of regeneration. In an attempt to produce
inert hydrolytically degradable matrices for encapsulation of MSCs, hydrogels based on
star PEG macromonomers chain-extended with short hydroxy acid (HA) segments
(SPEXA) were synthesized and characterized with respect to gelation kinetics, water
content, degradation rate and mechanical properties. HA monomers included glycolide,
lactide, p-dioxanone and ε-caprolactone. The degradation rate of SPEXA hydrogels was
strongly dependent on HA type and number of HA repeat units. SPEXA gels chainextended with the least hydrophobic glycolide completely degraded within days, lactide
within weeks, and p-dioxanone and ε-caprolactone degraded within months. Further,
there was a biphasic relationship between HA segment length and gel degradation. There
was a significant decrease in gelation time of SPEXA macromonomers with HA chainextension for all HA types due to micelle formation. Meso-scale simulations revealed
formation of micellar structures within the SPEXA precursor solutions for all HA types.
The micellar SPEXA hydrogels supported osteogenic differentiation, collagen
production, and mineralization of MSCs. We further investigated the effect of
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concentration and hydrophobicity a BMP-2 protein derived peptide on osteogenic
differentiation of mesenchymal stem cells (MSCs) encapsulated in a PEG based
hydrogel. The dose-osteogenic response curve of the BMP-2 peptide was in the 0.00050.005 mM range, and osteoinductive potential of the BMP-2 peptide was significantly
less than that of BMP-2 protein even at 1000-fold higher concentrations. There was a
higher osteogenic differentiation of encapsulated hMSCs when the BMP-2 peptide was
dissolved in the hydrogel matrix as compared to the peptide conjugated to the hydrogel
network. The BMP-2 peptide with a positive index of hydrophobicity had a critical
micelle concentration (CMC) and formed aggregates in aqueous solution. Results
revealed that osteoinductive potential of the BMP-2 peptide is correlated with its CMC
and the free peptide concentration in aqueous medium and not the total concentration.

vi

TABLE OF CONTENTS
DEDICATION ....................................................................................................................... iii
ACKNOWLEDGEMENTS........................................................................................................ iv
ABSTRACT ............................................................................................................................v
LIST OF TABLES ....................................................................................................................x
LIST OF FIGURES ................................................................................................................. xi
CHAPTER 1: INTRODUCTION ............................................................................................1
CHAPTER 2: BACKGROUND AND LITERATURE REVIEW ..........................................7
2.1 OSTEOGENIC DIFFERENTIATION OF STEM CELLS IN BONE ...............7
2.2 CROSSLINKING OF POLYMER CHAINS AND GELATION ......................10
2.3 APPLICATIONS OF HYDROGELS ................................................................11
2.4 NATURAL VS. SYNTHETIC HYDROGELS ..................................................12
2.5 PHYSICALLY CROSSLINKED HYDROGELS ..............................................14
2.6 COVALENTLY CROSSLINKED HYDROGELS ............................................16
2.7 MICELLAR HYDROGELS ...............................................................................17
2.8 HYDROGEL SWELLING AND MESH SIZE ..................................................19
2.9 MECHANICAL PROPERTIES OF HYDROGELS ..........................................21
2.10 DEGRADATION OF HYDROGELS ...............................................................23
2.11 BIOACTIVE MODIFICATION OF HYDROGELS ........................................25
CHAPTER 3: SYNTHESIS AND GELATION CHARACTERISTICS OF PHOTOCROSSLINKABLE STAR POLY(ETHYLENE OXIDE-CO-LACTIDE-GLYCOLIDE
ACRYLATE) MACROMONOMERS ..............................................................................27

vii

3.1 INTRODUCTION .............................................................................................28
3.2 EXPERIMENTAL ............................................................................................30
3.3 RESULTS ..........................................................................................................37
3.4 DISCUSSION ...................................................................................................44
3.5 CONCLUSION .................................................................................................51
CHAPTER 4: GELATION CHARACTERISTICS AND OSTEOGENIC
DIFFERENTIATION OF STROMAL CELLS IN INERT HYDROLYTICALLY
DEGRADABLE MICELLAR POLYETHYLENE GLYCOL HYDROGELS ................53
4.1 INTRODUCTION .............................................................................................54
4.2 MATERIALS AND METHODS ......................................................................56
4.3 SIMULATION METHOD ................................................................................64
4.4 RESULTS AND DISCUSSION .......................................................................67
4.5 CONCLUSION .................................................................................................91
CHAPTER 5: NANOSTRUCTURE FORMATION AND TRANSITION FROM
SURFACE TO BULK DEGRADATION IN POLYETHYLENE GLYCOL GELS
CHAIN-EXTENDED WITH SHORT HYDROXY ACID SEGMENTS .........................93
5.1 INTRODUCTION .............................................................................................94
5.2 SIMULATION METHOD ................................................................................96
5.3 EXPERIMENTAL METHODS ........................................................................99
5.4 RESULTS AND DISCUSSION .....................................................................106
5.5 CONCLUSION ...............................................................................................126
CHAPTER 6: MESOSCALE SIMULATION OF THE EFFECT OF A LACTIDE
SEGMENT ON THE NANOSTRUCTURE OF STAR POLY(ETHYLENE GLYCOLCO-LACTIDE)-ACRYLATE MACROMONOMERS IN AQUEOUS SOLUTION ....126
6.1 INTRODUCTION ...........................................................................................127
6.2 METHODS ......................................................................................................129

viii

6.3 RESULTS AND DISCUSSION .....................................................................134
6.4 CONCLUSION ...............................................................................................147
CHAPTER 7: EXPERIMENTAL AND COMPUTATIONAL INVESTIGATION OF THE
EFFECT OF HYDROPHOBICITY ON AGGREGATION AND OSTEOINDUCTIVE
POTENTIAL OF BMP-2 DERIVED PEPTIDE IN A HYDROGEL MATRIX ............149
7.1 INTRODUCTION ...........................................................................................150
7.2 MATERIALS AND METHODS ......................................................................152
7.3 RESULTS ........................................................................................................163
7.4 DISCUSSION .................................................................................................178
7.5 CONCLUSION ...............................................................................................181
CHAPTER 8: CONCLUDING REMARKS .......................................................................183
REFERENCES .....................................................................................................................184
APPENDIX A: PERMISSION TO REPRINT ....................................................................211

ix

LIST OF TABLES
Table 3.1 Relative intensity of the chemical shifts in the NMR spectra of SPELGA
macromers ..........................................................................................................................39
Table 3.2 Number average molecular weight, weight average molecular weight and PI of
the synthesized SPELGA macromers ................................................................................39
Table 4.1 Number of lactide monomers (nL), number-average molecular weight, average
number of lactide units per end group, and average number of acrylate groups per end
group for SPELA and LPELA macromonomers as a function of lactide to PEG molar
feed ratio in the polymerization reaction ...........................................................................70
Table 6.1 DPD Interaction Parameters used in the Simulation .......................................134

x

LIST OF FIGURES
Figure 1.1 Schematic representation of cell-laden hydrogels for tissue regeneration .........3
Figure 2.1 Schematic representation of the bone and periosteum micro-structures ............8
Figure 2.2 Schematic representation of crosslinking the multi-functional macromonomers
and formation of an infinite network .................................................................................10
Figure 2.3 (a) Schematic diagram of an A-B-A triblock copolymer with solvophilic block
B (green) and solvophobic block A (brown); (b) conformation of chains in A-B-A
triblock copolymer chains in solution and formation of micellar structure by aggregation
of solvophobic A blocks; (c) formation of a physical network in a solution of A-B-A
triblock copolymers ...........................................................................................................18
Figure 2.4 Schematic representation of the swelling of a crosslinked network and the
mesh size ............................................................................................................................19
Figure 3.1 Reaction scheme for the synthesis of SPELGA macromonomer .....................32
Figure 3.2 NMR spectra for SPELGA800-L50. The inset is the spectra of SPELG800L50 before acrylation .........................................................................................................38
Figure 3.3 The effect of UV initiator concentration on shear storage modulus of
SPELGA5K-L100-M25-N0 hydrogels ..............................................................................41
Figure 3.4 The effect of macromonomer concentration on the modulus (a) and sol
fraction (b) of SPELGA5K-L100-N0-I0.16 hydrogel .......................................................42
Figure 3.5 The effect of NVP monomer concentration on (a) evolution and (b) plateau
shear storage modulus of SPELGA5K-L100-M25-I0.16 hydrogels .................................43
Figure 3.6 The effect of initiator molecular weight and LA/GL ratio of SPELGA
macromonomer on shear storage modulus of SPELGA-M15-N0-I0.16 hydrogels ..........44
Figure 3.7 The effect of initiator molecular weight and LA/GL ratio of SPELGA on (a)
mass loss and (b) swelling ratio of SPELGA-N0-I0.16 hydrogels ....................................45
Figure 3.8 Schematic diagram to illustrate the cross-propagation reaction of the polymer
chains in the sol with network-bound SPELGA acrylates to facilitate crosslinking .........49

xi

Figure 4.1 Coarse-grained representations of LPELA and SPELA macromonomers,
respectively ........................................................................................................................65
Figure 4.2 1H-NMR spectrum of SPELA-nL14.8 macromonomer. The inset shows the
chemical shifts with peak positions between 5.8 and 6.5 at higher intensity ....................68
Figure 4.3 1H-NMR spectrum of (a) SPELA-nL0 , (b) SPELA-nL3.4 , (c) SPELA-nL6.4
and (d) SPELA-nL11.6, (e) LPELA-nL0 , (f) LPELA-nL3.6 , (g) LPELA-nL7.4 , (h)
LPELA-nL9.6 and (i) LPELA-nL14.8 macromonomers ...................................................69
Figure 4.4 Effect of number of lactide monomers per macromonomer on time evolution
of the storage modulus of SPELA-M20 hydrogels ............................................................72
Figure 4.5 Effect of UV initiator concentration on (a) storage modulus and (b) gelation
time of LPELA-nL7.4-M20 and SPELA-nL14.8-M20 hydrogels.....................................72
Figure 4.6 Effect of macromonomer concentration on (a) storage modulus and (b)
gelation time of LPELA-nL7.4 and SPELA-nL14.8 hydrogels ........................................76
Figure 4.7 (a) DPD simulation of micelle formation and (b) simulated crosssection of
one of the micelles for SPELA-nL14.8- M20 aqueous soultion (c) shows intramolecular
running integration number (IN) for Ac−Ac beads for LPELA-nL7.4 and SPELA-nL14.8
macromonomers in aqueous solution.................................................................................78
Figure 4.8 Effect of macromonomer concentration on (a) swelling ratio and (b) sol
fraction of LPELA-nL7.4 and SPELA-nL14.8 hydrogels .................................................80
Figure 4.9 Effect of number of lactide monomers per macromonomer (nL) on (a) storage
modulus and (b) gelation time of LPELA-M20 and SPELA-M20 hydrogels ...................81
Figure 4.10 Effect of number of lactide monomers per macromonomer (nL) on (a)
swelling ratio and (b) sol fraction of LPELA-M20 and SPELA-M20 hydrogels ..............83
Figure 4.11 Effect of number of lactide monomers per macromonomer (nL) on mass loss
of (a) SPELA-M20 and (b) LPELA-M20 hydrogels with incubation time .......................85
Figure 4.12 Live (green) and dead (red) image of MSCs 1 h after encapsulation in (a)
SPELA-nL3.4, (b) SPELA-nL6.4, (c) SPELA-nL11.6, and (d) SPELA-nL14.8 hydrogels
(without BMP2) .................................................................................................................87
Figure 4.13 (a) DNA content, (b) ALPase activity, and (c) calcium content of MSCs
encapsulated in SPELA-14.8 hydrogel ..............................................................................88
Figure 4.14 mRNA Expression levels, as fold difference, of (a) Dlx5, (b) Runx2, (c) OP,
and (d) OC of MSCs encapsulated in SPELA-14.8 hydrogels ..........................................90

xii

Figure 5.1 Bead reperesentation of SPEXA macromonomers in DPD ............................97
Figure 5.2 H-NMR spectra of (a) star PEG, (b) SPEGA (G-m2.8), (c) SPEDA (D-m2.9),
(d) SPELA (L-m2.9) and (e) SPECA (C-m2.8) ..............................................................107
Figure 5.3 Evolution of core of the micelles in 20% aqueous solutions of SPEXA........109
Figure 5.4 Cross section of the micelles formed in 20% aqueous solutions of SPEXA..110
Figure 5.5 Effect of number of HA repeat units on each arm on (a) core radius (a),
aggregation number (b), number density of micelles (c) and free arm fraction of the
micelles (d) in 20% aqueous solutions of SPEXA...........................................................112
Figure 5.6 (a) Distribution of photoinitiator molecules and (b) cross-section of one of the
micelles in the SPELA-m3 precursor solution, (c) effect of number of lactide monomers
per SPELA arm on fraction of initiators in aqueous solution. (d) Effect of exposure of
MSCs to photoinitiator (10 mg/mL) in 20 wt% SPEXA precursor solution on the
fraction of viable cells (e) Effect of number of HA monomers per arm on simulated AcAc running integration number and (f) experimental gelation time of 20% SPEXA
precursor solutions. ..........................................................................................................115
Figure 5.7 (a) Effect of number of HA monomers per arm (m) on predicted hydrolysis
rate of 20 wt% SPEXA precursor solutions. (b) Effect of HA monomer type on
experimental mass loss of SPEXA hydrogels (c-f) Effect of number of HA monomers per
macromonomner on experimental mass loss of SPEXA hydrogels, with incubation time.
(g) Effect of HA monomer type on distribution of water beads around core of the
micelles. (h) Effect of number of HA monomers per arm on experimentally-measured
equilibrium water content of SPEXA hydrogels .............................................................119
Figure 5.8 (a) Total collagen, (b) ALP activity and (c) calcium content of MSCs
encapsulated in SPEXA hydrogels with incubation time in osteogenicc medium. mRNA
expression of (d) Col-1, (e) ALP and (f) OC of MSCs encapsulated in SPEXA hydrogels
with incubation time in osteogenic medium ....................................................................123
Figure 6.1 Bead representation of SPELA macromonomer in DPD ...............................130
Figure 6.2 Evolution of micellar cores for SPELA-nL macromonomers in 30% aqueous
solution.............................................................................................................................135
Figure 6.3 Cross section of the micelles for SPELA-nL macromonomers in 30% aqueous
solution.............................................................................................................................137
Figure 6.4 The effect of the number of lactide beads on each arm on (a) the micelle core
size and number density and (b) the aggregation number of micelles in 30% aqueous
solution of SPELA-nL macromonomers .........................................................................138

xiii

Figure 6.5 The effect of macromonomer concentration on the core size and number
density of the micelles in aqueous solution of SPELA-4L macromonomers ..................140
Figure 6.6 Schematic representation of bridge, loop ,and free arm conformations of
SPELA macromonomers in aqueous solution .................................................................140
Figure 6.7 The effect of the number of lactide beads on each arm on the number of
bridges per micelle and bridge fraction in 30% aqueous solution of SPELA-nL
macromonomers ...............................................................................................................142
Figure 6.8 The running integration numbers for (a) Ac−W beads and (b) Ac−Ac beads of
SPELA-nL macromonomers in 30% aqueous solution ...................................................144
Figure 6.9 The distribution of Ac beads in the core of micelles for SPELA-nL
macromonomers in 30% aqueous solution ......................................................................145
Figure 6.10 The effect of the number of lactide beads on each arm on the fraction of Ac
beads on free arms and core surface of the micelles for SPELA-nL macromonomers in
30% aqueous solution ......................................................................................................146
Figure 7.1 Bead representation of the BMP-2 peptide (a) and the peptide/lactide-capped
PEG conjugate (b). (c) Schematic representation of hMSCs encapsulated in the PEGDA
(blue network) hydrogel matrix. Experimental groups included the peptide dissolved in
the hydrogel network (d), peptide covalently attached to the hydrogel network (e), and
peptide/lactide-capped PEG conjugate attached to the hydrogel network (f)..................155
Figure 7.2 DNA content (a, day 7), ALP activity (b, day 14), and calcium content (c, day
21) of hMSCs encapsulated in PEGDA hydrogel (15 wt%) and incubated in osteogenic
medium without DEX as a function of dissolved BMP-2 peptide concentration in the
hydrogel matrix ................................................................................................................165
Figure 7.3 (a) Hydrophobicity index for each amino acid of the BMP-2 peptide. (b)
intensity of scattered light (c) Simulated aggregation number of the BMP-2 peptide and
(d) density of free BMP-2 peptide and total peptide density as a function of peptide
concentration in aqueous solution....................................................................................168
Figure 7.4 ALP activity (b, day 14), and calcium content (c, day 21) of hMSCs
encapsulated in PEGDA hydrogel (15 wt%) and incubated in osteogenic medium without
DEX as a function of dissolved BMP-2 peptide concentration in the hydrogel matrix ..171
Figure 7.5 DNA content (a), ALP activity (b), and calcium content (c) of hMSCs
encapsulated in PEGDA hydrogel and incubated in basal medium (BM, control group),
osteogenic medium without DEX (OM, control group), OM with the BMP-2 peptide
covalently attached to the hydrogel network (cP), OM with BMP-2 peptide dissolved in
the hydrogel (P), OM with peptide/lactide-capped PEG conjugate with zero (cPL0), 2
(cPL2), 4(cPL4) and 6 (cPL6) lactide units, attached to the hydrogel network ..............172

xiv

Figure 7.6 Evolution of the BMP-2 peptide aggregates in PEGDA hydrogel (15 wt%)
without the peptide or lactide-capped PEG macromer (a), with lactide-capped PEG
macromer (b), the peptide (c), the peptide-PEG conjugate (d), the peptide/lactide-capped
PEG conjugate with 2 (e), 4 (f), and 6 (g) lactides ..........................................................174
Figure 7.7 Cross-section of one of the BMP-2 peptide aggregates with green beads
representing ethylene oxide units. Images (a-g) correspond to aggregates without the
peptide or lactide-capped PEG macromer (a), with lactide-capped PEG macromer (b), the
peptide (c), peptide-PEG conjugate (d), peptide/lactide-capped PEG conjugate with 2 (e),
4 (f), and 6 (g) lactides. (h) Simulated average aggregation number and the fraction of
free peptide (h) and the water-amino acid integration number for lysine (charged), serine
(uncharged but polar), and isoleucine (nonpolar) (i) .......................................................176
Figure 7.8 Effect of an aggregate of the BMP-2 peptide (top images) and an aggregate of
the peptide-PEG conjugate (bottom images) on energetic interaction, penetration of the
peptide and pore formation in the cell membrane ...........................................................178

xv

CHAPTER 1
INTRODUCTION
The clinical needs for bone tissue regeneration are diverse and include
applications arising from skeletal defects caused by fracture, trauma, infection,
neurosurgical procedures, resection of tumors and spinal deformities. [1-3] There are
more than 280000 and 700000 hip and vertebral fractures in the USA annually.[4]
Approximately 500000 and 2.2 million bone grafting procedures are performed inside the
US and worldwide respectively each year.[5] The total number of spinal fusion
procedures in the U.S. was 673,000 in the year 2012. [6]
The gold standard for bone implantation is use of grafts harvested from the
patient‟s body (Autologous grafts). However, autologous bone grafting needs an
additional surgery for harvesting the bone from the donor site. Furthermore, the donor
site may undergo morbidity, infection and pain after operation. [7] The use of cadaveric
bone (allograft) suffers from a risk of disease transmission [8]. Further, the use of
devitalized allografts was associated with 60% graft failure over 10 years due to the
absence of bone osteoprogenitor cells within the graft.[9] It is well established that the
presence of stem cells or osteoprogenitor cells has a significant role in bone
regeneration.[10, 11] A 63% reduction in bone formation was reported when the stem
cell containing periosteum and bone marrow were removed from a live bone graft in a
murine segmental femoral bone graft model. [9] In addition, a significant increase in the
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bone formation and neuvascularization were observed with immobalizing MSCs on the
surface of allografts or directing MSCs to the surface of allografts in-vivo.[12, 13]
However, MSCs had a limted viability and an extensive migration from the site of
regeneration when they were incorporated into the grafts without a three dimensional
carrier similar to the stem cell carrier matrix in the natural bone. [13]
Bone is a composite matrix consisting of a mineral and a gel phase.[14, 15] The
mineral phase provides the mechanical strength as well as osteoconductivity while the gel
phase, with a significantly lower stiffness than the mineral phase, plays a critical role in
maturation and differentiation of stem cells and progenitor cells.[14, 15] Multiple
bioactive ligands within the gel phase interact with stem cells to initiate the cascade of
differentiation and mineralization.[16] For instance, the interaction between RGD, a
ligand in collagen I and fibronectin proteins, and cell surface receptors, facilitates cell
spreading and focal adhesion to the ECM which is critical for cell differentiation.[17]
Also, a peptide corresponding to residues 73-92 of the knuckle epitope of the BMP-2
protein is shown to have an osteo-inductive potential. [18] Differentiation of stem cells to
bone cells in the natural bone is regulated by an optimal matrix stiffness (mechanical
cues) and optimal spatio-temporal distribution of bio-active ligands (biological cues)
within the soft gels. [19]
An exciting approach to bone tissue engineering is to deliver progenitor cells to
the regeneration site in natural or synthetic hydrogels modified with the bioactive lignds
(see Figure 1.1). This allows the encapsulated cells to secrete the desired extracellular
matrix (ECM).[20] In that approach, the gel degrades gradually, providing space for the
new bone formation and eventually displacing the gel with the patient‟s own bone tissue.
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Cell-laden bioactive hydrogels can be used alone for minimally invasive non-load
bearing applications or combined with supportive structures for load bearing applications.
Hydrogels are hydrophilic polymeric networks that retain a significant fraction of water
in their structure in physiological solution. Nutrient molecules and proteins diffuse
through hydrogels and cells immobilized in hydrogels display higher biological
activity.[21-25] Due to these unique properties, hydrogels are very attractive as a matrix
for cell encapsulation and delivery to the regeneration site in regenerative medicine.[2630]

Figure 1.1. Schematic representation of cell-laden hydrogels for tissue regeneration. A
fluorescent image of live MSCs (green dots) encapsulated in a PEG based hydrogel is
shown at right.
Minor variation in the sequence distribution of natural gels can significantly affect
the fate of encapsulated cells. With many cell-binding ligands and regulatory factors, it is
difficult to adapt the properties of natural matrices to a particular application in
regenerative medicine.[31] For instance, differentiation of mesenchymal stem cells
(MSCs) shifted from osteogenic to chondrogenic lineage by changing the matrix from
collagen type I to type II.[32, 33] Moreover, due to their low stiffness, natural gels are
limited in practical applications by soft tissue compression.[34-36] Therefore, there is a
need to synthesize novel hydrogels with tunable physical, mechanical, and biological

3

properties for a wide range of applications in regenerative medicine such as MSC
implantation for treatment of skeletal defects and spinal fusion, chondrocyte implantation
in cartilage regeneration or as cardiac patches to treat heart infarction.
Synthetic polyethylene glycol (PEG) based hydrogels are used extensively for cell
encapsulation to elucidate the effect of physiochemical, mechanical, and biological
factors in the microenvironment on cell fate in vitro.[36-39] PEG hydrogels, due to their
inert, hydrophilic and immunogenic nature, provide enormous flexibility in designing and
controlling the cell microenvironment.[40, 41] Unlike small-molecule monomers that
cross the cell membrane, the flexible PEG macromonomers crosslink to produce
hydrogels with high compressive modulus without adversely affecting the viability of the
encapsulated cells.[42-46]
Although inert PEG hydrogels provide flexibility in controlling the cell
microenvironment, their use for in vivo applications in tissue regeneration is limited by
their persistence (non-degradability) in the site of regeneration.[30] In that regard, design
and synthesis of PEG hydrogels with hydrolytically degradable hydroxyl acid (HA) links
would substantially increase their use as cell delivery matrices in tissue regeneration.[4749] We hypothesized that degradation and stiffness of PEG-HA gels are dependent on the
length and characteristics of the HA segment as well as functionality, molecular weight
and concentration of the PEG-HA macromonomer. To test the hypothesis, hydrogels
based on star PEG macromonomers chain-extended with short HA segments (SPEXA)
were synthesized and characterized with respect to gelation kinetics, degradation rate, sol
fraction, mechanical properties and water content.[35, 50-52] Star PEG macromonomers
have lower radius of gyration and shear viscosity, and higher density of functional groups

4

than the linear PEGs,[25, 53] leading to the formation of gels with higher crosslink
density and modulus.[54-57] HA monomers included least hydrophobic glycolide,
lactide, p-dioxanone, and most hydrophobic ε-caprolactone. Further, MSCs were
encapsulated into the developed gels and their viability and differentiation to the
osteogenic lineage were measured.[35, 51] In addition, Dissipative Particle Dynamics
simulation method [58, 59] was used to simulate aggregation, micelle formation and the
distribution of reactive groups in SPEXA hydrogel precursor solutions.[35, 51, 60]
Experimental and simulation results demonstrated that SPEXA hydrogels with a wide
range of degradation rate, gelation kinetics and mechanical properties can be synthesized
with adjusting the hydrophobicity and length of the HA segment, functionality and
molecular weight of the PEG and concentrations of the macromonomer and initiator.
Further, results revealed the formation of micellar structures within the hydrogels‟
precursor solution at the nano-scale that affects the gelation kinetics, degradation rate and
macroscopic properties of the hydrogels.[59]
It is well established that bone morphogenic protein (BMP-2) plays a dominant
role in osteogenic differentiation of MSCs and formation of the new bone tissue.[16, 61]
BMP-2 has been used extensively in certain clinical applications such as sinus
augmentation, spinal fusion, and alveolar ridge augmentation to accelerate bone
regeneration and reduce the chance of graft failure.[62, 63] Due to its short-half-life and
diffusion of the protein away from the site of regeneration, doses much higher than the
endogenous amount are used in clinical applications.[62, 64] High doses of BMP-2
protein in vivo cause undesired side effects such as bone overgrowth, immune response,
and tumor formation.[65] For example, the probability of an adverse side effect with the
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use of BMP-2 in spine fusion may be as high as 40%.[65] An attractive approach to
reduce the protein‟s side effects in bone tissue engineering is to use peptides derived from
the bioactive segements of BMP-2.[66] In order to design a BMP-2 peptide incorporated
hydrogel for osteogenic differentiation of MSCs there is a need to know how peptide
concentration, peptide aggregation and peptide grafting affect the bio-activity of the
peptide within the hydrogel. The effect of concentration and hydrophobicity of a BMP-2
peptide on peptide aggregation and differentiation of MSCs encapsulated in an inert
polyethylene glycol (PEG) hydrogel was investigated through experiments and
simulations.[67] Results demonstrated that the osteo-inductive potential of the BMP-2
peptide within the PEG hydrogel is correlated with the peptide hydrophobicity and
concentration of the non-aggregated peptide and not the total peptide concentration. [67]
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CHAPTER 2
BACKGROUND AND LITERATURE REVIEW
2.1. OSTEOGENIC DIFFERENTIATION OF STEM CELLS IN BONE
Mesenchymal stem cells (MSCs) are multipotent stem cells that have self-renewal
ability and also can differentiate to osteoblasts, chondrocytes or adipocytes. It is well
established that MSCs and osteoprogenitor cells play a vital role in bone regeneration
during development and bone healing. A 50% loss of bone graft strength and a 60% graft
failure were observed after 10 years of the decellularized allograft implantation. [9]
Further, a 63% reduction in bone formation was reported when the stem cell containing
periosteum and bone marrow were removed from a live bone graft in a murine segmental
femoral bone graft model. [9] In addition, a significant increase in the bone formation and
neuvascularization were observed with immobalizin MSCs on the surface of the
allografts or directing MSCs to the surface of allografts in-vivo.[12, 13] Stem cells and
progenitor cells do not reside within the calcified part of the bone. Bone MSCs in adults
mainly reside within the perivascular region of the bone marrow whereas osteoprogenitor
cells exist in bone marrow, endostum and periostium. [68, 69] MSCs differentiate to
osteoprogenitors in bone marrow. Osteoprogenitor cells undergo differentiation into
preosteoblasts and osteoblasts in the osteoblastic region of the bone marrow as well as the
soft osteogenic layer of the periosteum (see Figure 2.1). [19] The osteoblasts develop to
osteocytes which participate in bone remodeling and bone regeneration. Osteoprogenitor
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Figure 2.1. Schematic representation of the bone and periosteum micro-structures.
Osteogenic differentiation of osteoprogenitor cells to bone cells occurs within the soft
osteogenic layer of the periosteum.
cells in periosteum and bone marrow concurrently give rise to osteoblasts during bone
repair. [15] Differentiation of stem cells to the bone cells in periosteum and endosteum is
regulated by an optimal matrix stiffness (mechanical cues) and optimal concentration of
growth factors (biological cues) at the site of differentiation. [19] While bone is
composed of a stiff inorganic-organic composite matrix with elastic modulus of 17 GPa,
the thin periosteum with an elastic modulus of 1.9 MPa is four orders of magnitude less
stiff. [70, 71] Furthermore, the inner osteogenic layer of the periosteum, that hosts the
differentiating of osteoprogenitor cells, is softer than the outer fibrous layer (see Figure
2.1). The process of bone remodeling in adults is compareable with intramembranous
ossification in infants, in that they both initiate from the differentiation of stem cells to
osteoblasts in soft un-calcified matrices.[72] It is well established that the stiffness of
extracellular matrix (ECM) affects the fate of stem cells. [73, 74] For instance, MSCs
encapsulated in a semi-synthetic alginate based hydrogel undewent osteogenic
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differentiation when the matrix elastic modulus was in the 11-30 kPa range while the
adipogenic differentiation occurred in softer matrices with elastic modulus of 2.5-5 kPa.
[75] The osteogenic differentiation of MSCs increased when the elastic modulus of cellladen PEG gels increased from 0.2 to 59 kPa. [76] In addition, MSCs underwent
neuronal, myogenic and osteogenic differentiation when they were cultured on gels with
low (0.1-1 kPa), intermediate (8-15 kPa) and high (25-40 kPa) elastic modulus
respectively. [73]
In addition to the matrix stiffness, an optimal spatio-temporal distribution of
growth factors plays a key role in differentiation of stem cells/osteoprogenitor cells to
bone cells during bone remodeling or bone development. Although several growth factors
including fibroblast growth factor (FGF), transforming growth factor-β (TGF-β), insulinlike growth factor (IGF) and vascular endothelial growth factor (VEGF) contribute in
development and remodeling of a vascularized bone tissue, bone morphogenic proteins
(BMPs) play a dominant role in osteogenic differentiation of MSCs. [16, 61] In
intramembranous ossification, clustered MSCs in a soft matrix differentiate into
osteoblasts by localized secretion of BMPs.[72, 77] In a developed bone tissue, migration
of MSCs from bone marrow toward endosteum and secretion of BMPs promote bone
formation. [78] Several clinical studies have shown that the rate of healing increases and
the failure rate decreases with incorporation of BMP-2 and BMP-7 proteins in fracture
repair or spinal fusion procedures. [62, 63, 79] All in all, the cascade of bone formation
initiates with osteogenic differentiation of MSCs promoted by mechanical cues and
growth factors specifically BMPs within a soft matrix.
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2.2. CROSSLINKING OF POLYMER CHAINS AND GELATION
As mentioned before, hydrogels are crosslinked networks of hydrophilic
polymeric chains. If monomers (or macromonomers) of a polymerization reaction show a
functionality higher than 2, crosslinking between macromonomers will form branched
structures (see Figure 2.2). If the expected number of chains in each succeeding
generation of branched structures is greater than the number of chains in the preceding
generation, crosslinking may result to formation of an infinite network (see Figure 2.2).
Starting from a randomly chosen primary molecule “A”, the probability that “A” belongs
to an infinite network is dependent on the total number of crosslinks on a molecule “B”
which is crosslinked to molecule “A”. If  is the average number of crosslinks on “B”
excluding the one that primarily connects A to B, the crosslinking is finite when   1
because each generation tends to be smaller than the preceding one. Infinite networks can
be formed only if   1.

Figure 2.2. Schematic representation of crosslinking the multi-functional
macromonomers (left) to form branched structures (middle) and an infinite network
(right).
Therefore, the critical condition for gelation is   1 .[80] At the critical point of gelation
(   1 ), the number average molecular weight of the chains ( x n ) has a finite value but
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the weight average molecular weight of chains ( x w ) is infinite. So the molecular weight
distribution has an infinite breadth at the gelation point.[80]
2.3. APPLICATIONS OF HYDROGELS
Hydrogels have been used commercially to fabricate oscular contact lenses. [81]
Furthermore, hydrogels based on poly(2-hydroxyethyl methacrylate) (pHEMA)
copolymerized with methacrylic acid (MAA) and N-vinyl pyrrolidone (NVP) were used
as ophthalmic drug carriers for treatment of glaucoma. [82, 83] In cancer treatment,
biodegradable hydrogels based on PEG and PLGA were used for delivery of Paclitaxel to
tumors and they were shown to be effective in localizing drug concentration and
decreasing the systemic drug concentration. [84] In addition, pH, temperature or
magnetic sensitive PEG based hydrogels have been used in cancer treatment. [85, 86]
Hydrogels, due to their high water content and high diffusivity of nutrients and
biomolecules, can be potentially applied as carrier matrices for delivery of cells to the site
of regeneration in cell based therapies and tissue regeneration.[21, 24, 28, 87, 88] Since
injectable cell-laden hydrogels can be formed in-situ, they can be used for filling
irregularly-shaped defects through minimally invasive procedures.[89] After injection
and in situ hardening, the hydrogel matrix guides the development of seeded cell into the
desired tissue.[24]. The mechanical properties of tissue engineering hydrogels can be
tuned to prevent deformation or rupture and at the same time keep the cells viable. [44] In
addition, resorption of biodegradable hydrogels provides volume for tissue formation and
gradually displaces the hydrogel with cell secreted matrices.[48] Hydrogels have been
used for encapsulation of different cell lines and regeneration of different tissues. For
instance, PHEMA and PVA hydrogels were used for engineering of corneas. [90] MSCs
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were encapsulated in a number of hydrogels including collagen, chitosan, alginate PEG
and polypeptides for osteogenic differentiation.[30, 75, 91-93] Neural Stem Cells (NSCs)
were encapsulated in alginate hydrogels and underwent neuronal differentiation when the
the gel elatic mosulus was 180 Pa within the range of brain tissue modulus (100-1000
Pa).[94] Different hydrogels including PEG/agarose [95], collagen [96], PEG [97]
chitosan [98] and hyaluronic acid/chitosan [99] were used for encapsulation of
chondrocyte cells for cartilage tissue engineering. Co-cultures of Endothelial Colony
Forming Cells (ECFCs) and Mesenchymal Stem Cells (MSCs) encapsulated in Gelatin
Methacrylate hydrogels with a compressive modulus of 2 kPa underwent vasculogenic
differentiation and generated extensive capillary like networks in-vitro. [100]
2.4 NATURAL VS SYNTHETIC HYDROGELS
Only those hydrogels that are biocompatible, support cell-matrix interactions and
provide free volume for the newly formed tissue through degradation can be utilized as
supporting matrices in regenerative medicine.[101, 102] Consequently, natural hydrogels,
derived from the components of extracellular matrix (ECM) that degrade enzymatically,
are frequently used as delivery matrices in clinical applications. Collagen gel, one of the
main parts of mammalian tissues, is the most widely used natural hydrogel.[103]
Collagen gel is formed from physically crosslinked collagen fibers self-asembled from
triplehelic collagen molecules.[104] Gelatin is a thermosensitive gel formed from
physically crosslinked gelatin protein molecules which are deformed collagen molecules
with distorted secondary and tertiary structures.[105] Modified collagen and gelatin were
also chemically crosslinked to make more robust hydrogels. [100, 106, 107] Fibrin gels
were formed by the enzymatic polymerization of fibrinogen, a natural component of the
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body, in the presence of thrombin.[103] Alginate is a biomaterial derived from brown
algae and can be gelled in the presence of divalent cations such as: Mg2+, Ca2+ and Ba2+.
[108] In addition to alginate, other polysaccharide based natural hydrogels including
chitosan, hyaluronic acid and agarose have been extensively used in tissue engineering
applications. [20, 109] With many cell-interactive ligands and regulatory factors, it is
difficult to tailor the properties of natural hydrogels to a particular application in
regenerative medicine.[31] Moreover, due to their low stiffness, natural gels are limited
in practical applications by soft tissue compression.[34-36] Therefore, there is a need to
synthesize hydrogels with adjustable physical, mechanical, and biological properties for a
wide range of applications in tissue engineering.
Hydrogels based on several synthetic hydrophilic macromers including
poly(hydroxyethyl methacrylate) (pHEMA), poly(ethylene glycol) (PEG), poly(vinyl
alcohol) (PVA), polyurethane , polyacrylate and polypeptides have been synthesized and
characterized.[20, 103, 110] pHEMA hydrogels have excellent biostability and are being
used in fabrication of contact lenses.[103] Degradable pHEMA hydrogels were also
synthesized with incorporation of oligomeric polycaprolactone (PCL) crosslinkers.[111]
Polyethylene glycol (PEG) hydrogels are inert, non-immunogenic, and compatible with
stem cells and can be conjugated with multiple bioactive peptides to modify the cell
microenvironment and regulate cell fate.[112-114] Furthermore, the stiffness of PEG
hydrogels can be changed in a wide range with altering the concentration of highly
soluble PEG macromonomers in the aqueous precursor solution or using multifunctional
PEG macromonomers. [35, 115] However, PEG hydrogels are non-degradable which
limits their use as a supporting matrix in regenerative medicine. Degradable PEG based
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hydrogels were synthesized via copolymerization of PEG macromonomer with
hydrolytically degradable monomers or incorporation of hydrolytically or enzymatically
crosslinkers within the hydrogel. [52, 116] PVA hydrogels have been synthesized using
glutaraldehyde, acetaldehyde or formaldehyde as crosslinking reagents.[117] Chemical
crosslinking of PVA macromonomers were also performed using electron beam or γ
irradiation.[117] Physically crosslinked PVA hydrogels were developed by freezethawing the PVA aqueous solutions or by annealing the dried film. [118, 119]
Furthermore, cytocompatable PVA based hydrogels for cell encapsulation were
fabricated by photo-crosslinking of modified PVA chains. [120, 121] Self complementary
β-sheet forming peptides and amphiphilic peptides have been used to synthesize
physically bonded fibrous gels. [122, 123] The properties of peptide based gels were
influenced by the hydrophobicity and flexability of the aminoacids within the peptide
structure. [124, 125].
2.5. PHYSICALLY CROSSLINKED HYDROGELS
Physically crosslinked hydrogels are composed of macromonomers crosslinked
through non-covalent bonds including hydrophobic, ionic or hydrogen bonds. Physically
bonded macromonomers are capable of phase transition in response to external stimuli
such as temperature, pH and ionic strength. Collagen and gelatin are thermo-sensitive
natural gels and undergo gelation at physiological temperature. [105, 106] Aqueous
solutions of Poly(N-isopropylacrylamide) (PNIPAAm) form thermo-sensitive physical
gels with increasing the temperature above 32°C that is the Lower Critical Solution
Temperature (LCST) for the aforementioned polymer solutions. [126, 127] The number
of water molecules bound to isopropyl side chains of PNIPAAm decreases and inter-
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molecular hydrophobic interactions increases with increasing the temperature above
LCST that causes micro-phase separation and gelation.[128] Solutions of micelle forming
block copolymers such as PEO-PPO-PEO or PEO-PLGA-PEO were shown to have
reversible thermogelling properties.[129] Triblock copolymers containing a hydrophilic
middle block and two hydrophobic blocks at the chains ends such as PPO-PEO-PPO or
PCL-PEO-PCL underwent micelle formation with bridge and loop conformations in the
aqueous solutions and formed gels with increasing the temperature due to the
hydrophobic effect.[126]
Hydrogels based on Polyacrylic acid or macromonomers with amine group on the
backbone are examples of pH responsive gels. The weak acidic or basic side groups on
pH sensitive macromonomers undergo a transition from neutral to charged, leading to a
structural transition from collapsed to extended chains with increasing or decreasing the
pH respectively. [128, 130] β-sheet forming and surfactant like peptides were desi
gned to form physical gels through hydrogen bonding and hydrophobic interactions. For
example, peptides with alternating Arginine-Alanine-Aspartate (RAD) residues with 16
amino acids (RADA)4 and (RARADADA)2 with 1-10 mg/mL peptide concentration
formed fibrous gels with 10-20 nm fiber diameter in physiological medium or in salt
solution [123]. The self-assembly of aforementioned peptides to nanostructured gels was
governed by inter-molecular hydrogen bonding between peptides‟ backbone in β-sheets,
ionic interactions between the charged side chains on one side of β-sheets and
hydrophobic interactions between hydrophobic side chains at the other side of β-sheet
[123, 131, 132]. Solutions of a peptide with an alkyl tail of 16 carbon atoms and a head
composed of 4 consecutive cysteines, 3 glycines, a serine and a segment of arginine-
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glycine-aspartic acid (RGD) underwent self-assembly to form nanofibrous gels upon
decreasing pH below 4 [122].
2.6. COVALENTLY CROSSLINKED HYDROGELS
Crosslinks can be generated by chemical reactions and formation of covalent
bonds between macromonomers. Covalently crosslinked gels are significantly stiffer than
those that are physically crosslinked [88, 133]. In addition, degradability of covalentlycrosslinked gels can be controlled independently of gelation by the molecular weight and
ratio of hydrophobic/hydrophilic domains [134-136]. Covalently crosslinked hydrogels
have been synthesized using different types of reactions including conventional free
radical reaction, Michael-type conjugation and click reaction.[110] The free radical
reaction for synthesis of hydrogels can be initiated using redox or photo-initiators. [56,
137, 138] Synthetic or natural polymers modified with acrylate or methacrylate groups at
the chain ends or fumarate groups on the backbone have been crosslinked via redox
initiated free radical polymerization. For instance, acrylated PEG-PLA, oligo
polyethylene glycol fumarate, PEG-PLA famarate and methacrylated chitosan were
crosslinked using ammonium persulfate (APS, redox initiator) and tetramethylethylene
diamine (TEMED, radical catalyst). [139-142] Advantages of photo-initiated reactions
over redox-initiated ones include spatial and temporal control on the crosslinking reaction
and faster gelation time. [143] Different photo-initiators including 2,2-Dimethoxy-1,2diphenylethan-1-one (IRGACURE 651) [137], 1-[4-(2-Hydroxyethoxy)-phenyl]-2hydroxy-2-methyl-1-propane-1-one

(IRGACURE

2959)

[35,

144,

145]

and

eosin/triethanolamine [146] were used for photo-crosslinking of macromonomer to
synthesize hydrogels. Free radical photo-initiation was performed under visible light
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[147] , UV [35, 52] or argon laser [146]. Acrylated or methacrylated PEG [148, 149],
poly(ethylene oxide-co lactide-co glycolide) [52], poly(ethylene oxide-co lactide )
fumarate [150], methacrylated gelatin[151], methacrylated hyaluronic acid[152] and
methacrylated alginate[152] were used for synthesis of photo-crosslinked hydrogels.
Acrylate or methacrylate functionalized macromers were crosslinked to thiol or amine
functionalized macromers through Michael addition.[110, 153, 154] Furthermore, click
chemistry was applied to synthesize hydrogels from PEG based macromers
functionalized with acetylene and azide functional groups. [155]
2.7. MICELLAR HYDROGELS
A-B-A triblock copolymers can form micellar gels in selective solvents [156,
157]. These micelles are responsive to pH and temperature depending on the nature of
“A” and “B” blocks. The formed micelles pack into an ordered phase at high
concentrations (higher than 20 wt%) and form a gel when the “A” block is solvophilic
[156, 158]. However, when the “B” block is solvophilic, gelation takes place by bridge
formation between the micelles [159, 160]. Micelle formation in A-B-A triblock
copolymers is illustrated schematically in Figure 2.3. At low concentrations, the block
copolymers are freely dissolved in the solvent. As the concentration exceeds the critical
micelle concentration (CMC), the solvophobic “B” blocks aggregate and form the core of
the micelles and the solvophilic “A” blocks form the shell or corona.[161] Each
macromer chain adopts one of four possible conformations: bridge, loop in which two
chain ends are in the same micelle, tethered in which one chain end is free and free chains
(see Figure 2.3.b and 2.3.c). The probability of bridge formation as well as total number
of bridges increase with increasing the macromer concentration[162]. The increase in
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macromer concentration beyond a finite percolation threshold leads to the formation of a
transient micellar network cross-linked by inter-micellar bridges (see Figure 2.3.c). Each

Figure 2.3. (a) Schematic diagram of an A-B-A triblock copolymer with solvophilic
block B (green) and solvophobic block A (brown); (b) conformation of chains in A-B-A
triblock copolymer chains in solution and formation of micellar structure by aggregation
of solvophobic A blocks; (c) formation of a physical network in a solution of A-B-A
triblock copolymers by aggregation and micelle formation of solvophobic A blocks.
Solvophilic (B block) and solvophobic (A block) segments of the copolymer are shown
in green and brown, respectively.(reprinted from [161])
bridge in a transient network has a finite residence time in the micelle. The stability of
physical cross-links increases with increasing the solvophobicity and length of the
solvophobic segment. A transient network of micelles is mechanically reinforced and
permanently stabilized by the formation of covalent bonds within the core of the micelles.
The confinement of the crosslinking reaction inside the micelle cores imparts unique
features to the hydrogel. In the case of degradable hydrophobic segments, degradation of
the hydrogel network is confined to the micellar domains. Furthermore, the cytotoxic low
molecular weight molecules are not exposed to the live cells with positioning within the
hydrophobic micelles‟ cores. [51]
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2.8. HYDROGEL SWELLING AND MESH SIZE
Hydrophilic macromonomers are individually soluble in water or other selective
solvents. However, the solubility of hydrophilic macromers decreases with formation of
crosslinks and increasing the average molecular weight of the chains. When the degree of
crosslinking exceeds the critical point of gelation, the resulting polymeric network can
not be dissolved in water or selective solvents but it swells (see Figure 2.4). The degree
of swelling (or water content) of a hydrogel is controlled by two opposing forces, namely
thermodynamic force of mixing between polymer-water and elastic force of the extended
polymer chains. The force of mixing tends to increase the water content of the gel by
attractive interactions between water molecules and the network chains [80].

Figuure 2.4. Schematic representation of the swelling of a crosslinked network and the
mesh size.
The elastic force of the polymeric chains on the other hand tends to decrease the
water content of the gel due to the extension of favorable random coil chain
conformation. The difference in the chemical potential of the gel penetrating solvent is
given by: [80, 163]

1  1,0   mixing   elastic

equation 2.1

where 1 is the chemical potential of solvent within the polymeric gel, 1, 0 is the
chemical potential of the pure solvent, mixing is the change of chemical potential caused
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by mixing and elastic is the change of chemical potential due to the presence of elastic
retractive forces of the polymer chains. At equilibrium, the difference between the
chemical potential of the solvent inside and outside of the gel (left hand side of the
equation 1) is zero. In other words, force of mixing and elastic force of extended chains
become equal at equilibrium. Several factors including molecular weight, hydrophobicity,
functionality and flexability of the macromonomers, degree of crosslining, nanostructure
of the gel and temperature affect the swelling of hydrogels.[55, 164] Specifically, the
swelling of hydrogels decreases with increasing the hydrophobicity of the chains and
degree of crosslining (crosslinking density) through influencing the force of mixing and
the elastic force of the chains respectively. [163]
The molecular weight between crosslinks ( M c ) can be found from equation 2.2
which is derived via incorporation of thermodynamic of mixing and theory of rubber
elasticity into equation 2.1. [163]
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equation 2.2

where M n is the number average molecular weight of the chains,  is the specific volume
of the polymer, V1 is the molar volume of solvent,  2, s is the polymer volume fraction in
the swollen state and 1 is the Flory-Huggins interaction parameter between the polymer
and solvent.

The mesh size of a gel, the average distance between two adjacent

crosslinks (see Figure 2.4), can be obtained following determination of M c from equation
2.2 by using:[163]
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equation 2.3

where Cn , M r and l are the Flory characteristic ratio, molecular weight of the repeating
unit and length of the bond along the polymer backbone respectively. The degree of
swelling and mesh size of the hydrogels are particularly important variables for
controlling the diffusion rate of nutrients, oxygen, growth factors and waste products into
or out of the cell-laden hydrogels in tissue engineering applications. [165, 166]
2.9. MECHANICAL PROPERTIES OF HYDROGELS
Mechanical properties of tissue engineering hydrogels need to be optimal to
prevent deformation or rupture of the construct and at the same time keep the cells viable
while tailoring them to a specific lineage.[167] It is well established that the stiffness of
3D matrix affects fate of the encapsulated cells. For instance, MSCs encapsulated in
alginate hydrogels underwent adipogenic differentiation when the elastic modulus of the
matrix was 2.5-5 kPa whereas they went through osteogenic differentiation in the gels
with elastic modulus of 11-30 kPa.[75]
When a constant stress is applied on a hydrogel, an instantaneous strain is
followed by an increasing strain over time.[168] Since hydrogels exhibit both viscous
and elastic behaviors they are classified as viscoelastic materials. The time dependant (or
frequency dependant in dynamic tests) response of hydrogels to an external force is
related to the time needed for macromolecular motions. At short time scales, polymeric
chains cannot be relaxed under an external force whereas at longer times polymeric
chains have time to become relaxed.[168] The elastic behavior of hydrogels can be
elucidated using the rubber elasticity theory which was developed by Treloar and
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Flory[80] and modified by Peppas and Merrill[163]. The elastic behavior of a water
swollen crosslinked gel is given by:

RT  2M c
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equation 2.4

Where  is the stress,  , R , T ,  and  2,r are the polymer density, gas universal
constant, absolute temperature, elongation ratio and the polymer volume fraction before
swelling respectively. Based on the constitutive relationships, the shear modulus (G)
is:[168]
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equation 2.5

According to equation 2.5 the modulus of hydrogels is inversely correlated with
molecular weight between crosslinks ( M c ). Therefore, the shear modulus of the
hydrogels increases with increasing the density of crosslinks (decreasing M c ). The
crosslink density can be enhanced with increasing the macromonomer concentration,
macromonomer functionality or incorporation of multi-functional crosslinkers in the
solution.[52] It is worth mentioning that intra-molecular reactions lead to the formation
of loops that do not contribute to the network elasticity [150, 162]. Therefore, an increase
in the probability of intra-molecular crosslinking through a decrease in macromonomer
molecular weight or macromonomer concentration negatively affects the mechanical
properties of hydrogel networks.[35]
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2.10. DEGRADATION OF HYDROGELS
Although hydrogels provide flexibility in controlling the cell microenvironment,
their use for in vivo applications in tissue engineering is limited by their persistence in the
site of regeneration.[30] Therefore, hydrogels for tissue engineering applications need to
be degradable with a degradation rate matched with tissue formation (ECM production)
and remodeling. ECM production is limited by free volume when rate of matrix
degradation is slower than that of ECM production. Conversely, ECM production is
limited by cell adhesion when rate of matrix degradation is faster than that of ECM
production. [102, 169] The essential role of matrix degradation in determining the cell
fate has been shown for different cell lines. For example , the C2C12 mouse myoblast
cells encapsulated in a degradable alginate gel had a higher extent of differentiation into
myotubes and lower proliferation than those encapsulated in a non-degradable gel [170].
Similarly, MSCs encapsulated in a non-degradable hyaluronic acid (HA) gel did not
spread and underwent adipogenic differentiation whereas those MSCs encapsulated in a
degradable HA gel spread and differentiated to the osteogenic lineage [171].
Natural hydrogels are mostly enzymatically degradable. For instance,
myofibroblast cell-laden fibrin gels were degraded after 2 days in the absence of inhibitor
for enzymatical degradation. [172] Hyaluronic acid based hydrogels are degradable by
hyaluronidase enzyme.[173] Gelatin based hydrogels were completely degraded over 6
hours in collagenase solution. [100] Alginate gels were degraded by alginase enzyme
released from PLGA microspheres and the gel degradation rate increased with increasing
the alginase loading concentration.[174]
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Synthetic hydrogels can be made degradable with incorporation of enzymatic,
hydrolytic or photolytic degradable segments into the macromonomer chains or
crosslinkers. [175] For instance, Matrix Metalloproteinase (MMP) sensitive peptide was
incorporated into the non-degradable PEG hydrogel using Michael addition reaction to
make the gel enzymatically degradable. [176, 177] Fibroblast cells were shown to
migrate within the MMP-sensitive PEG gels whereas the migration was limited within
the non-degradable PEG gels or when the enzymatic degradation was inhibited. [176]
Degradable PEG based gels were synthesizd with incorporation of poly(α-esters). For
example, Copolymerization of PEG with poly(lactide) (PLA) has been used to impart
degradability to PEG macromers. The degradation and water content of the copolymers
could be adjusted by the fraction of hydrophobic lactide segments,[88, 178] but solubility
of the copolymers in aqueous solution decreased with increasing lactide content.[56]
Hydrogels synthesized from PEG and Ɛ-caprolactone co-polymers were shown to be
hydrolytically degradable, but the degradation rate was limited by the hydrophobicity of
Ɛ-caprolactone

and formation of micellar aggregates in the solution.[179] Hydrogels

based on PEG macromers co-polymerized with 5-15% (wt) glycolide underwent
complete degradation over 2 to 8 days.[51] Due to a relatively fast degradation rate and
hydrophilicity of the glycolide monomer, that has been extensively used with lactide or
caprolactone for adjusting the degradation rate and water content of hydrogels.[52, 180,
181] In addition to poly(α-esters) , other hydrolytically degradable polymers including
poly(ester amide)[182], polyphosphoester [183, 184], poly(amino-ester urethane) [185]
were used to synthesize degradable hydrogels. Furthermore, photodegradable hydrogels
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were synthesized with incorporation of a nitrobenzyl-ether-derived moiety into the PEG
based hydrogels.[186]
Tissue engineered constructs often times require multiphase hydrogels with
different but complementary microenvironments. For example, osteogenic differentiation
of MSCs requires a supporting matrix with high compressive modulus and slow
degradation [187] whereas vasculogenic differentiation of progenitor endothelial cells
necessitates a low modulus, relatively fast-degrading matrix [100, 188]. This presents a
need to develop synthetic hydrogels with tunable degradation and stiffness for wideranging applications in regenerative medicine.
2.11. BIOACTIVE MODIFICATION OF HYDROGELS
It is well established that cell-matrix interactions within a cell-laden hydrogel play
a significant role in regulating cell function.[189, 190] In natural ECM, cell adhesive
proteins such as laminin and fibronectin bind to the integrin cell surface receptors.[189,
191] It has been shown that cell-matrix attachment is crucial for cell proliferation and
differentiation.[192] Furthermore, soluble or tethered growth factor proteins, present in
the natural ECM, modulate cell functions including proliferation, migration and
differentiation.[193]
Natural gels such as collagen, gelatin and fibrin possess cell-adhesive ligands.
Despite this, it is difficult to adjust the properties of natural gels for a specific application
in tissue engineering. [31] Further, the use of natural gels in regenerative medicine is
limited due to their poor mechanical properties. [194] The properties of synthetic
hydrogels including the matrix stiffness can be tuned for a specific application in
regenerative medicine. However, synthetic hydrogels need to be modified with bioactive
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ligands for optimal cell-matrix interactions. [195] A number of cell-adhesive peptides
derived from laminin, fibronectin, elastin and collagen proteins have been incorporated
into the synthetic inert hydrogels.[195] For example, when Arg-Gly-Asp (RGD), a
laminin and fibronectin derived adhesive peptide, was added to PEG hydrogels the
adhesion and mieralization of encapsulated osteoblest cells significantly increased. [17]
The viability of human mesenchymal stem cells (hMSCs) was significantly higher in
RGD modified PEG gels compared with non-modified PEG gels. [196] The viability and
insulin secretion of β-cells significantly increased when acrylate terminated IKLLI and
IKVAV cell-adhesive peptides were conjugated to the cell-laden PEG hydrogel. [197]
In addition to the cell-adhesive ligands, growth factors or growth factor derived
peptides have been incorporated into the synthetic hydrogels to direct the stem cells into a
specific liniage. A conjugation of SVVYGLR osteopontin derived peptide to the PEG
based hydrogel, stimulated the formation of new blood vessels by encapsulated human
umbilical vein endothelial cells (HUVECs). [198] Similarly, the vasculogenic
differentiation of MSCs seeded on a PEG hydrogel increased when the osteopontin
derived peptide was grafted to the hydrogel. [199] The collagen and glycosaminoglycan
production by hMSCs increased significantly when KLER, a chondro-inductive decorin
derived peptide, was incorporated into the PEG cell-laden hydrogels.[200] MSCs seeded
on PEG hydrogels modified with RGD and an osteo-inductive BMP-2 protein derived
peptide, KIPKASSVPTELSAISTLYL, showed 5 and 12 fold increase in ALP activity
and calcium content after 14 and 21 days respectively. [113] The aformentioned BMP-2
derived peptide tethered to alginate gels induced new bone formation after 4 weeks in a
rat tibial bone defect. [201, 202]
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CHAPTER 3
SYNTHESIS AND GELATION CHARACTERISTICS OF PHOTO-CROSSLINKABLE
STAR POLY(ETHYLENE OXIDE-CO-LACTIDE-GLYCOLIDE ACRYLATE)
MACROMONOMERS

Seyedsina Moeinzadeh, Saied Nouri Khorasani, Junyu Ma, Xuezhong He, Esmaiel
Jabbari, Synthesis and gelation characteristics of photo-crosslinkable star Poly (ethylene
oxide-co-lactide-glycolide acrylate) macromonomers. Polymer, 2011. 52(18): 3887-3896.
Reprinted here with permission of publisher.
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3.1. INTRODUCTION
A novel approach to tissue regeneration is the use of injectable in situ
crosslinkable hydrogels as a carrier for the delivery of therapeutic agents and cells [28,
203]. Less invasive injectable gels coupled with minimally invasive arthroscopic
techniques are an attractive alternative to implantation of pre-formed polymers for
treating irregularly shaped or inaccessible defects [27, 87, 204, 205]. Furthermore,
diffusivity of nutrients [206, 207] and proteins [166, 208] in hydrogels is 4-5 orders of
magnitude higher than solid polymers, thus providing a supportive matrix for
differentiation, proliferation, and maturation of seeded cells into the desired tissue [209].
In addition, hydrogels can be reinforced with calcium phosphate nanoparticles to produce
injectable cements for hard tissue applications [28, 210, 211].
Biodegradable polymers are widely used as a supportive carrier in tissue
engineering and drug delivery [49, 212-215]. Among them, poly(lactide-co-glycolide)
(PLGA) is the most widely used biodegradable polymer because its degradation products
(lactic and glycolic acid) are resorbed through metabolic pathways [216, 217]. PLGA and
poly(ε-caprolactone) (PCL) polymers have been copolymerized with poly(ethylene
oxide) (PEO) to produce amphiphilic macromers that form thermally-induced physical
gels [136, 218, 219]. Studies concerning the effect of macromer structure on water
content and modulus [218, 220] demonstrate that physically crosslinked gels are
significantly weaker than those that are chemically crosslinked [88, 133], limiting them
for use in non load-bearing biomedical applications. In addition, degradability of
chemically-crosslinked gels can be controlled independent of gelation by the molecular
weight and ratio of hydrophobic/hydrophilic domains [134-136]. To control the hydrogel
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water content (and therefore mechanical strength), degradation rate and the rate of
crosslinking, our laboratory has previously developed a poly(lactide-co-ethylene oxide
fumarate) (PLEOF) macromonomer consisting of low molecular weight poly(L-lactide)
(LMW-PLA) and PEG blocks linked by unsaturated fumarate units [88, 205]. The water
content of the PLEOF hydrogel could be adjusted by the ratio of hydrophilic PEG to
hydrophobic PLA blocks and by PEG molecular weight [88]. Degradation rate of the
network could be controlled by the ratio of PLA to PEG blocks or by the molecular
weight of PLA segments [88]. However, due to steric hindrance of the fumarate groups
along the chain and their lower reactivity (compared to acrylates and methacrylates) [88,
221, 222], the gelation kinetics depended strongly on UV initiator and small molecule
monomer concentrations [88]. It is well established that the viability of cells encapsulated
in synthetic gels is largely determined by the fraction of small-molecule initiators and
monomers that cross the cell membrane [42, 223].
Terminal reactive groups at chain ends are less sterically hindered compared to
those along the macromonomer chain. The reactivity of acrylates is an order of
magnitude higher than fumarates [88, 141, 205]. In addition, star macromonomers have
lower shear viscosity than linear ones at the same molecular weight [224], resulting in the
onset of gelation at higher conversions and a higher extent of crosslinking. We
hypothesized that a multi-arm star amphiphilic poly(ethylene oxide-co-lactide-glycolide)
based macromonomer each arm terminated with an acrylate group would significantly
increase the rate of crosslinking, thus reducing the minimum required concentration of
initiator/monomer to produce robust networks. The objective of this work was to
synthesize a novel star poly(ethylene oxide-co-lactide-glycolide acrylate) (SPELGA)
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macromonomer and investigate the effect composition had on gelation kinetics and
degradation of the hydrogels. In this work, SPELGA macromonomer was synthesized by
ring-opening polymerization of lactide and glycolide monomers using hydrophilic
pentaerythritol ethoxylate or poly(ethylene glycol) initiators, followed by acrylation of
the chain ends with acryloyl chloride. The structure of the synthesized macromonomers
was characterized by 1H-NMR and GPC. The kinetics of photopolymerization of the
SPELGA macromonomers in aqueous solution was investigated by rheometry. The
SPELGA hydrogels were characterized with respect to sol fraction, swelling and
degradation.
3.2. EXPERIMENTAL
3.2.1. MATERIALS
Lactide (LA; >99.5% purity by GPC) and glycolide (GL; >90% purity) monomers
were purchased from Ortec (Easley, SC) and Boehringer Chemicals (Ingelheim,
Germany), respectively. The ring opening polymerization initiators 4-arm pentaerythritol
ethoxylate (PEE800; 15/4 EO/OH; Mn=797 Da; purity >98%) and 4-arm poly(ethylene
glycol) (4PEG5K; nominal molecular weight of 5 kDa; purity >98%) were purchased
from Sigma-Aldrich (St. Louis, MO), respectively. The initiators were dried by
azeotropic distillation from toluene prior to the reaction. Triethylamine (TEA), tin (II) 2ethylhexanoate (TOC), N-vinyl-2-pyrrolidone (NVP), and acryloyl chloride were
purchased from Sigma-Aldrich. Methylene chloride (MC; VWR) was dried by distillation
over calcium hydride (Sigma-Aldrich). All other solvents were reagent grade and used as
received.
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3.2.2. SYNTHESIS OF SPELGA MACROMONOMER
Star

poly(ethylene

oxide-co-lactide-glycolide)

(SPELG)

macromer

was

synthesized by ring-opening polymerization of LA and GA monomers with star 4PEE800
or 4PEG5K initiators, following a procedure similar to the synthesis of low molecular
weight poly(L-lactide) [205, 225, 226]. The schematic diagram for the synthesis of
SPELG with 4PEE800 is shown in Figure 3.1. TOC was used as the polymerization
catalyst and LA/GL ratio was 100/0 for SPELGA-5K and 100/0, 75/25, 50/50 for
SPELGA-800. In a typical procedure for the synthesis of 100/0 SPELGA, 30g LA
(0.2084 mol) and 0.0116 mol initiator (7 ml 4PEE800 or 58 g 4PEG5K) were added to a
three-neck reaction flask equipped with an overhead stirrer. The reaction flask was
submerged in an oil bath and gradually heated to 110-120ºC to melt the monomers while
under steady flow of nitrogen. After melting, 3 ml TOC as the polymerization catalyst
was added to the reaction mixture with stirring. The reaction was allowed to proceed for
6 h at 135ºC. Upon completion, the product was dissolved in DCM and precipitated in ice
cold methanol, ether, and hexane to fractionate the PLA product and remove the
unreacted monomer and initiator [225]. The solvent was decanted and the star SPELG
product was vacuum dried (<5 mmHg) to remove any residual solvent and stored at 20ºC. With TEA as the reaction catalyst, the chain ends of the star SPELG were acrylated
by the reaction of acryloyl chloride with the hydroxyl end-groups of the SPELG (see
Figure 3.1). Prior to this reaction the SPELG macromer was dried by azeotropic
distillation from toluene to remove residual moisture. The polymer was cooled under
steady flow of nitrogen and dissolved in dried DCM. The reaction flask was immersed in
an ice bath to limit a temperature rise from the exothermic reaction. In a typical reaction
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Figure 3.1. Reaction scheme for the synthesis of SPELGA macromonomer. The 4-arm
PEG, lactide-co-glycolide segments, and terminal acrylate groups are shown by black,
red, and blue colors, respectively.
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5.6 ml acryloyl chloride and 9.7 ml TEA, each dissolved in DCM, were added drop-wise
to the reaction with stirring. The reaction was allowed to proceed for 12 h under nitrogen
flow. After completion of the reaction the solvent was removed by rotary evaporation and
the residue was dissolved in anhydrous ethyl acetate to precipitate the by-product
triethylamine hydrochloride salt. Next, ethyl acetate was removed by vacuum distillation;
the macromonomer was re-dissolved in DCM and precipitated twice in ice cold ethyl
ether. The macromonomer was dissolved in dimethylsulfoxide (DMSO) and further
purified by dialysis to remove any unreacted acrylic acid. The SPELGA product was
dried in vacuum (<5 mmHg) to remove residual solvent and stored at –20°C.
3.2.3. MACROMONOMER CHARACTERIZATION
The chemical structure of the SPELGA macromonomer was characterized by a
Varian Mercury-300 1H-NMR (Varian, Palo Alto, CA) at ambient conditions with a
resolution of 0.17 Hz as described [205]. The sample was dissolved in deuterated
chloroform (Sigma-Aldrich, 99.8% deuterated) at a concentration of 50 mg/ml, and 1%
v/v trimethylsilane (TMS; Sigma-Aldrich) was used as the internal standard. The
molecular weight distribution of the macromonomer was measured by GPC [205].
Measurements were carried out with a Waters 717 Plus Autosampler GPC system
(Waters, Milford, MA) connected to a model 616 HPLC pump, model 600S controller,
and a model 410 refractive index detector. The columns consisted of a styragel HT guard
column (7.8 x 300 mm, Waters) in series with a styragel HR 4E column (7.8 x 300 mm,
Waters) heated to 37C in a column heater. The Empower software was used for
determination of number ( M n ) and weight ( M w ) average molecular weights and
polydispersity index (PI). The sample (20 l) with a concentration of 10 mg/ml in
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tetrahydrofuran (THF) was eluted with degassed THF at a flow rate of 1 ml/min.
Monodisperse polystyrene standards (Waters) with peak molecular weights (Mp) of 0.5819.9, 66.35, and 143.4 kDa and polydispersities of <1.1 were used to construct the
calibration curve.
3.2.4. SPELGA GELATION
The SPELGA macromonomer was crosslinked in aqueous solution by free-radical
UV polymerization with 4-(2-hydroxyethoxy) phenyl-(2-hydroxy-2-propyl) ketone
(Irgacure 2959; CIBA, Tarrytown, NY) photo-initiator [88, 141, 211]. The photo-initiator
was dissolved in distilled deionized (DI) water at 50ºC. The SPELGA macromonomer
was dissolved in DI water by vortexing and heating to 50ºC to aid dissolution. The
initiator solution was added to the SPELGA solution, this mixture was then vortexed and
loaded on the Peltier plate of the rheometer. To make 10, 15, and 20% SPELGA
precursor solution, 30, 45, and 60 mg of the macromonomer solution was added to 270,
255 and 240 ml of the initiator solution, respectively. In samples with NVP added as a
crosslinking agent, the initiator was first dissolved in the desired amount of NVP before
addition to the macromonomer solution. The sample was irradiated with a BLAK-RAY
100-W mercury long wavelength (365 nm) UV lamp (Model B100-AP; UVP, Upland,
CA) [88]. The notation “SPELGAa-Lb-Mc-Nd-Ie” is used to identify the composition of
the samples, where a, b, c, d and e represent initiator molecular weight, lactide fraction
and macromonomer molecular weight, NVP and initiator concentrations (wt%),
respectively. The results are for SPELGA, NVP and initiator concentrations of 25 wt%, 0
mol%, and 0.16 mol%, respectively, unless otherwise specified.
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3.2.5. RHEOLOGICAL MEASUREMENTS
Rheological measurements were carried out at 37°C on an AR-2000 rheometer
(TA Instruments, New Castle, DE) equipped with a parallel plate geometry (acrylic plate
transparent to UV light; 20 mm diameter; TA Instruments) [88]. A sinusoidal shear strain
profile was exerted on the sample via the upper geometry at a constant frequency of 1 Hz.
The deformation amplitude was kept at 1% to remain within the linear viscoelastic
region. The polymerizing mixture was injected on the Peltier plate and the upper
geometry was lowered to a gap of 500 µm. The sample was irradiated with a long
wavelength UV lamp (Model B100-AP; UVP, Upland, CA) as described above. The
elapsed time between mixing/injection and the start of data collection was ≤1 min for all
experiments. The storage modulus (G‟) during the gelation process was monitored by the
rheometer. The intensity of the transmitted UV light was measured by a BLAK-RAY
long wave ultraviolet radiation meter (Model J-221; UVP). The transparency of the
acrylic geometry to long wave (365nm) UV light was confirmed by comparing the
intensity of the transmitted light through the geometry to the incident light (transmitted
intensity was >95%). The measured UV intensities at distances of 10, 30, 35, and 40 cm
from the lamp were 46,000, 5,300, 4,000, and 3,000 µW/cm2, respectively. We have
previously shown that a UV intensity of 46,000 µW/cm2 applied 10 cm from the sample
and exposure time of 1800 s results in the highest extent of crosslinking [88]. Therefore,
all gelation results are with UV intensity, distance, and exposure time of 46,000 μW/cm2,
10 cm, and 1800 s, respectively. In the text,”modulus” is defined as the storage shear
modulus of the sample after 1800 s of UV radiation.
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3.2.6. MEASUREMENT OF SWELLING RATIO AND SOL FRACTION
After crosslinking, samples with dimensions 20 mm diameter × 300 µm thickness
were removed from the Peltier plate to measure their swelling ratio and sol fraction.
Samples were dried at ambient conditions for 12 h followed by drying in vacuum for 1 h
at 40°C and the total dry weights ( Wi ) were recorded. Next, dry samples were swollen in
DI water for 24 h at 37°C and swelling medium changed every 6 h. After swelling the
surface water was removed and the swollen weight ( Ws ) was recorded. Then, the swollen
samples were dried as described above and the dry weight ( Wd ) were recorded. The
weight swelling ratio (Q) and sol fraction (S) were calculated by the following equations:

Q

Ws  Wd
100
Wd

equation 3.1

S

Wi  Wd
100
Wi

equation 3.2

3.2.7. MEASUREMENT OF DEGRADATION
The SPELGA precursor solution was degassed, transferred into a PTFE mold
(3cm × 5cm × 750µm), covered with a transparent glass plate fastened with clips, and UV
crosslinked as described above. After crosslinking the sample was removed from the
mold and disks were cut from the gel using an 8 mm cork borer. Degradation was
measured as a function of time in primary culture media (5 ml per sample) without fetal
bovine serum (FBS) at 37°C under mild agitation. To prepare the primary media 13.4 g
of Dulbecco‟s Modified Eagle Medium (DMEM; 4.5 g/l glucose with L-glutamine and
without sodium pyruvate; Mediatech, Herndon, VA) was dissolved in 900 ml of DI water
containing 3.7 g sodium bicarbonate and 10 ml antibiotic and antimycotic agent (1% v/v).
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At each time point samples were removed from the media, rinsed with DI water to
remove excess electrolytes, and dried under vacuum. The dry sample weight was
recorded and compared with the initial dry weight to determine fractional mass remaining
with respect to time.
3.3. RESULTS
The 1H-NMR spectrum of SPELGA800-L50 is shown in Figure 3.2. The
chemical shifts with peak positions at 1.6 and 5.2 ppm were attributed to the methyl (CH3) and methine (  CH ) hydrogens of the lactide units in SPELGA, respectively [227].
The shift centered at 4.8 ppm was attributed to the methylene hydrogens (=CH2) of the
glycolide units in SPELGA. The shifts centered at 3.6 and 4.3 ppm were attributed to the
methylene hydrogens (=CH2) of the 4-arm initiator (4PEE800 or 4PEG5K) attached to
the ether (-CH2-O-CH2-) and ester (-CH2-OOC-) groups of lactide/glycolide units,
respectively [227]. The chemical shifts with peak positions from 5.85-6.55 ppm were
attributed to the vinyl hydrogens of the acrylate groups (-CH=CH2) at chain ends; the
latter shifts were absent in the spectra of unacrylated SPELG (see the inset of Figure 3.2).
The relative intensities of the NMR shifts of SPELGA macromonomers are presented in
Table 3.1. The ratio of the shifts centered at 1.6 and 5.2 ppm (lactide hydrogens) to that at
4.8 ppm (glycolide hydrogens) was related to the molar ratio of LA/GL. The ratio of the
shifts centered at 1.6, 5.2, and 4.8 (lactide+glycolide hydrogens) to those at 3.6 and 4.3
ppm (4-arm initiator hydrogens) was related to M n of SPELGA. The ratio of the shifts
centered at 5.85-6.55 ppm (acrylate hydrogens) to those at 3.6 and 4.2 ppm (initiator
hydrogens) was related to the average number of acrylate groups per macromonomer.
The LA/GL molar ratio, M n , and the number of acrylate groups per SPELGA800
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Figure 3.2. NMR spectra for SPELGA800-L50. The inset is the spectra of SPELG800L50 before acrylation.
calculated from the NMR data are given in Table 3.1. For SPELGA800-L50 and
SPELGA800-L75 with feed LA/GL ratios of 1.0 and 3.0, respectively, the actual ratios
from the NMR data were 1.2 and 3.4. The actual LA/GL ratio was slightly higher than
the feed indicating that the reactivity of lactide monomer with the growing chain was
slightly higher than that of glycolide. The number of acrylate groups per macromonomer
for SPELGA800-L50 and SPELGA800-L75 were 3.2 and 3.6, respectively.
M n , M w , and PI of the synthesized SPELGA macromonomers which were

measured by GPC are presented in Table 3.2. M n , M w , and PI of SPELGA800 were
independent of LA/GL ratio. SPELGA5K, due to higher PEG chain length, had the
highest molecular weight and lowest PI. The M n values measured by GPC were within
10% of the values calculated from the intensity of NMR shifts. All SPELGA
macromonomers were dissolved in water, heated to 50ºC and crosslinked into a hydrogel.
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Table 3.1. Relative intensity of the chemical shifts in the NMR spectra of SPELGA
macromers.
NMR shift
(ppm)

5.856.55

5.16

4.77

4.28

3.64

1.56

LA/GL
(NMR)

Macromonomer

Mn
(NMR)

# of
acrylates/
Macromonomer
(NMR)

(LA/GL
feed)
PLGA800L50

---

1.0

2.42

1.52

6.03

1.82

1.2

1910

---

PLGAA800L50

2.93

3.52

9.73

3.51

18.05

8.03

1.2

2260

3.2

PLGAA800L75

2.96

5.64

5.41

3.41

15.81

12.61

3.4

2600

3.6

Table 3.2. M n , M w , and PI of the synthesized SPELGA macromers.
Macromonomer

Mn

Mw

PI

SPELGA800-L50

2490

4460

1.80

SPELGA800-L75

2650

4900

1.85

SPELGA800-L100

2640

4400

1.70

SPELGA5K-L100

6570

9460

1.40

The SPELGA800-L100 with low PEG molecular weight and 100% hydrophobic lactide
fraction was not used in the subsequent gelation experiments due to its low solubility in
aqueous solution. SPELGA5K-L100 had the highest solubility in water as measured by a
turbidity test (data not shown).
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To determine the effect of UV initiator on crosslinking, the gelation kinetics of
SPELGA5K-L100-M25-N0 macromonomer were monitored by rheometry and the results
are shown in Figure 3.3. As the initiator concentration was increased from zero to 0.11,
0.16, and 0.22 mol%, modulus increased from 1.3±0.3 to 10.0±2.1, 27.1±4.1, and
23.6±4.7, respectively. G‟ initially increased for up to 0.16 mol% initiator concentration
and then decreased for >0.16 mol% concentration. Figures 3.4.a and 3.4.b show the effect
of macromonomer concentration (based on the weight of polymerizing mixture) on the
modulus and sol fraction of SPELGA5K-L100-N0-I0.16 gels, respectively. SPELGA5K,
due to its higher solubility in water, was selected to study the effect of macromonomer
concentration. There was a continuous increase in G‟ with increasing macromonomer
concentration. G‟ increased from 0.16±0.03 to 0.47±0.12, 3.4±0.4, 5.9±1.0, 6.9±0.9,
13.4±2.4, and 27.1±4.1 kPa as the macromonomer concentrations increased from 10 to
12.5, 15, 17.5, 20, 22.5, and 25 wt%, respectively, with 170-fold overall increase in
modulus. Sol fraction decreased from 17.8±1.1 to 15.6±1.5, 12.2±1.6, 13.8±3.0,
12.0±1.2, 9.4±0.9, and 7.6±0.9% as the macromonomer concentration increased from 10
to 12.5, 15, 17.5, 20, 22.5, and 25 wt%, respectively. The sol fraction of the PLEOF
hydrogel with and without NVP monomer is also shown in Figure 3.4.b. SPELGA
macromonomers with higher reactivity and lower steric hindrance of the acrylate groups
had significantly lower sol fraction (S=8-18% in the absence of NVP) compared to
PLEOF without (S=71%) or with (S=39%) NVP. It is well-established that the
diffusivity/mobility of the growing chain affects gelation and the extent of crosslinking
[88, 228]. Therefore, NVP was used to investigate the effect of a small molecule
monomer on the plateau shear modulus of SPELGA hydrogels. Figures 3.5.a and 3.5.b
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Figure 3.3 The effect of UV initiator concentration on shear storage modulus of
SPELGA5K-L100-M25-N0 hydrogels. The intensity, distance from the sample, and
exposure time of the UV radiation were 46,000 µW/cm2, 10 cm, and 1800 s, respectively.
Values are the mean of three samples with error bars representing one standard deviation
from the mean.
show the effect of NVP concentration on the evolution and plateau modulus of
SPELGA5K-L100-M25-I0.16 hydrogels, respectively. Addition of only 0.4 mol% NVP
(0.004 moles NVP per mole of solution) to the polymerization mixture increased the
modulus 2.2-fold from 27±4 (no NVP) to 60±10 kPa but the modulus did not change
appreciably for concentrations >0.4 mol%. The gelation time of the samples was <60 s
for all NVP fractions (50, 35, and 41 s for zero, 0.4, and 0.61% NVP, respectively).
Based on Figure 3.5.a, addition of 0.4 mol% NVP affected modulus after the gelation
point, but the curves were almost identical for higher NVP fractions. The effect of
initiator molecular weight and LA/GL ratio of SPELGA-M15 on modulus is shown in
Figure 3.6. SPELGA5K had a significantly lower modulus (3.3±0.4 kPa) compared to
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Figure 3.4. The effect of macromonomer concentration on the modulus (a) and sol
fraction (b) of SPELGA5K-L100-N0-I0.16 hydrogel. The open square and open circle in
(b) are the sol fractions of PLEOF hydrogels crosslinked without (17.5%
macromonomer) and with (21% macromonomer) 4.1 mol% NVP crosslinker,
respectively. The intensity, distance from the sample, and exposure time of the UV
radiation were 46,000 µW/cm2, 10 cm, and 1800 s, respectively. Values are the mean of
three samples with error bars representing one standard deviation from the mean.
SPELGA800 (11.6±3.0 and 15.4±3.2 for SPELGA800-L75 and SPELGA800-L50,
respectively). This can be attributed to the higher molecular weight of SPELGA5K
compared to SPELGA800, resulting in lower density of reactive acrylate groups in the
sample.
The effect of initiator molecular weight and LA/GL ratio on sample mass loss
and swelling ratio is shown in Figures 3.7.a and 3.7.b, respectively. SPELGA800-L50
with the highest content of the less hydrophobic glycolide monomer had the highest mass
loss over a period of 7 weeks, followed by SPELGA5K-L100 and SPELGA800-L75. For
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Figure 3.5. The effect of NVP monomer concentration on (a) evolution and (b) plateau
shear storage modulus of SPELGA5K-L100-M25-I0.16 hydrogels. The intensity,
distance from the sample, and exposure time of the UV radiation were 46,000 µW/cm2,
10 cm, and 1800 s, respectively. Values are the mean of three samples with error bars
representing one standard deviation from the mean.
example, after 4 weeks, SPELGA800-L50, SPELGA5K-L100, and SPELGA800-L75 lost
50.0±7.7, 33.0±1.9, and 23±0.4% mass, respectively. The swelling ratios support the
mass loss results with SPELGA5K and SPELGA800-L75 showing the highest and lowest
water contents, respectively. For example, after 4 weeks SPELGA5K-L100,
SPELGA800-L50, and SPELGA800-L75 had swelling ratios of 645, 43, and 7%,
respectively, corresponding to water fractions of 87, 30, and 6 wt%. Interestingly,
SPELGA800 hydrogel showed delayed swelling characteristics, which could potentially
be useful for the design of delayed drug release systems. For example, SPELGA800-L50
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Figure 3.6. The effect of initiator molecular weight and LA/GL ratio of SPELGA
macromonomer on shear storage modulus of SPELGA-M15-N0-I0.16 hydrogels. The
intensity, distance from the sample, and exposure time of the UV radiation were 46,000
µW/cm2, 10 cm, and 1800 s, respectively. Values are the mean of three samples with
error bars representing one standard deviation from the mean.
and SPELGA800-L75 had only 5.7 and 3.8 wt% water content after 4 weeks of
incubation; however, their water content increased to 83 and 11 wt% after 7 weeks.
3.4. DISCUSSION
SPELGA macromonomers crosslinked in the absence of NVP (see Figure 3.5)
produced a relatively high modulus hydrogel (27±4 kPa). The results in Figures 3.3 and
3.5 demonstrate that initiator and NVP concentrations as low as 0.16 and 0.4 mol%,
respectively, produced hydrogels with >10 kPa shear modulus. It should be noted that the
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Figure 3.7. The effect of initiator molecular weight and LA/GL ratio of SPELGA
macromonomer on (a) mass loss and (b) swelling ratio of SPELGA-N0-I0.16 hydrogels.
The intensity, distance from the sample, and exposure time of the UV radiation were
46,000 µW/cm2, 10 cm, and 1800 s, respectively. Values are the mean of three samples
with error bars representing one standard deviation from the mean.
initiator and NVP concentrations used in this study were an order of magnitude lower
than those used for gelation of the linear PLEOF macromonomer [88]. The higher
reactivity of the acrylates in SPELGA compared to fumarates in linear PLEOF reduced
the minimum required concentration of the initiator and NVP to produce robust networks.
It is well established that the viability of cells encapsulated in hydrogels depends strongly
on the concentration of small molecule initiator and monomer that can cross the cell
membrane. Therefore, the lower initiator and NVP concentrations required for gelation
has potential to improve biocompatibility of SPELGA hydrogels for cell encapsulation.
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The modulus initially increased with initiator concentration for up to 0.16 mol%
and then decreased at higher fractions. The dependence of propagation rate, RP , on
initiator concentration in the absence of NVP is given by [229]:

 Ri , AC 
RP  k P , AC [ AC ] 

 kt 

1/ 2

  I 0  [ I ] 
 k P , AC [ AC ] 

kt



1/ 2

equation 3.3

where k P , AC and k t are the rate constant for chain propagation and termination, Ri , AC is
the radical initiation rate, [AC ] is the concentration of unreacted SPELGA acrylates,  is
photo-initiation efficiency,  is molar extinction coefficient, I 0 is incident radiation
intensity,  is gel thickness, and [I ] is the initiator concentration. Higher initiator
concentrations below 0.16 mol% increased the rate of propagation, leading to a hydrogel
with higher network density and higher modulus, as shown in Figure 3.3. At
concentrations above 0.16 mol%, although the propagation rate continued to increase,
there was a higher probability of localized formation of multiple radicals on growing
chains, leading to cluster formation and increased cyclization within those clusters. This
premise is supported by the decrease in gelation time from 460 s to 100, 50 and <30 s, as
the initiator concentration was increased from zero to 0.11, 0.16, and 0.22 mole%,
respectively. The increased cyclization and cluster formation reduced the modulus at
initiator concentrations >0.16 mol%. Wang and collaborators observed a similar effect
when UV intensity was increased above a threshold level in UV photocrosslinked
polyacrylamide gels [230]. Similarly, a reduction in tensile modulus above a certain
initiator concentration was reported for multi-functional methacrylamide, poly(ethylene
glycol), and N-vinyl pyrrolidone hydrogels [231]. Results in Figure 3.3 indicate that the
optimum initiator concentration in the absence of NVP was 0.16 mol%.
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The addition of NVP monomer increased the hydrogel modulus, as shown in
Figure 3.5. At any time there are monomers, linear and branched chains and a gel
network in the polymerization reaction. The four propagation reactions involving the
acrylate groups of NVP monomer and SPELGA macromonomer are given by:

~X

*

~X

*

X

*

X

*

 NVP




k P , As

AC

 NVP



k P ,Vs



kP ,Vg



kP , Ag

AC



~ NVP *

equation 3.4

~ AC *

equation 3.5

 NVP *

equation 3.6

 AC *

equation 3.7

where [NVP] and [AC] are concentrations of unsaturated vinyl groups of NVP and
SPELGA, respectively, and symbols “~” and “>” denote a linear or branch chain in the
sol (not part of the network) and the gel, respectively. For example, ~X* is a growing
chain in the sol with a radical attached to X terminal group, with X being NVP (~NVP*)
or SPELGA acrylate (~AC*). Symbol >X* denotes a growing chain in the gel with a
radical attached to X terminal group. There are also four propagation reactions involving
unreacted acrylates of those SPELGA macromonomers that are part of a chain in the sol
or the gel (~AC or >AC), which are given by:

~X
~X

*

*

 ~ AC
  AC

kP ,br



kP , dc1



~ AC *  br

equation 3.8

 AC *  d .c.

equation 3.9
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 AC *  d .c.
 AC *  n.c.

equation 3.10

equation 3.11

Notation “br” stands for a branch in a chain (not part of the gel). Notations “d.c.”
and “n.c.” denote a dangling (non-load bearing) and a network (load bearing) chain,
respectively. In propagation reactions (3.4) and (3.5), a growing radical in the sol (~X*)
reacts with an NVP and SPELGA monomer, respectively, with rate constants kP,Vs and
kP,As. Reactions (3.4) and (3.5) produce linear or branched polymer chains that dilute the
hydrogel network. In propagation reactions (3.6) and (3.7), a growing radical in the
network (>X*) reacts with an NVP monomer and SPELGA macromonomer, respectively,
with rate constants kP,Vg and kP,Ag, forming dangling radical chains in the network. In
reaction (3.8), a growing radical in the sol reacts with a SPELGA acrylate that is part of a
chain in the sol (~AC) with rate constant KP,br, thus adding a branch to the chain.
Reactions (3.9) and (3.10) form dangling chains attached to the gel by the reaction of a
growing radical in the sol with a SPELGA acrylate in the gel (>AC*; rate constant kP,dc1)
or by the reaction of a growing radical in the gel with a SPELGA acrylate on a chain in
the sol (~AC, rate constant kP,dc2). In reaction (3.11), a growing radical in the network
(>X*) reacts with a SPELGA acrylate in the network (>AC) with rate constant kP,nc
forming a network chain, as shown in Figure 3.8. Since the ratio of NVP/SPELGA vinyl
groups for 0.4, 0.61, and 0.83 mol% NVP is 1.3, 2.1, and 2.7, respectively, reactions (3.4)
through (3.11) all contribute to the polymerization and gelation.
Reactions (3.4), (3.5), and (3.8) produce polymer chains in the sol which act as
diluents and delay the onset of diffusion-controlled polymerization. The delay potentially
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Figure 3.8. Schematic diagram to illustrate the cross-propagation reaction of the polymer
chains in the sol with network-bound SPELGA acrylates to facilitate crosslinking:
scheme a) SPELGA macromonomer with PEG (blue), LA/GL (green), and acrylate (red)
groups; the growing polymer chain is shown with a purple dot at the chain end; scheme
b) a growing chain in the sol (~X*) cross-propagates by reaction with a network-bound
SPELGA acrylate (>AC; reaction 3.9) followed by propagation with SPELGA and NVP
monomers (reactions 3.6 and 3.7) to form a propagating chain bound to the gel; scheme
c) the growing chain in the gel cross-propagates with a network-bound SPELGA acrylate
to form a load-bearing network chain (reaction 3.11). Some SPELGA macromonomers
(4-arm blue stars) are shown with a smaller size for clarity.
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reduces the trapping of reactive acrylate groups in localized SPELGA clusters. This
increases the overall conversion, resulting in a higher storage modulus as shown in Figure
3.5. Nowers and collaborators observed a similar effect when acrylated poly(ethylene
glycol) (PEG) was added to epoxy polymerization [232]. Reactions (3.6) and (3.7) are
propagation reactions between a growing radical on the network with NVP monomer and
SPELGA macromonomer, respectively. In reactions (3.9) and (3.10), a growing radical
on the network cross-propagates with a SPELGA acrylate on a chain in the sol, or a
growing radical in the sol cross-propagates with a SPELGA acrylate on the network to
form a dangling chain attached to the network. In reaction (3.11), a growing radical on
the network (>X*) reacts with a network-bound SPELGA acrylate to form a load-bearing
crosslink point (see Figure 3.8), leading to a hydrogel with a higher modulus (Figure 3.5).
As the NVP fraction is increased beyond a certain value, the delay in the onset of
diffusion-controlled polymerization counteracts the dilution effect of polymer chains in
the sol. Ultimately, this leads to no further increase in modulus (see Figure 3.5 for 0.4,
0.61, and 0.83 mol% NVP). Since the diffusivities of NVP monomer and NVP-rich
growing chains (reactions 3.4 and 3.6) are relatively higher those that of SPELGA
macromonomer and SPELGA-rich growing chains (reactions 3.5 and 3.7), the
propagation reactions (3.6) and (3.7) and the cross-propagation reactions (3.9) and (3.10)
serve as a bridge between the network-bound SPELGA acrylates to increase the number
of network density. Therefore, the higher modulus of the hydrogels in the presence of
NVP can be explained by the dilution effect of polymer chain in the sol to delay the onset
of diffusion-controlled reaction, and by propagation of NVP monomer and growing
chains with network-bound SPELGA acrylates to facilitate crosslinking.
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The average molecular weight between crosslinks, M c , can be determined by the
equation for rubber elasticity [233]:

M c  RT


G'

(1  S )

(equation 3.12)

where  is the macromonomer mass density (1100 kg/m3), G ' is modulus (Pa), R is gas
constant (8.31 J/mol K), T is absolute temperature (310 K), and S is sol fraction (see Eq.
3.2 and data in Figure 3.4.b). Using Eq. (3.12), M c decreased from 97  12 to 43  5 kDa
as the NVP concentration was increased from 0 to 3.6 wt% for SPELGA5K-L100-P25I0.16 hydrogel.
Degradation of SPELGA gels depends on the gel water content and density of
hydrolytically degradable ester linkages. The relatively fast degradation of SPELGA800L50 can be contributed to the high density of degradable LA/GL units (70% LA/GL and
30% 4PEE800), higher content of less hydrophobic glycolide monomer (50% by weight),
and the autocatalytic effect of acidic degradation products [234]. SPELGA5K-L100 with
76% by weight PEG content had high water content (540 wt% swelling ratio after 1 week
as shown in Figure 3.7.b) but low density of degradable lactide units (24%), resulting in a
degradation rate lower than that of SPELGA800-L50. SPELGA800-L75 with a high
density of more hydrophobic lactide groups and low water content (see Figure 3.7.b)
exhibited the lowest mass loss with time.
3.5. CONCLUSION
A novel star poly(ethylene oxide-co-lactide-glycolide acrylate) (SPELGA)
macromonomer was synthesized and characterized with respect to gelation, sol fraction,
degradation, and swelling in aqueous solution. We hypothesized that a multi-arm star
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amphiphilic poly(ethylene oxide-co-lactide-glycolide) based macromonomer with each
arm terminated with an acrylate group would significantly increase the rate of
crosslinking, thus reducing the minimum required concentration of initiator/monomer to
produce robust networks. Addition of only 0.4 mol% NVP to the polymerization mixture
increased modulus by 2.2-fold but modulus did not change appreciably for higher NVP
concentrations. The higher modulus can be explained by the dilution effect of polymer
chains in the sol, to delay the onset of diffusion-controlled reaction, and by propagation
of growing polymer chains with network-bound SPELGA acrylates to facilitate network
formation. It is interesting to note that the minimum NVP concentration of 0.4% was at
least an order of magnitude less than that used in previous studies for gelation of PLEOF
macromonomers. Depending on macromonomer concentration, sol fraction ranged
between 8-18%. The higher reactivity and lower steric hindrance of the acrylates in
SPELGA compared to fumarates in PLEOF significantly reduced sol fraction and
minimum NVP concentration to produce robust networks. SPELGA gels with highest
LA/GL content (SPELGA800-L50) had the highest mass loss but lowest water uptake
with incubation time which was attributed to the high fraction of degradable units and the
autocatalytic effect of acidic degradation products. SPELGA gels with highest LA/GL
content

(SPELGA800-L75

and

SPELGA800-L50)

characteristics.
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CHAPTER 4
GELATION CHARACTERISTICS AND OSTEOGENIC DIFFERENTIATION OF STROMAL
CELLS IN INERT HYDROLYTICALLY DEGRADABLE MICELLAR POLYETHYLENE
GLYCOL HYDROGELS

Seyedsina Moeinzadeh, Danial Barati, Xuezhong He, Esmaiel Jabbari, Gelation
Characteristics and Osteogenic Differentiation of Stromal Cells in Inert Hydrolytically
Degradable Micellar Polyethylene Glycol Hydrogels. Biomacromolecules, 2012. 13(7):
p. 2073-2086. Reprinted here with permission of publisher.
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4.1. INTRODUCTION
The overall goal of this work was to synthesize inert and non-fouling degradable
hydrogels as a matrix for cell encapsulation. Hydrogels are hydrophilic polymeric
networks that retain a significant fraction of water in their structure in physiological
solution without dissolving. Nutrient molecules and proteins diffusive readily through
hydrogels and cells immobilized in hydrogels display higher biological activity.[21-25]
Due to these unique properties, hydrogels are very attractive as a matrix for cell
encapsulation and delivery to the regeneration site in regenerative medicine.[26-30]
Polyethylene glycol (PEG) hydrogels are used extensively as a matrix for cell
encapsulation to elucidate the effect of physiochemical, mechanical, and biological
factors in the microenvironment on cell fate in vitro.[36-39] PEG hydrogels, due to their
inert, hydrophilic and immunogenic nature, provide enormous flexibility in designing and
controlling the cell microenvironment.[40, 41] Unlike small-molecule monomers that
cross the cell membrane, the flexible PEG macromonomers crosslink to produce
hydrogels with high compressive modulus without adversely affecting the viability of the
encapsulated cells.[42-46]
An exciting approach to in vivo tissue engineering is to deliver progenitor cells to
the regeneration site in an inert matrix, such as the PEG hydrogel, and allow the
encapsulated cells to secrete the desired extracellular matrix (ECM). In this approach, the
encapsulated progenitor cells, guided by cell-cell interactions and soluble factors, create
and reorganize their ECM as they go through lineage commitment, differentiation, and
maturation. Although inert PEG hydrogels provide flexibility in controlling the cell
microenvironment, their use for in vivo applications in tissue regeneration is limited by
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their persistence (non-degradability) in the site of regeneration to provide free volume for
tissue formation and remodeling. In that regard, design and synthesis of PEG hydrogels
with hydrolytically degradable links would substantially increase their use as a cell
delivery matrix in tissue regeneration.[47-49]
Copolymerization of PEG with poly(lactide) (PLA) has been used to impart
degradability to PEG macromers. However, due to the hydrophobicity of lactide, these
copolymers form thermo-responsive physical gels in aqueous solution with orders of
magnitude lower modulus than the covalently crosslinked PEG hydrogels.[150, 235] The
degradation and water content of the copolymers could be adjusted by the fraction of
hydrophobic lactide segments,[88, 178] but solubility of the copolymers in aqueous
solution decreased with increasing lactide content.[56] Furthermore, the covalently
crosslinked copolymer gels had significantly lower modulus compared to PEG hydrogels
due to entrapment of reactive groups in micellar domains.[56, 59, 236, 237]
We hypothesized that degradation and crosslink density of PEG-PLA gels and
viability of encapsulated cells is strongly dependent on the number of lactides per
macromonomer. We further hypothesized that PEG macromers with short lactide
segments could produce mechanically robust hydrogels with tunable degradation rate.
Previous molecular dynamic simulations demonstrated that the micelle size and reactivity
of PEG-acrylates with short lactide segments depended strongly on the lactide segment
length.[59]
The objective of this work was to synthesize star 4-arm poly(ethylene oxide-colactide) acrylate (SPELA) macromonomers and investigate the effect of number of
lactides per macromonomer on gelation time, modulus, sol fraction, water content, and
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degradation and to compare the results with the linear poly(ethylene oxide-co-lactide)
acrylate (LPELA). Star PEG macromonomers have lower radius of gyration and shear
viscosity, and higher density of functional groups than the linear PEGs,[25, 53] leading to
the formation of gels with higher crosslink density and modulus.[54-57] Dissipative
Particle Dynamics method[58, 59] was used to simulate aggregation and nanostructure
formation and the distribution of reactive groups in SPELA and LPELA hydrogel
precursor solutions. Bone marrow derived stromal cells (MSCs) were used to measure
viability and differentiation of encapsulated cells to the osteogenic lineage.
4.2. MATERIALS AND METHODS
4.2.1.MATERIALS
Lactide monomer (LA; >99.5% purity) was purchased from Ortec (Easley, SC)
and dried under vacuum at 40°C for at least 12 h prior to use. Calcium hydride,
tetrahydrofuran (THF), deuterated chloroform (99.8% deuterated), trimethylsilane
(TMS), triethylamine (TEA), tin (II) 2-ethylhexanoate (TOC), acryloyl chloride,
dimethylsulfoxide (DMSO), Linear polyethylene glycol (LPEG, nominal Mw=4700), 4arm PEG ( SPEG, Mw=5000) Ethylenediaminetetraacetic acid disodium salt (EDTA),
penicillin, streptomycin, and paraformaldehyde were purchased from Sigma-Aldrich (St.
Louis, MO). The protected amino acids and Rink Amide NovaGel resin for the synthesis
of acrylamide-terminated GRGD peptide were purchased from EMD Biosciences (San
Diego, CA). Dichloromethane (DCM, Acros Organics, Pittsburgh, PA) was dried by
distillation over calcium hydride. Diethyl ether and hexane were obtained from VWR
(Bristol, CT). DCM Spectro/Por dialysis tube (molecular weight cutoff 3.5 kDa) was
purchased from Spectrum Laboratories (Rancho Dominquez, CA). Dulbecco's phosphate-
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buffered saline (PBS) and Dulbecco's Modified Eagle's Medium (DMEM; 4.5 g/L
glucose with L-glutamine and without sodium pyruvate) were obtained from GIBCO
BRL (Grand Island, NY). Fetal bovine serum (FBS, screened for compatibility with rat
BMS cells) was obtained from Atlas Biologicals (Fort Collins, CO). Trypsin and Quant-it
PicoGreen dsDNA reagent kit were obtained from Invitrogen (Carlsbad, CA).
QuantiChrom calcium and alkaline phosphatase (ALPase) assay kits were purchased
from Bioassay Systems (Hayward, CA). BMP2 solution (100 μL, 1.5 mg/mL in BMP2
buffer) was generously donated by Medtronic (Minneapolis, MN). The Live/Dead calcein
AM (cAM) and Ethidium homodimer-1 (EthD) cell viability/cytotoxicity kit was
purchased from Molecular Probes (Life Technologies, Grand Island, NY).
4.2.2. SYNTHESIS OF LPELA AND SPELA MACROMONOMERS
A two-step procedure was used to synthesize linear (LPELA) and star (SPELA)
poly(ethylene glycol-co-lactide) acrylate macromonomers. In the first step, linear (LPEL)
and star (SPEL) poly(ethylene glycol-co-lactide) macromers were synthesized by melt
ring-opening polymerization with LPEG and SPEG, respectively, as polymerization
initiators and TOC as the reaction catalyst, using a procedure similar to our previous
work.[56] The PEG polymers were dried by azeotropic distillation from toluene.The LA
and PEG were added to a three-neck reaction flask equipped with an overhead stirrer.
The LA:PEG molar ratio was varied from 0 to 20 to synthesize macromonomers with
different lactide segment lengths. The reaction flask was heated to 120ºC with an oil bath
under steady flow of dry nitrogen to melt the reactants. Next, 1 ml of TOC was added and
the reaction was allowed to continue for 8 h at 135ºC. After the reaction, the product was
dissolved in DCM and precipitated in ice cold methanol followed by ether and hexane to
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fractionate and remove the unreacted monomer and initiator. The synthesized LPEL and
SPEL macromers were vacuum dried to remove any residual solvent and stored at -20ºC.
In the next step, the terminal hydroxyl groups of LPEL and SPEL macromers
were reacted with acryloyl chloride to produce LPELA and SPELA macromonomers,
respectively. Prior to the reaction, macromers were dissolved in DCM and dried by
azeotropic distillation from toluene to remove residual moisture. After cooling under
steady flow of nitrogen, the macromer was dissolved in DCM and the reaction flask was
immersed in an ice bath. Equimolar amounts of acryloyl chloride and TEA were added
drop-wise to the solution to limit the temperature rise of the exothermic reaction. The
reaction was allowed to proceed for 12 h. After the reaction, solvent was removed by
rotary evaporation, the residue was dissolved in ethyl acetate to precipitate the by-product
triethylamine hydrochloride salt. Next, ethyl acetate was removed by vacuum distillation,
the macromer was re-dissolved in DCM and precipitated twice in ice cold ethyl ether.
The synthesized macromonomer was dissolved in DMSO and purified by dialysis to
remove any unreacted acrylic acid. The LPELA and SPELA products were dried in
vacuum to remove residual solvent and stored at –40°C.
4.2.3. MACROMONOMER CHARACTERIZATION
The chemical structure of the macromonomers was characterized by a Varian
Mercury-300 H-NMR (Varian, Palo Alto, CA) at ambient conditions with a resolution of
0.17 Hz.[41] The sample was dissolved in deuterated chloroform at a concentration of 50
mg/ml and 1% v/v TMS as the internal standard.
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4.2.4. MACROMONOMER GELATION AND RHEOLOGICAL MEASUREMENTS
The macromonomers were crosslinked in aqueous solution by UV free-radical
polymerization with 4-(2-hydroxyethoxy)phenyl-(2-hydroxy-2-propyl) ketone (Irgacure
2959; CIBA, Tarrytown, NY) photoinitiator as described.[56, 150] The initiator was
dissolved in distilled deionized (DI) water at 50ºC. The macromonomer was dissolved in
DI water by vortexing and heating to 50ºC. The macromonomer solution was added to
the initiator solution, vortexed for 5 minutes, and loaded on the Peltier plate of the
rheometer (TA Instruments, New Castle, DE) to monitor the crosslinking reaction. A 20
mm plate acrylic geometry was used at a gap distance of 500 µm. A sinusoidal shear
strain with frequency of 1 Hz and 1% strain was applied to the sample while sample was
irradiated with a BLAK-RAY 100-W mercury long wavelength (365 nm) UV lamp
(Model B100-AP; UVP, Upland, CA).[24, 45, 150] The UV exposure time for all
samples was 1000s. The storage and loss moduli ( G ,G '' ) of the samples were recorded
with irradiation time. The reported shear modulus is the measured G  after 1000 s of UV
exposure. The notations LPELA-nLa-Mb and SPELA-nLa-Mb are used to identify the
architecture (linear versus star) as well as composition of the samples, where a and b
represent number of lactide monomers (nL) per macromonomer and macromonomer
concentration (wt %), respectively.
4.2.5. MEASUREMENT OF SWELLING RATIO AND SOL FRACTION
After crosslinking, samples with dimensions 20 mm diameter × 300 µm thickness
were removed from the Peltier plate to measure their swelling ratio and sol fraction.
Samples were dried at ambient conditions for 12 h followed by drying in vacuum for 1 h
at 40°C and the dry weight ( wi ) was recorded. Next, dry samples were swollen in DI
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water for 24 h at 37°C and swelling medium changed every 6 h. After swelling, the
surface water was removed and the swollen weight ( ws ) was recorded. Then, the swollen
samples were dried as described above and the dry weight ( wd ) was recorded. The
weight swelling ratio (Q) and sol fraction (S) were calculated by the following
equations:[56, 150]

Q

ws  wd
 100
wd

S

wi  wd
 100
wi

(equation 4.1)

(equation 4.2)

4.2.6. MEASUREMENT OF MASS LOSS
The macromonomer precursor solutions were degassed, transferred to a PTFE
mold (5 cm × 3 cm × 750 µm ), covered with a transparent glass plate, fastened with
clips, and UV crosslinked as described.[41] Disc shape samples were cut from the gel
using an 8 mm cork borer. The mass loss was measured in primary culture media (5 ml
per sample) without fetal bovine serum at 37ºC and under mild agitation. The primary
media was prepared by dissolving 13.4 g of Dulbecco‟s Modified Eagle Medium
(DMEM) in 900 ml of DI water containing 3.7 g sodium bicarbonate and 10 ml antibiotic
and antimycotic agents (1% v/v). At each time point, samples were removed from the
media, washed with DI water several times to eliminate the excess salts and dried under
vacuum. The dried sample weight was measured and compared with the initial dry weight
to determine the fractional mass loss.
4.2.7. BONE MARROW STROMAL CELL ISOLATION
MSCs were isolated from the bone marrow of young adult male Wistar rats
according to established protocols.[113, 238] Cell isolation was performed under a
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protocol approved by the Institutional Animal Care and Use Committee of the University
of South Carolina. The bone marrow cell suspensions were centrifuged at 200×g for 5
min, cell pellets were re-suspended in 12 mL basal medium (DMEM supplemented with
10% FBS, 100 units/mL penicillin (PEN), 100 µg/mL streptomycin (SP), 50 µg/mL
gentamicin sulfate (GS) and 250 ng/mL fungizone (FZ)) and aliquoted into T-75 flasks.
The flasks were subsequently maintained in a humidified 5% CO2 incubator at 37°C.
Cultures were replaced with fresh medium at 3 and 7 days to remove haematopoietic and
other unattached cells. After 10 days, cells were detached from the flasks with 0.05%
trypsin-0.53 mM EDTA and used for in vitro experiments.
4.2.8. ENCAPSULATION OF MSCS IN SPELA HYDROGEL
SPELA-nL14.8 macromonomer was dissolved in PBS at 15 %wt and sterilized by
filtration with a 0.2 µm filter. Acrylamide-terminated GRGD peptide (Ac-GRGD) was
synthesized on Rink Amide NovaGel resin in the solid phase, purified by HPLC, and
characterized by electrospray ionization (ESI) mass spectrometry as described
previously.[113] To the macromonomer solution, 1 wt% Ac-GRGD (based on SPELA)
was added to improve cell viability and cell-matrix interaction after MSC
encapsulation.[113] For experiments with BMP2, 200 ng/mL of the protein was added to
the precursor hydrogel solution.[239] Next, 1x106 MSCs, suspended in 100 µL of PBS,
was added to the SPELA macromonomer precursor solution and mixed gently with a presterilized glass rod. The density of MSCs in the gel was 2x106 cells/mL. The mixture was
injected between two sterile microscope glass slides and crosslinked by UV irradiation.
After removing the gel from the glass slide under sterile condition, disks were cut with a
sterile cork-borer and incubated in 2 ml PBS for 1 h with two PBS changes. Next, the
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medium was replaced with osteogenic medium for two groups; with and without the
addition of 200 ng/mL BMP2, and the encapsulated MSCs were incubated for 21 days.
At each time point, some of the disks were stained with cAM/EthD live/dead assay (1
µg/ml) to image live and dead cells, respectively. Stained samples were imaged with an
inverted fluorescent microscope (Nikon Eclipse Ti-ε, Nikon, Melville, NY).
At each time point, DNA content (cell number), ALPase activity, calcium content,
and mRNA expression of osteogenic markers Dlx-5, Runx2, OP, and OC were measured.
4.2.9. MEASUREMENT OF DNA CONTENT, ALPASE ACTIVITY, AND CALCIUM
CONCENTRATION
At each time point, some of the disks were homogenized and sonicated to rupture
the membrane of the encapsulated cells and expose the DNA. Double stranded DNA
(dsDNA) content of the homogenized samples were analyzed using a PicoGreen assay as
described.[113] Analysis of dsDNA was performed using a Synergy HT plate reader
(Bio-Tek, Winooski, VT) with emission and excitation wavelength of 485 and 528 nm,
respectively. Alkaline phosphatase (ALPase) activity of the samples were measured with
p-nitrophenyl phosphatase (Sigma-Aldrich) on a Synergy HT plate reader at 405 nm as
described.[113] The measured p-nitrophenol concentration was correlated to ALPase
activity in IU/L and normalized to cell numbers. Calcium content of the samples, as a
measure of the total mineralized deposit in the sample, was measured using QuantiChrom
Calcium Assay kit as described.[113] The absorbance was measured on a Synergy HT
plate reader at 575 nm. Measured intensities were correlated to the amount of equivalent
Ca2+ using a calibration curve made with calcium chloride solutions of known
concentrations.
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4.2.10. mRNA ANALYSIS
At each time point, total cellular RNA was isolated using TRIzol (Invitrogen,
Carlsbad, CA) or RNeasy Mini-Kit (Qiagen, Valencia, CA) and analyzed with NanoDrop
2000 (Thermo Scientific, Waltham, MA) as described.[113] 1µg of the extracted total
RNA was subjected to cDNA conversion using the Reverse Transcription System
(Promega, Madison, WI). The obtained cDNA was subjected to real time polymerase
chain reaction (PCR) amplification with appropriate gene specific primers. The
expression level of ribosomal protein S16 was used as the endogenous control. Primers
for real-time PCR analysis were designed and selected using the Primer3 web-based
software as described.[188] The PCR products were analyzed by agarose gel
electrophoresis. The annealing temperatures and other parameters for amplification were
optimized by classical PCR and agarose gel electrophoresis as described.[188] Real-time
PCR (RT-qPCR) was performed to analyze the differential expression of Dlx5 and
Runx2, markers for osteogenic differentiation, osteopontin (OP, early marker), and
osteocalcin (OC, late marker) with SYBR green RealMasterMix (Eppendorf, Hamburg,
Germany) using Bio-Rad CXF96 PCR system (Bio-Rad, Hercules, CA). The following
forward and reverse primers were synthesized by Integrated DNA technologies
(Coralville, IA): OP: forward 5′-GAC GGC CGA GGT GAT AGC TT-3′ and reverse 5′CAT GGC TGG TCT TCC CGT TGC-3′; OC: forward 5‟-AAA GCC CAG CGA CTC
T-3′ and reverse 5‟-CTA AAC GGT GGT GCC ATA GAT-3′; Dlx5: forward 5′- CCT
CAT GGC TAC TGC TCT CC-3′ and reverse 5′-CTC GGC CAC TTC TTT CTC TG-3′;
Runx2: forward 5′-GCC GGG AAT GAT GAG AAC TA-3′ and reverse 5′-GGA CCG
TCC ACT GTC ACT TT-3′; S16: forward 5′-AGT CTT CGG ACG CAA GAA AA-3′
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and reverse 5′-AGC CAC CAG AGC TTT TGA GA-3′.[240] Quantification of gene
expression was based on the crossing-point threshold value (CT) for each sample, which
was evaluated by the Relative Expression Software Tool (RESTTM) as the average of
three replicate measurements.[241] The model of Pfaffl was used to determine the
expression ratio of the gene.[241] The expression of S16 housekeeping gene was used as
the reference and the fold difference in gene expression was normalized to the first time
point.
4.2.10. STATISTICAL ANALYSIS
Data are expressed as means±standard deviation. All experiments were done in
triplicate. Significant differences between groups were evaluated using a two-tailed
Student's t-test. A value of p<0.05 was considered statistically significant.
4.3. SIMULATION METHOD
The aqueous solutions of SPELA and LPELA macromonomers were simulated
via Dissipative Particle Dynamics (DPD) approach, as described previously.[59] Figure
4.1 shows the molecular structure and different bead types on SPELA and LPELA
macromonomers. The bead types with equal mass and volume in the simulation volume
were L (one lactide monomer), EO (four ethylene oxide repeat units), Ac (the acrylate
group), SPEGc (the star PEG center) and W (eight water molecules). In DPD, each bead
represents a soft particle interacting with the other beads via a soft pair-wise force
function given by:[242, 243]

f ij   FijC  FijD  FijR  FijS

(equation 4.3)

i j

where f ij is the total force and FijC , FijD , FijR and FijS are the conservative, dissipative,
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Figure 4.1. Coarse-grained representations of LPELA and SPELA macromonomers,
respectively. Colors yellow, green, brown, and red represent SPEGc center, EO and L
repeat units, and Ac terminal group. In a given arm, the length of lactide segment was
significantly less than that of EO, leading to micellization and structure formation on the
nanoscale.
random and spring components of the force, respectively. Different components of the
force in a cutoff distance (rc) are calculated by:

αij ( 1  rij ) eij
F 
0
C
ij

rij  1
(equation 4.4)

rij  1

FijD   [ wD ( rij )] ( eij .vij ) eij

(equation 4.5)

FijR   [ wR ( rij )] ij eij

(equation 4.6)

FijS   Crij

(equation 4.7)

j

where rij is the vector joining bead i to j, eij and rij are the unit vector in the direction
of rij and the magnitude of rij respectively. vij is the velocity vector given by vij  vi  v j .
w D and w R are weight functions for dissipative and random forces, respectively, and  ,

 are the magnitude of the dissipative and random forces. The FijD and FijR act together
65

through the relation of their weight functions and constants ( w D (rij )  [w R (rij )]2 and

 2  2 k B T  )[242] to preserve the dissipation as well as conservation of total
momentum of the system. The spring force term acts to impose geometrical constraints
on the covalently bonded beads[244]. The values of  and C constants were 4.5 and 4
respectively[59, 244]. The repulsion between beads i and j is mainly dictated by the
constant αij in the conservative force function. By choosing the system density   3
rc 3 , the DPD length scale,

rc ,

was 8.18 Ǻ and the pair-wise interaction parameter

between beads i and j, αij , were determined using[58]:

 ij  25  3.27  ij

(equation 4.8)

where  ij is the Flory-Huggins parameter between beads i and j. The values of  ij in turn
are given by:

 ij 

( i   j ) 2 V

(equation 4.9)

RT

where  i and  j are the solubility parameters of beads i and j, respectively, V is the bead
molar volume, T is absolute temperature, and R is the gas constant. The solubility
parameters were calculated via atomistic molecular dynamics simulation (Forcite and
Amorphous Cell modules, Materials Studio v5.5, Accelrys)[152] using the COMPASS
force field, which is an ab initio force field optimized for condensed-phase systems[245].
The position and velocity of the beads at each time point were determined by
solving the equation of motion (equation 4.10)[242] using the force function (equation 3):

d ri
 vi ,
dt

mi

d vi
 fi
dt

(equation 4.10)
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All DPD simulations were performed in a 30  30  30 rc simulation box with 3D periodic
boundary conditions with over 200000 time steps and dimensionless time step of 0.05.
The Mesocite module of the Materials Studio (v5.5) was used to perform the DPD
calculations.[152]
4.4. RESULTS AND DISCUSSION
4.4.1. MACROMONOMERS CHARACTERIZATION
1

H  NMR spectrum of SPELA-nL14.8 macromonomer is shown in Figure 4.2.

NMR spectra of other SPELA macromonomers and LPELA are provided in Figures 4.3.
The chemical shifts with peak positions at 3.6 and 4.3 ppm were attributed to the
methylene hydrogens (  CH 2 ) of PEG attached to ether (  CH 2  O  CH 2  ) and ester
(  CH 2  OOC  ) groups of lactide respectively.[246] The shifts with peak positions at
1.6 and 5.2 ppm were attributed to the methyl (  CH 3 ) and methine (  CH ) groups of
lactide respectively.[246] The shifts with peak positions from 5.85 to 6.55 ppm (see the
insets in Figure 4.2 and Figure 4.3) were attributed to the vinyl hydrogens (  CH  CH 2 )
of the acrylate group at the end of each macromonomer arm as follows: Peak positions in
the 5.82-5.87 ppm range were associated with the trans proton of unsubstituted carbon of
the Ac; those in the 6.10-6.20 ppm range corresponded to the protons bonded to
monosubstituted carbon of the Ac; and those in the 6.40-6.46 ppm range were associated
with the proton of unsubstituted carbon of the acrylate group. The M n of SPELA was
determined from the ratio of shifts centered at 1.6 and 5.2 ppm (lactide hydrogens) to
those at 3.6 and 4.3 ppm (PEG hydrogens).

The number of acrylate groups per

macromonomer was determined from the ratio of shifts between 5.85 and 6.55 ppm
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Figure 4.2. 1H-NMR spectrum of SPELA-nL14.8 macromonomer. The inset shows the
chemical shifts with peak positions between 5.8 and 6.5 at higher intensity.
(acrylate hydrogens) to those at 3.6 and 4.2 ppm (PEG hydrogens). The number of lactide
monomers (nL) and functional acrylate groups per macromonomer, and M n for LPELA
and SPELA macromonomers as a function of lactide to PEG (LEGF) molar feed ratio are
summarized in Table 4.1. LEGF ratio was varied from zero to 20 with intervals of 5. The
nL values, shown in the first column, changed from 0 to 3.4, 6.4, 11.6 and 14.8 for
SPELA and from 0 to 3.6, 7.4, 9.6 and 14.8 for LPELA as LEGF values were increased
from zero to 5, 10, 15, and 20, respectively. As LEGF ratio was increased from zero to
20, M n of SPELA (column 2) increased from 5.2 to 7.4 kDa and M n of LPELA
increased from 4.7 to 6.8 kDa. As LEGF ratio was increased from zero to 20, number of
lactides per arm of the macromonomer (column 4) increased from zero to 3.7 for SPELA
and from zero to 7.4 for LPELA. The range for acrylate fraction per arm of SPELA and
LPELA macromonomers was 0.75-0.86 and 0.71-0.89, respectively. It should be noted
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Figure 4.3. 1H-NMR spectrum of (a) SPELA-nL0 , (b) SPELA-nL3.4 , (c) SPELA-nL6.4
and (d) SPELA-nL11.6, (e) LPELA-nL0 , (f) LPELA-nL3.6 , (g) LPELA-nL7.4 , (h)
LPELA-nL9.6 and (i) LPELA-nL14.8 macromonomers. The inset shows the chemical
shifts with peak positions between 5.8 and 6.5 at higher intensity. EO, L, and Ac
represent ethylene oxide and lactide repeat units, and acrylate terminal group,
respectively.
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Table 4.1. Number of lactide monomers (nL), number-average molecular weight ( M n ),
average number of lactide units per end group, and average number of acrylate groups
per end group for SPELA and LPELA macromonomers as a function of lactide to PEG
molar feed ratio in the polymerization reaction.

Macromonomer

Mn

Lactide units per end
group in the feed

Lactide units
per end group

Acrylate groups
per end group

SPELA-nL0
SPELA-nL3.4
SPELA-nL6.4
SPELA-nL11.6
SPELA-nL14.8

5300
5800
6200
6900
7400

0
1.25
2.5
3.75
5

0
0.8
1.6
2.9
3.7

0.85
0.86
0.82
0.74
0.75

LPELA-nL0
LPELA-nL3.6
LPELA-nL7.4
LPELA-nL9.6

4700
5200
5800
6100

0
2.5
5
7.5

0
1.8
3.7
4.8

0.89
0.85
0.87
0.77

LPELA-nL14.8

6800

10

7.4

0.71

that the standard deviation from the mean (s.d.) for, M n , average number of lactide units
per end group, and average number of acrylates per end group were 100 Da, 0.1, and
0.05, respectively. Therefore, the differences in acrylate groups per end group for
SPELA-nL0, SPELA-nL3.4, and SPELA-nL6.4 (0.85, 0.86, and 0.82, respectively) and
those between LPELA-nL0, LPELA-3.6 nL, and LPELA-7.4 nL (0.89, 0.85, and 0.87,
respectively) were not statistically significant. In general, there was a decrease in the
average number of acrylates per arm with increasing nL. This decrease was related to
higher steric hindrance of hydroxyl endgroups in LPELA and SPELA macromonomers
with longer length of lactide segments, leading to a lower effective reactivity with
acryloyl chloride. In general, polydispersity of SPELA and LPELA macromonomers was
<1.5.
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4.4.2. GENERAL OBSERVATIONS IN RHEOLOGICAL EXPERIMENTS
Time evolution of the shear storage modulus ( G  ) for gelation of SPELA
macromonomer as a function of number of lactide monomers (nL) is shown in Figure 4.4.
The intersection of storage and loss moduli ( G  , not shown in the figure), where G  =

G  , was used to determine the gelation time. All time sweep tests exhibited a lag or
induction time, a developing portion, and a plateau region.[24] However the length of
each region as well as the final value of G  were affected by the macromonomer
structure, i.e., linear versus star and the number of lactides. In general, the time for
induction/lag time decreased with increasing nL, because the average distance between
the reactive acrylate groups of the macromonomers decreased with increasing nL (see
Figure 4.3). The slope and duration of the developing portion of the gelation curve
decreased with increasing nL, mainly due to micelle/cluster formation by the
hydrophobic lactide segments (See Figure 4.3). There was also a decrease in plateau
shear modulus with increasing nL due to micelle/cluster formation (see Figure 4.3).
4.4.3. EFFECT OF INITIATOR ON GELATION KINETICS
The effect of initiator concentration on the storage modulus and gelation time of
LPELA-nL7.4 and SPELA-nL14.8 macromonomers (both having 3.7 lactide monomers
per end group) is shown in Figure 4.5.a and 4.5.b, respectively. SPELA-nL14.8 had the
longest

hydrophobic

lactide

segment

length,

compared

with

other

SPELA

macromonomers, potentially leading to highest steric hindrance of the acrylate groups in
each arm in aqueous solution and lowest effective reactivity during cross-linking.
Therefore, the effect of initiator concentration on gelation was investigated with SPELAnL14.8 as the least favorable case, and LPELA-nL7.4 with a similar lactide segment
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Figure 4.4. Effect of number of lactide monomers per macromonomer on time evolution
of the storage modulus of SPELA-M20 hydrogels.

Figure 4.5. Effect of UV initiator concentration on (a) storage modulus and (b) gelation
time of LPELA-nL7.4-M20 and SPELA-nL14.8-M20 hydrogels. Error bars correspond to
means ± 1 SD for n = 3.
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length was used for comparison. It is well established that the viability of cells
encapsulated in synthetic gels is adversely affected by low molecular weight species such
as initiator, crosslinker, and small-molecule monomers that cross the cell membrane.[42]
On the basis of previous studies, photoinitiator concentrations >2 wt% (based on the
weight of macromonomer) significantly decreased viability of the seeded cells.[43]
Therefore, the effect of initiator on gelation of SPELA and LPELA was tested with
concentrations <1.4 wt%. In the absence of photoinitiator (0.00 wt%) the modulus of
LPELA-nL7.4 and SPELA-nL14.8 systems was 0.13 and 0.08 Pa respectively and

G' ' / G'

was 5.3 and 1.8. Therefore, the precursor solutions without initiator did not

form a hydrogel network with UV irradiation (no gelation time in Figure 4.5.b). For each
initiator concentration, the modulus of SPELA gel was significantly higher than that of
LPELA. The modulus of the hydrogels showed a maximum at 0.38 wt % initiator
concentration for both LPELA-nL7.4 and SPELA-nL14.8 macromonomers. As the
initiator concentration was increased from 0.08 to 0.38 wt%, the modulus of LPELA and
SPELA gels initially increased from 13.1  3.0 to 20.2  4.1 kPa and from 17.5  2.0 to
37.5  2.5 kPa, respectively. After that, the modulus decreased to 17.2  2.1 and 32.9 
2.5 kPa for LPELA and SPELA hydrogels, respectively, when the initiator concentration
was increased to 1.31 wt%. The modulus of the gels did not change for initiator
concentrations >0.8 wt%. The initial increase in the gel modulus with initiator
concentration can be attributed to an increase in propagation rate ( R p ) given by:[229]

R 
RP  K P [ AC ]  i 
 Kt 

1/ 2

(equation 4.11)

Ri    I 0  [ I ]

(equation 4.12)
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where K P and K t are the rate constants for chain propagation and termination
respectively, R i is the radical initiation rate, [AC] is the concentration of unreacted
acrylates,  is initiation efficiency,  is molar extinction coefficient, I 0 is the intensity
of incident radiation,  is sample thickness, and [ I ] is photoinitiator concentration.
According to equation 4.12, the rate of radical production increased with increasing
initiator concentration to 0.38 wt% leading to a higher propagation rate of acrylates and
higher extent of crosslinking. For initiator concentrations exceeding 0.38 wt%, the
probability of formation of more than one radical on the same macromonomer increased,
which led to the formation intra-molecular crosslinks, as opposed to inter-molecular
crosslinks, and cluster formation and a decrease in storage modulus.[56] For initiator
concentrations >0.8 wt%, the increase in propagation rate was offset by the increase in
the rate of intra-molecular crosslinking, resulting in no change in modulus with increase
in initiator concentration.
As the initiator concentration was increased from 0.08 to 0.78 wt%, gelation time
of LPELA and SPELA macromonomers decreased from 140  5 to 45  1 s and from 200

 9 to 42  2 s, respectively. At low initiator concentrations (0.08 to 0.23 wt%), SPELA
had higher gelation times than LPELA but the two macromonomers reached similar
gelation times for concentrations >0.5 wt%. The total volume of the hydrophobic
domains in SPELA-nL14.8 was higher than LPELA-nL7.4. As a result, at low initiator
concentrations, it was more likely for the SPELA polymerization reaction to become
diffusion controlled than LPELA, leading to a higher gelation time for SPELA. As the
initiator concentration was increased above 0.23 wt%, the reaction became less controlled
by diffusion, leading to comparable gelation times for LPELA and SPELA at higher
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concentrations. In addition, the higher concentration of reactive acrylates in SPELA was
offset by the higher probability of intra-molecular crosslinking, leading to comparable
gelation times for SPELA and LPELA at initiator concentrations >0.23 wt%. In the
experiments that follow, the initiator concentration of 0.75 wt% was used, unless
otherwise specified, to have low gelation times as well as high shear storage moduli.
4.4.4. EFFECT OF MACROMONOMER CONCENTRATION ON GELATION
KINETICS
The effect of macromonomer concentration in the hydrogel precursor solution on
gelation time and modulus of LPELA-nL7.4 and SPELA-nL14.8 hydrogels is shown in
Figures 4.6.a and 4.6.b, respectively. The gelation time of SPELA gels decreased from 45

 8 to 30  1 s whereas LPELA gels decreased from 65  8 to 32  6 s as the
macromonomer concentration increased from 10 to 25 wt%. The storage modulus of
LPELA and SPELA gels increased from 1.2  0.5 to 28.3  3.5 kPa and from 1.5  0.6 to
61.0  6.2 kPa, respectively, with increasing macromonomer concentration from 10 to 25
wt%. In the absence of a crosslinker, the dependence of propagation rate of the
crosslinking reaction on the concentration of reactive acrylate groups is given by Eq.
4.11. According to that equation, higher acrylate concentrations increase propagation rate
and density of crosslinks for both LPELA and SPELA macromonomers. Therefore, the
decreasing trend of gelation time with increasing SPELA and LPELA macromonomer
concentrations as well as the lower gelation time of SPELA at constant concentration (see
Figure 4.6.a) can be attributed to the higher concentration of acrylates.[56]
The shear modulus of an ideal network is proportional to the density of elastically
active links according to the theory of rubber elasticity:[247]
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Figure 4.6. Effect of macromonomer concentration on (a) storage modulus and (b)
gelation time of LPELA-nL7.4 and SPELA-nL14.8 hydrogels. Error bars correspond to
means ± 1 SD for n = 3.
G   E RT

(euation 4.13)

where  E is the concentration of elastically active chains, R is the gas constant and T is
absolute temperature. The higher acrylate densities for SPELA compared to LPELA and
higher macromonomer concentrations led to higher propagation rates, higher density of
elastically active chains, and higher modulus. Furthermore, due to a larger average
distance between the macromonomers at low concentrations, the probability of intramolecular crosslinks that lead to loop formation and cyclization was higher.[24] Since
intra-molecular crosslinks are not elastically active and do not contribute to the network
modulus, the higher density of acrylates in SPELA was offset by higher intra-molecular
crosslinks, leading to a smaller difference between the moduli of SPELA and LPELA
gels at low concentrations (see Figure 4.5.b). As macromonomer concentration was
increased, the probability of intra-molecular links decreased,[162] leading to higher
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fraction of elastically active crosslinks in SPELA and larger difference between the
moduli of SPELA and LPELA.
As shown in Figure 4.6.b, the shear modulus of SPELA gels was significantly
higher than those of LPELA for all macromonomer concentrations. For example, the ratio
of G'SPELA / G' LPELA increased from 1.2 at 10 wt% macromonomer concentration to 2.2 at
25 wt%. As mentioned in the last paragraph, the lower values of G'SPELA / G' LPELA at low
concentrations can be attributed to the macromonomer architecture and its effect on nanoscale structure formation. DPD simulations of the macromonomers in aqueous solution
showed a uniform distribution of Ac beads over the simulation box in the absence of L
beads [60]. With the addition of lactide segments to the macromonomer, the hydrophobic
L and Ac beads aggregated and formed core of the micelles, as shown in Figure 4.7.a for
SPELA-nL14.8-M20 . (W, EO and SPEGc beads are not shown for clarity.) The crosssection of one of the micelles corresponding to the DPD simulations in Figure 4.7.a is
shown in the Figure 4.6.b. According to simulation results, hydrophilic ethylene oxide
segments (EO beads) of the macromonomers surrounded the core and formed the
micelle‟s corona. Localization of Ac beads in the micelles‟ cores led to the formation of
elastically active inter-molecular and elastically inactive intra-molecular crosslinks. To
quantify the proximity of Ac beads to other beads on the same macromonomer, the
average number of intra-molecular acrylate beads [( INint ra Ac (R ) ] in a sphere of radius R
around an Ac bead or the running integration number (IN) is calculated by:[248]
R

IN int ra Ac (R )  4 Ac0  g int ra Ac (r ) r 2 dr

(equation 4.14)

0
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Figure 4.7. (a) DPD simulation of micellar cores for SPELA-nL14.8- M20; L and Ac
beads are shown in brown and red, respectively, whereas other beads are not shown for
clarity. (b) simulated crosssection of one of the micelles in panel a; L, Ac, EO, and
SPEGc beads are shown in brown, red, green, and yellow, respectively, whereas water
beads are not shown for clarity. (c) Intramolecular running integration number (IN) for
Ac−Ac beads as a function of radius around an Ac bead for LPELA-nL7.4 and SPELAnL14.8 macromonomers in aqueous solution. SPELA macromonomers have significantly
higher Ac−Ac integration number than LPELA, leading to shorter gelation times and
higher modulus.
where  Ac0 is the overall number density of Ac beads and g int ra Ac (r) is the radial
distribution function of intra-molecular acrylates in a shell of infinitesimal thickness at
distance r from each Ac bead, located at the origin. The IN int ra Ac profile for LPELA and
SPELA hydrogels at 10% and 25% macromonomer concentrations is shown in Figure
4.7.c. The IN int ra Ac for LPELA and SPELA at R=15 Å decreased from 0.22 to 0.16 and
from 0.93 to 0.60, respectively, with increasing macromonomer concentration from 10%
to 25%. Therefore, the probability of intra-molecular reaction for SPELA was more
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sensitive to macromonomer concentration than that of LPELA. This effect is reflected in
the higher G'SPELA / G' LPELA ratios at higher macromonomer concentrations. Hiemstra et
al. synthesized star eight-arm methacrylate-functionalized PEG-PLLA (L-lactide) and
PEG-PDLA (D-lactide) with molecular weight of 28 kDa and 12 lactides per
macromonomer. The modulus of those gels was generally <10 kPa, which is significantly
lower than the four-arm SPELA gel synthesized in this work [57]. The effect of
macromonomer concentration on swelling ratio and sol fraction of LPELA-nL7.4 and
SPELA-nL14.8 hydrogels is shown in Figures 4.8.a and 4.8.b, respectively. The LPELAnL7.4-M10 samples disintegrated upon removal from peltier plate of the rheometer, so
the swelling and sol fraction of that sample was not measured. The swelling ratio of
SPELA and LPELA gels decreased from 430 to 300% and from 810 to 580%,
respectively, as the macromonomer concentration increased from 10/15% to 25%. The
higher swelling ratio of LPELA gels compared to SPELA was related to the lower
fraction of hydrophobic segments per macromonomer in LPELA along with lower
crosslink density of LPELA gels. Sol fraction of LPELA gels decreased from 32.1  2.0%
to 26.8  1.5% as concentration increased from 15 to 25%. The sol fraction of SPELA
decreased from 13.2  1.1 to 11.6  1.1, 6.4  1.0 and 4.9  0.9 as macromonomer
concentration increased from 10 to 15, 20 and 25%, respectively. Sol fraction of the
hydrogels decreased by 2.7, 4.8 and 5.4 folds by changing macromonomer architecture
from linear to star at 15, 20 and 25% concentration, respectively. The significantly lower
sol fraction of SPELA hydrogel compared to LPELA was due to the higher concentration
of reactive acrylate groups in SPELA at the same macromonomer concentration. The
decreasing trend in sol fraction with macromonomer concentration was related to the
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Figure 4.8. Effect of macromonomer concentration on (a) swelling ratio and (b) sol
fraction of LPELA-nL7.4 and SPELA-nL14.8 hydrogels. Error bars correspond to means
± 1 SD for n = 3.
decrease in inter-molecular distance between the acrylate groups with concentration,
which enhanced the probability of formation of elastically active crosslinks.
4.4.5. EFFECT OF NUMBER OF LACTIDES PER MACROMONOMER ON
GELATION KINETICS
Figure 4.9 (a,b) shows the effect of number of lactide monomers per
macromonomer on shear modulus and gelation time, respectively, for LPELA-M20 and
SPELA-M20 hydrogels. G  of the hydrogels initially decreased from 116  10 kPa to 58

 2 kPa and from 69  8 kPa to 26  4 kPa with the addition of 3.6 and 3.4 lactide
monomers per macromonomer (nL) for SPELA and LPELA hydrogels, respectively,
corresponding to 1.8 and 0.85 monomers per arm of LPELA and SPELA hydrogels.
Afterward, G  decreased at a slower rate to 6.5  2.5 kPa and 37.0  2.0 kPa for LPELA
and SPELA gels, respectively, when nL increased to 14.8. The gelation time of SPELA
hydrogel decreased from 115  10 s to 32  1 s whereas that of LPELA decreased from 85
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Figure 4.9. Effect of number of lactide monomers per macromonomer (nL) on (a) storage
modulus and (b) gelation time of LPELA-M20 and SPELA-M20 hydrogels. Error bars
correspond to means ± 1 SD for n = 3.

 10 s to 39  2 s with increasing nL from 0 to 14.8. The decrease in G  and gelation time
of the hydrogels with increasing lactide segment length is related to aggregation and
micelle formation of the macromonomers in aqueous solution. The size of the micelles‟
core increased with increasing lactide segment length[60]. At any given time,
macromonomer arms can have one of three conformations, namely bridge, which
connects two different micelle cores, loop with at least two arms of a macromonomer in
the same micelle, and free arm which is in solution (not part of the micelles).[59] The
dynamic nature of these conformations leads to the formation of a transient physical
network in the precursor solution. In SPELA-nL0 system, the gelation time was high due
to a relatively large average distance between the uniformly distributed acrylate groups.
The localization of reactive acrylate groups in the micelles core with increasing lactide
content decreased the average distance between the acrylate groups.[59] As a result, the
reaction rate between acrylates increased with increasing lactide segment length. In
addition, the lifetime of the bridging arms in the core increased with increasing lactide
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segment length.[59, 249] Those factors worked together to decrease gelation time with
increasing lactide content of the macromonomer. At the same time, due to very low water
content of the micelles, mobility of the acrylate groups and diffusion of initiator in the
micelles significantly decreased with increasing micelles‟ core size. As a result, a fraction
of the acrylates, trapped in the micelles‟ core, did not react to form elastically active
crosslinks, which led to a decrease in the hydrogel

modulus with increasing

macromonomer lactide content.
The effect of number of lactides per macromonomer on sol fraction and swelling
ratio of LPELA and SPELA hydrogels is shown in Figure 4.10.a and 4.10.b, respectively.
The swelling ratio of LPELA gels decreased dramatically from 700% to 110% when nL
increased from 0 to 14.8 while that of SPELA decreased slightly from 430% to 350%.
The decrease in network density with increasing nL had a positive effect on swelling ratio
whereas the increase in hydrophobicity with increasing nL had a negative effect on
swelling ratio. . The molecular weight between crosslinks, M c , for an ideal network in
the affine model is given by:[55, 247]

1
G   2,r
 F  1



M c  F  2  M n RT   2,s

1/ 3






(equation 4.15)

where F is functionality of crosslinks (three for crosslinks at chain ends), M n is
macromonomer molecular weight, G is the network modulus,  is specific volume of the
macromonomer, and  2,r and  2,s are the macromonomer volume fraction in the
crosslinked gel before and after swelling equilibrium, respectively. According to the
above equation, in the absence of inhomogeneity in the gel (e.g. PEG networks with no
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Figure 4.10. Effect of number of lactide monomers per macromonomer (nL) on (a)
swelling ratio and (b) sol fraction of LPELA-M20 and SPELA-M20 hydrogels. Error bars
correspond to means ± 1 SD for n = 3.
lactide segments), M c increases and G decreases with M n . Therefore, the higher
swelling of LPELA-nL0 compared with SPELA-nL0 is attributed to the lower crosslink
density of the linear LPELA compared with star SPELA. In the presence of lactide,
aggregation of hydrophobic segments produced micellar inhomogeneity in the network
and increased hydrophobicity. On the basis of simulation results, water content of the
hydrophobic domains was <1%. So the SPELA and LPELA gels may be better described
as nanophase separated networks.[250] The interfacial free energy of the micelles with
the aqueous phase increased with increasing nL for both SPELA and LPELA
macromonomers. However, the micelles in SPELA had a lower interfacial energy than
LPELA. The ethylene oxide chains in star SPELA macromonomer provided greater
surface coverage for micelles‟ core, as predicted by DPD simulation (data not shown),
thus lowering the interfacial energy of SPELA compared with LPELA. In addition, the
lower radius of gyration of star SPELA led to higher steric repulsion between the EO
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units in the macromonomer, which reduced the equilibrium core size and the average
distance between the micelles in SPELA compared with LPELA. Therefore, as nL
increased, SPELA macromonomers formed smaller micelles closer to each other while
LPELA formed larger micelles farther away from each other. The higher inter-micellar
distance in LPELA and extension of the bridging arms of the cores sharply reduced
swelling ratio of LPELA as nL was increased (see Figure 4.10.a) while the swelling ratio
of SPELA was unaffected by nL. SPELA hydrogel had a significantly lower sol fraction
than LPELA, as shown in Figure 4.11.b. For example, sol fraction of LPELA and SPELA
hydrogels increased from 24  2% to 32  3% and from 2.5  0.5% to 6.4  1.0% as nL
increased from 0 to 14.8. This was attributed to the higher density of reactive acrylate
groups in SPELA compared to LPELA, which increased the probability of incorporating
macromonomers in the gel network.
The effect of lactide content per macromonomer on mass loss of the SPELA and
LPELA hydrogels is shown in Figure 4.11(a,b) respectively. There was no significant
difference between the mass loss curves of SPELA-nL6.4 and SPELA-nL14.8 (p = 0.34),
but there was a significant difference between the mass loss of all other SPELA pairs (p <
0.05). There was a significant difference between the mass loss of all LPELA pairs (p <
0.05). Mass loss of SPELA-nL0 and LPELA-nL0 was <10% after 42 days. For a given
time, mass loss of SPELA increased with increasing nL up to nL = 11.6, followed by a
decrease in mass loss for higher nL values, but it was higher than LPELA at any
incubation time. Mass loss of LPELA increased with nL. For example, mass loss of
SPELA hydrogels after 28 days changed from 7 to 37, 80, 100, and 87% as the number of
lactide monomers in SPELA increased from zero to 3.4, 6.4, 11.6, and 14.8, respectively,
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whereas those of LPELA increased from 7 to 15, 26, 38, and 46% as the number of
lactide monomers in LPELA increased from zero to 3.6, 7.4, 9.6, and 14.8. Sawhney et
al. reported degradation time of 50 days for LPELA with PEG molecular weight of 6 kDa
and 5 lactide units per macromonomer, but the swelling ratio of those gels were
significantly higher than our gels.[251] The addition of only 3.4 lactides per
macromonomer (<9 wt % of dry macromonomer and <2 wt % of swollen hydrogel)
increased mass loss to 50% after 42 days.

Figure 4.11. Effect of number of lactide monomers per macromonomer (nL) on mass loss
of (a) SPELA-M20 and (b) LPELA-M20 hydrogels with incubation time. Error bars
correspond to means ±1 SD for n = 3.
The SPELA hydrogel with 11.6 lactides per macromonomer completely degraded after
28 days. Assuming the formation of carboxylic acid groups by degradation of lactides
does not significantly affect mass loss, degradation rate of SPELA is given by:

Rdeg,SPELA  k  COO H 2 O

(equation 4.16)

where k is the degradation rate constant, and [-COO-] and [H2O] are the concentrations
of ester groups and water in the hydrogel, respectively. Degradation of PLA matrices is
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controlled by the low concentration of water in the matrix while degradation of SPELA
hydrogel is controlled by relatively low concentration of degradable ester units. The
decline in the concentration of ester groups in the hydrogel with degradation was offset
by the increase in water content (increased swelling ratio), leading to nearly constant
degradation rate, as shown in Figure 4.12. The increase in mass loss with nL (up to 11.6)
was attributed to the higher concentration of ester groups in SPELA hydrogel. The
decrease in mass loss for nL>11.6 was attributed to micelle formation with significantly
reduced local concentration of water, leading to reduced rate of degradation.
Images a−d in Figure 4.12 show live (green) and dead (red) cells 1 h after
encapsulation in SPELA-nL3.4, SPELA-nL6.4, SPELA-nL11.6, and SPELA-nL14.8
hydrogels, respectively. On the basis of the images, the number of lactides per
macromonomer did not have a significant effect on cell viability. Cell viability was
quantified by dividing the image into smaller squares and counting the number of live
and dead cells. The fraction of viable cells for SPELA-nL0, SPELA-nL3.4, SPELAnL6.4, SPELA-nL11.6, and SPELA-nL14.8 gels was 92 ± 3, 90 ± 4, 92 ± 4, 94 ± 4, and
91 ± 3, respectively.
DNA content, ALPase activity, and extent of mineralization of MSCs
encapsulated in SPELA are shown in Figure 4.13(a−c), respectively. The cell free gels
did not have DNA count, ALPase activity, and mRNA expression (Figure 4.13) but
showed slight calcium content. For all time points, MSCs in BM had higher cell count
than those cultured in OM, and the addition of BMP2 did not affect DNA count. At day
21, DNA count of MSCs in BM decreased slightly (statistically significant) compared
with days 4−14. For days 14 and 21, DNA content of MSCs in OM and OM+BMP2
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Figure 4.12. Live (green) and dead (red) image of MSCs 1 h after encapsulation in (a)
SPELA-nL3.4, (b) SPELA-nL6.4, (c) SPELA-nL11.6, and (d) SPELA-nL14.8 hydrogels
(without BMP2). The scale bar is 100 μm.
groups was statistically lower than days 4 and 7 (indicated by a star in Figure 4.13.a) and
statistically lower than BM group. This trend is consistent with previous reports that cell
number decreases with differentiation of MSCs in osteogenic medium. Wang et al.
reported a decrease of 24 and 51% in DNA content after 3 and 6 weeks, respectively,
with osteogenic differentiation of human umbilical cord MSCs seeded in PLGA
scaffolds.[252] Oliveira et al. reported a decrease of 20% in DNA content after 7−14 days
with osteogenic differentiation of rat MSCs.[253] Burdick et al. observed a decreasing
trend in cell viability in 2 weeks for rat calvarial osteoblasts encapsulated in PEGDA
hydrogels.[17] MSCs in BM group (green in Figures 4.13 and 4.14) had significantly

87

Figure 4.13. (a) DNA content, (b) ALPase activity, and (c) calcium content of MSCs
encapsulated in SPELA-14.8 hydrogel. Experimental groupsinclude gels without MSCs
incubated in osteogenic media (OM+no MSCs, red, control), gels with MSCs incubated
in basal media (BM, green,control), gels with MSCs incubated in osteogenic media (OM,
blue), and gels with MSCs and BMP2 incubated in osteogenic media
(OM+BMP2,orange). One star indicates statistically significant difference (s.d.; p < 0.05)
between the test time point and first time point (day 4) in the samegroup, and two stars
indicate significant difference between the test group and all other groups at the same
time point. Error bars correspond tomeans ±1 SD for n = 3.
lower ALPase activity, calcium content, and expression of osteogenic marker than OM
and OM+BMP2. ALPase activity of both groups (with and without BMP2) significantly
increased (indicated by one star) from day 4 to 7 and 14 and returned to the baseline level
after 21 days. This was consistent with our previous results that the peak ALPase activity
is the start of mineralization.[113] ALPase activity of BMP2 group at days 7 and 14 was
significantly higher than that of OM (without BMP2, indicated by two stars). Calcium
content of both groups increased significantly on days 7−21 compared with day 4
(indicated by one star). However, calcium content of the BMP2 group was significantly
higher that the OM group for days 7−21 (indicated by two stars). For example, calcium
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contents of the BMP2 group after 7, 14, and 21 days were 8.7 ± 1.0, 27.1 ± 2.7, and 45.1
± 1.4 mg/dL, respectively, whereas those of OM were 3.1 ± 1.3, 11.6 ± 1.6, and 34.4 ±
2.6 mg/dL. Results in Figure 4.13.c demonstrate that the calcium content of MSCs in OM
and OM+BMP2 groups was due to osteogenic differentiation and mineralization of
MSCs and not due to the calcium in osteogenic media. mRNA expression levels of Dlx5,
Runx2, OP, and OC of the MSCs for both groups (with and without BMP2) are shown in
Figure 4.14(a−d) with incubation time. The fold differences in mRNA expression of the
markers are normalized to those at time zero. BMP2 protein forms complexes with type I
and type II BMP2 receptors (BRI and BRII) on the surface of MSCs, which activates the
Smad-dependent and Smad-independent p38 pathways as well as internalization of the
receptors.[254] The expression of Dlx5 and Runx2 is the early event in the BMP2
signaling cascade. Dlx5 regulates the activity of osteogenic master transcription factor
Runx2 by Smad-dependent pathways, which in turn drives the expression of osteogenic
genes. The expressions of Dlx5 and Runx2 were up-regulated for all time points (Figure
4.14.a,b) for both OM and BMP2 groups. However, for BMP2 group, there was a sharp
increase in the expression of Dlx5 on days 7 and 14 and the expression of Runx2 on day
7. mRNA expression of OP and OC increased gradually for both OM and BMP2 groups
with incubation time, but the fold difference was significantly higher for BMP2 group at
each time point. For example, the fold differences in OC mRNA expression for OM
group increased from 0.4 ± 0.2 to 1.1 ± 0.4, 3.5 ± 0.5, and 6.0 ± 0.4 after 4, 7, 14, and 21
days of incubation, respectively, whereas those for BMP2 group increased from 0.6 ± 0.2,
2.2 ± 0.2, 7.4 ± 1.1, and 11.5 ± 1.3. Results in Figures 4.13 and 4.14 taken together
demonstrate that the encapsulated MSCs in OM and OM+BMP2 groups differentiated in
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Figure 4.14. mRNA Expression levels, as fold difference, of (a) Dlx5, (b) Runx2, (c) OP,
and (d) OC of MSCs encapsulated in SPELA-14.8 hydrogels. Experimental groups
include gels with MSCs incubated in basal media (BM, green, control), gels with MSCs
incubated in osteogenic media (OM, blue), and gels with MSCs and BMP2 incubated in
osteogenic media (OM+BMP2, orange). One star indicates statistically significant
difference (s.d.; p < 0.05) between the test time point and the first time point (day 4) in
the same group, and two stars indicate significant difference between the test group and
all other groups at the same time point. Error bars correspond to means ±1 SD for n = 3.
osteogenic media, whereas those incubated in BM did not undergo osteogenic
differentiation. Yang et al. investigated osteogenic differentiation of MSCs encapsulated
in RGD-conjugated PEG hydrogels.[114] The calcium content of MSCs with optimum
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RGD density after 21 days was 0.00008 mg/mg DNA, compared with 0.057 mg/mg DNA
in this work. The higher calcium content in this work may be related to the degradable
nature of SPELA matrix, leading to increase in water content, free volume, and greater
cell-matrix interaction with incubation time. The addition of inductive factors like BMP2
significantly enhanced differentiation and mineralization of MSCs. Kim et al. reported
that the addition of BMP2 to MSCs encapsulated in hyaluronic acid gels increased OC
expression by 80%.[255] Na et al. reported that the addition of BMP2 to MSCs
encapsulated in poly(N-isopropylacrylamide-co-acrylic acid) gels increased the
expression of OC after 8 weeks of incubation.[256]
4.5. CONCLUSION
A novel approach to tissues regeneration is to encapsulate progenitor cells in inert
and biodegradable hydrogels loaded with soluble growth factors to guide their
differentiation and maturation. To this end, linear (LPELA) and star (SPELA)
poly(ethylene glycol-co-lactide) acrylate macromonomers with short lactide segments
were synthesized. SPELA hydrogels had significantly higher modulus, lower gelation
time, and lower sol fraction compared with LPELA. Mass loss of the SPELA hydrogel
depended strongly on the number of lactides per SPELA macromonomer (nL) and
showed a biphasic behavior. Molecular dynamic simulations demonstrated that the
biphasic behavior mass loss was related to aggregation and micelle formation of the
lactide monomers of SPELA in aqueous solution. MSCs encapsulated in SPELA-nL14.8
and incubated in osteogenic media had significantly higher ALPase activity, extent of
mineralization, and expression of osteogenic markers compared with those incubated in
basal media. The expression of osteogenic markers and extent of mineralization increased
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with coencapsulation of BMP2 with MSCs in the SPELA hydrogel and incubation in
osteogenic media when compared to without BMP2. Results demonstrate that the PEGbased SPELA hydrogels are potentially useful as a degradable matrix for MSCs in tissue
regeneration.
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CHAPTER 5
NANOSTRUCTURE FORMATION AND TRANSITION FROM SURFACE TO BULK
DEGRADATION IN POLYETHYLENE GLYCOL GELS CHAIN-EXTENDED WITH
SHORT HYDROXY ACID SEGMENTS

Seyedsina Moeinzadeh, Danial Barati, Samaneh K. Sarvestani, Ozan Karaman, Esmaiel
Jabbari Nanostructure Formation and Transition from Surface to Bulk Degradation in
Polyethylene Glycol Gels Chain-Extended with Short Hydroxy Acid Segments,
Biomacromolecules, 2013. 14(8): p. 2917-2928. Reprinted here with permission of
publisher.
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5.1. INTRODUCTION
Hydrogels are used extensively in medicine for soft tissue repair.[176, 257-259]
Due to their high diffusivity of nutrients and biomolecules,[24-26] hydrogels are very
useful as a matrix in tissue engineering for in situ delivery of cells to the site of
regeneration and regulation of cell fate.[21, 29, 30, 41] Only those hydrogels that degrade
and provide free volume for the newly formed tissue can be utilized as a matrix in
regenerative medicine.[101, 102] However, viability and fate of the encapsulated cells are
limited by toxic side effects of gelation and degradation reactions in the hydrogel matrix.
Consequently, natural hydrogels derived from the components of extracellular matrix
(ECM) of biological tissues that physically crosslink and degrade enzymatically are
frequently used as the delivery matrix in clinical applications.
Minor variation in the sequence distribution of natural gels can dramatically affect
the fate of encapsulated cells. With many cell-interactive ligands and regulatory factors, it
is difficult to tailor the properties of natural matrices to a particular application in
regenerative medicine.[31] For example, differentiation of mesenchymal stem cells
(MSCs) shifted from osteogenic to chondrogenic lineage by changing the matrix from
collagen type I to type II.[32, 33] Moreover, due to their low stiffness, natural gels are
limited in practical applications by soft tissue compression.[34-36] Therefore, there is a
need to synthesize novel hydrogels with tunable physical, mechanical, and biological
properties for a wide range of applications in regenerative medicine such as chondrocyte
implantation in cartilage regeneration or as cardiac patches to treat heart infarction.
Polyethylene glycol (PEG) hydrogels are inert, non-immunogenic, and compatible
with stem cells and can be conjugated with multiple bioactive peptides to modify the cell
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microenvironment and regulate cell fate.[112-114] However, PEG hydrogels are nondegradable which limits their use as a supporting matrix in regenerative medicine. PEG
macromonomers copolymerized with hydroxy acid (HA) monomers produce block
copolymers that have limited solubility in aqueous solution[35] and self-assemble to form
nanoparticles for drug delivery.[260-266] We previously demonstrated that star PEG
macromonomers chain-extended with very short hydrolysable lactide segments (SPELA)
dissolved in aqueous solution and formed a micellar gel.[35] Remarkably, the results
showed a biphasic relationship between the lactide segment length and gelation or
degradation rate. We hypothesized that the observed biphasic dependence was related to
the transition from surface to bulk hydrolysis in the micelle phase with increasing lactide
segment length. To test the hypothesis, we investigate in this work gelation and
degradation of star PEG macromonomers chain-extended with short hydroxy acid (HA)
segments (SPEXA where “X” is HA monomer type) with a wide range of
hydrophobicity. HA monomers included least hydrophobic glycolide (G), lactide (L), pdioxanone (D), and most hydrophobic ε-caprolactone (C). All HA chain-extended PEG
hydrogels showed the transition from surface to bulk degradation with increasing HA
segment length. Chain extension of PEG macromonomers with short HA segments
localized the reactive moieties within micelles and reduced their average distance,
thereby increasing gelation and degradation rates with increasing segment length. As the
micelle size was increased above a certain value, the average distance between the
reactive moieties within the micelles began to increase and degradation rates decreased.
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5.2. SIMULATION METHOD
Solution of SPEXA macromonomers in water was simulated via Dissipative
Particle Dynamics (DPD) using an approach described previously.[35, 60] The molecular
structure of the macromonomer was divided into different beads with equal mass, as
shown in Figure 5.1. The beads included L (lactide repeat unit), G (glycolide), D (pdioxanone), C (ε-caprolactone), EO (ethylene oxide repeat unit), Ac (acrylate functional
group), SPEGc (star PEG core), and W (three water molecules). The meso-structure of
the macromonomer is also shown in Figure 5.1. The notations SPEXA-nA or SPEXAmB are used to identify length of the degradable segment, where A is the number of
repeat units or ester groups per arm, B is the number of monomers per arm, and X is HA
monomer type (G, L, D, and C). When X is C or D, A equals B but A=2B when X is G or
L. In DPD, each bead represents a soft particle interacting with the other beads via a soft
pairwise force function given by[242, 243]

f ij   FijC  FijD  FijR  FijS

(equation 5.1)

i j

where f ij is the total force and FijC , FijD , FijR and FijS are the conservative, dissipative,
random and spring components of the force, respectively. Different components of the
force in a cutoff distance (rc) are calculated by[58]

αij ( 1  rij ) eij
FijC  
0

rij  1
(equation 5.2)

rij  1

FijD   [ wD ( rij )] ( eij .vij ) eij

(equation 5.3)

FijR   [ wR ( rij )] ij eij

(equation 5.4)
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Figure 5.1. Bead reperesentation of SPEXA (X= L, G, C or D) macromonomer in DPD.
Beads SPEGc (yellow), EO (green), G (blue), D(pink), L (orange), C (purple) and Ac
(red) represent star PEG core, ethylene oxide repeat unit, glycolide, p-dioxanone, lactide,
ε-caprolactone repeat unit, and acrylate functional group, respectively.

FijS   Crij

(equation 5.5)

j

where rij is the vector joining bead i to j, eij and rij are the unit vector in the direction
of rij and the magnitude of rij , respectively. vij is the velocity vector given by vij  vi  v j
. w D and w R are weight functions for dissipative and random forces, respectively, and  ,

 are the magnitude of dissipative and random forces. FijD and FijR act simultaneously to
preserve dissipation and to conserve the total momentum in the system. The dissipative
and random force constants and weight functions are interrelated by w D (rij )  [w R (rij )]2
and  2  2 k B T  in order to satisfy the dissipation-fluctuation condition.[244] The
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spring force term imposes geometrical constraints on the covalently bonded beads.
Values of  and C constants were 4.5 and 4, respectively.[60] The repulsion between
beads i and j is mainly dictated by the constant αij in the conservative force function.
By choosing the system density   3 rc 3 , the DPD length scale, rc, was 6.74 Ǻ and the
values of αij were determined using[58]

 ij  78  3.27  ij

(equation 5.6)

where  ij is the Flory-Huggins parameter between beads i and j. Values of  ij in turn are
given by

 ij 

( i   j ) 2 V

(equation 5.7)

RT

where  i and  j are solubility parameters of beads i and j, respectively, V is bead molar
volume, T is absolute temperature, and R is gas constant. Solubility parameters were
calculated via atomistic molecular dynamics simulation performed via Forcite and
Amorphous Cell modules, Materials Studio (v5.5, Accelrys)[267] using the COMPASS
force field, which is an ab initio force field optimized for condensed-phase systems.[245]
Position and velocity of the beads at each time point were obtained by solving the
following equations of motion using the force function (equation 5.1).

d ri
 vi ,
dt

mi

d vi
 fi
dt

(equation 5.8)

All DPD simulations were performed in 30  30  30 rc boxes with 3D periodic
boundary conditions over 2x105 time steps and dimensionless time step of 0.05. The
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Mesocite module of Materials Studio (v5.5, Accelrys)[267] was used for DPD
calculations.
5.3. EXPERIMENTAL METHODS
5.3.1. MATERIALS
Lactide (L), glycolide (G) and p-dioxanone (D) monomers with >99.5% purity
were purchased from Ortec (Easley, SC). ε-Caprolactone (C) monomer with >99% purity
was purchased from Alfa Aesa (Ward Hill, MA). All monomers were dried under
vacuum at 40°C for at least 12 h prior to use. 4-(2-hydroxyethoxy)phenyl-(2-hydroxy-2propyl) ketone (Irgacure-2959) photoinitiator was obtained from CIBA (Tarrytown, NY).
Calcium hydride, tetrahydrofuran (THF), deuterated chloroform (99.8% deuterated),
trimethylsilane (TMS), triethylamine (TEA), tin (II) 2-ethylhexanoate (TOC), acryloyl
chloride (Ac) , dimethylsulfoxide (DMSO), 4-arm PEG (SPEG, 4 arm, nominal Mw=5
kDa), ethylenediaminetetraacetic acid disodium salt (EDTA), and paraformaldehyde were
purchased from Sigma-Aldrich (St. Louis, MO). The protected amino acids and Rink
Amide NovaGel resin for the synthesis of acrylamide-terminated GRGD peptide were
purchased from EMD Biosciences (San Diego, CA). Dichloromethane (DCM, Acros
Organics, Pittsburgh, PA) was dried by distillation over calcium hydride. Other solvents
were obtained from VWR (Bristol, CT) and used as received. Dulbecco's phosphatebuffer saline (PBS) and Dulbecco's Modified Eagle's Medium (DMEM; 4.5 g/L glucose
with L-glutamine and without sodium pyruvate) were obtained from GIBCO BRL (Grand
Island, NY). Fetal bovine serum (FBS), screened for compatibility with rat MSCs, was
purchased from Atlas Biologicals (Fort Collins, CO). TRIzol for isolation of cellular
RNA and trypsin were purchased from Invitrogen (Carlsbad, CA). Penicillin (PN),
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streptomycin (SP), fungizone (FG), gentamicin sulfate (GS), dexamethasone (DEX),
ascorbic acid (AA), and ß-sodium glycerophosphate (GP) were purchased from SigmaAldrich. Quant-it PicoGreen dsDNA reagent kit was obtained from Invitrogen (Carlsbad,
CA). QuantiChrom calcium and alkaline phosphatase (ALP) assay kits were purchased
from Bioassay Systems (Hayward, CA). Sircol total collagen assay kit was obtained from
Biocolor (Carrickfergus, UK).
5.3.2. CHARACTERIZATION
The chemical structure of SPEXA macromonomers was characterized by a Varian
Mercury-300 1H-NMR (Varian, Palo Alto, CA) at ambient conditions with a resolution of
0.17 Hz as described previously.[35] The sample was dissolved in deuterated chloroform
at a concentration of 50 mg/ml, and 1% v/v TMS was used as the internal standard.
Number- (Mn) and weight-average molecular weight (Mw) and polydispersity index (PI)
of the macromonomers were measured by Gel Permeation Chromatography (GPC,
Waters 717 System, Milford, MA) in THF with 1 mL/min flow rate as previously
described.[52]
5.3.3. MACROMONOMER SYNTHESIS
SPEG macromer chain-extended with short HA segments was synthesized by ring
opening polymerization (ROP) as described.[35] SPEG and TOC were the
polymerization initiator and catalyst, respectively. Briefly, dry HA monomer and SPEG
were added to a three-neck reaction flask with an overhead stirrer and immersed in an oil
bath (only SPEG was added to the flask for D monomer). Molar ratio of SPEG to
monomer was selected based on the desired theoretical length of the HA segment. Next,
the reaction flask was heated to 120°C under nitrogen to melt the mixture, maintained at
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that temperature for 1 h to remove moisture, and TOC was added to the mixture. The
reaction was run at 140°C for 12 h for C and L monomers and 160°C for 10 h for G
monomer. Since equilibrium was shifted toward monomer in polycondensation of pdioxanone for temperatures >100°C, SPEG and catalyst mixture was heated to 130°C for
10 min to remove moisture, the mixture was cooled to 85°C, D monomer was added, and
reaction was run at that temperature for 48 h. After the reaction, the product was purified
by precipitation in ice-cold hexane to remove any unreacted monomer, initiator and
catalyst.
In the next step, chain ends of the macromer were acrylated to produce SPEXA
macromonomer. SPEX macromer (product of the first reaction) was dried by azeotropic
distillation from toluene. The macromer was dissolved in DCM, the flask was immersed
in an ice bath, and the reaction was carried out by the addition of equimolar amounts of
AC and TEA drop-wise to the macromer solution under dry nitrogen. After 12 h, solvent
was removed by rotary evaporation and the residue was dissolved in ethyl acetate to
precipitate the byproduct triethylamine hydrochloride salt. After vacuum distilling ethyl
acetate, the product was re-dissolved in DCM and precipitated in ice-cold ethyl ether
twice. The product was dissolved in DMSO and dialyzed against water in a 3.5 kDa MW
cutoff Spectro/Por dialysis tube (Spectrum Laboratories, Rancho Dominquez, CA) to
remove any remaining impurities. SPEXA macromonomer was dried in vacuum to
remove residual solvent and stored at –20°C.
5.3.4. MACROMONOMER GELATION AND RHEOLOGICAL MEASUREMENTS
The aqueous SPEXA hydrogel precursor solution was crosslinked by UV freeradical polymerization with Irgacure-2959 photoinitiator as previously described.[150]
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To monitor gelation kinetics, the hydrogel precursor solution of the photoinitiator and
macromonomer on the peltier plate of an AR-2000 rheometer (TA Instruments, New
Castle, DE) was irradiated with a long wavelength (365 nm) mercury UV lamp (Model
B100-AP; UVP, Upland, CA) at a distance of 10 cm from the sample. The gap distance
between the peltier plate and the upper 20 mm transparent acrylic geometry was 500 µm.
A sinusoidal shear strain with frequency of 1 Hz and amplitude of 1% was exerted on the
sample via the upper geometry and the storage ( G  ) and loss moduli ( G ' ' ) was recorded
with time. The time at which G'  G' ' was recorded as the gelation time. The notation XmN is used for the hydrogels with X representing the HA monomer, m for monomer, and
N for the number of HA monomers per macromonomer arm. For example, m0 denotes
PEG hydrogel without chain extension with HA monomer and C-m1.8 denotes SPECA
hydrogel with average of 1.8 ε-caprolactone monomers per macromonomer arm.
5.3.5. MEASUREMENT OF EQUILIBRIUM WATER CONTENT AND MASS LOSS
Hydrogels

20 mm diameter and 300 µm thickness were removed from the

rheometer and dried in ambient conditions for 12 h followed by drying in vacuum for 1 h
at 40°C. Dry samples were swollen in DI water for 24 h at 37°C with a change of
swelling medium every 6 h. After swelling, surface water was removed and the swollen
weights (ws) were measured. The swollen samples were dried as described above and dry
weights (wd) were recorded. The equilibrium water content was calculated by dividing
the weight of water (the difference between swollen and dry weights) by the swollen
weight as described.[35] To measure mass loss, the hydrogel precursor solution was
crosslinked in a polytetrafluoroethylene (PTFE) mold (5 cm × 3 cm × 750 µm) covered
with a transparent glass plate. Disk-shape samples were cut from the gel and their mass
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loss was measured in 5 mL PBS at 37ºC under mild agitation. At each time point,
samples were washed with DI water several times and dried under vacuum. The dried
sample weight was measured and compared with the initial dry weight to determine mass
loss as described.[35]
5.3.6.MARROW STROMAL CELL ISOLATION AND ENCAPSULATION IN
HYDROGELS
MSCs were isolated from the bone marrow of young adult male Wistar rats as
described.[35, 268] Cell isolations were performed under a protocol approved by the
Institutional Animal Care and Use Committee of the University of South Carolina. The
suspension of bone marrow cells was centrifuged at 200g for 5 min and the cell pellets
were resuspended in 12 mL basal medium consisting of DMEM supplemented with 10%
FBS, 100 units/mL PEN, 100 μg/mL SP, 50 μg/µL GS and 250 ng/mL FZ, and cultured
in a humidified 5% CO2 incubator at 37°C. Cultures were replaced with fresh medium at
3 and 7 days to remove hematopoietic and other unattached cells. After 10 days, cells
were detached from the flasks with 0.05% trypsin-0.53 mM EDTA and used for in vitro
experiments. The experimental groups for encapsulation of MSCs in SPEXA hydrogels
included m0, L-m1.7, D-m1.7 and C-m1.8. SPEGA hydrogel was not used for cell
encapsulation because it completely degraded in a few days (see Figure 6d). Cell
encapsulation and osteogenic differentiation experiments were carried out in SPEXA
hydrogels while maintaining a constant compressive modulus of 50 kPa by varying the
concentration of SPEXA macromonomer in the hydrogel precursor solution. Acrylamideterminated GRGD peptide (Ac-GRGD) was synthesized on Rink Amide NovaGel resin
in the solid phase, purified by high-performance liquid chromatography (HPLC), and
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characterized by electrospray ionization (ESI) mass spectrometry as previously
described.[113] Ac-GRGD peptide in the amount of 2 wt%, based on the macromonomer
weight, was added to the hydrogel precursor solution to facilitate cell adhesion to SPEXA
matrix, and the mixture was sterilized by filtration. Next, 1×106 MSCs suspended in 100
μL PBS was gently mixed with the hydrogel precursor solution to reach the final density
of 5×106 cells/mL. The mixture was injected between two sterile glass slides and
crosslinked as described above. UV exposure time for all cell-seeded precursor solutions
was 200 s, which was the minimum required time for the gel to reach its plateau modulus.
After gelation, samples were incubated in 2 mL PBS for 1 h with two PBS changes. Next,
the medium was replaced with complete osteogenic medium (basal medium
supplemented with 100 nM DEX, 50µg/mL AA, 10mM GP) and cultured for 28 days. To
measure the effect of photoinitiator on cell viability, 10 mg/mL initiator was added to the
suspension of MSCs in SPEXA precursor solution. After 10 min, the suspension was
centrifuged and cells were re-suspended and cultured in basal medium (without initiator).
After incubation for 2 days, MSCs were counted with a hemocytometer and cell numbers
were normalized to those cells cultured in PBS (no exposure to initiator).
5.3.7. BIOCHEMICAL ANALYSIS AND MRNA ANALYSIS
At each time point (7, 14, 28 days), gel samples were washed with serum-free
DMEM for 8 h to remove serum components, washed with PBS, lysed with lysis buffer
(10 mM tris and 2% triton), and sonicated. After centrifugation, the supernatant was used
for measurement of total collagen content, alkaline phosphatase (ALP) activity and
calcium content. Total collagen content was measured with a Sircol collagen assay based
on selective binding of G-X-Y amino acid sequence of collagen to Sircol dye, according
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to manufacturer‟s instructions.[269] Briefly, 1 mL Sircol dye was added to the sonicated
cell lysate, incubated for 30 min and centrifuged at 10,000 rpm for 5 min to separate the
collagen–dye complex. After removing the supernatant, the collagen-dye complex was
mixed with 1 mL Sircol alkali reagent and absorbance was measured on a plate reader at
555 nm. ALP activity and calcium content as a measure of the total mineralized deposit
were measured using QuantiChrom ALP and calcium assays as previously
described.[199] For mRNA analysis, at each time point, total cellular RNA of the sample
was extracted and converted to cDNA as described.[199] The cDNA was amplified with
gene specific primers designed using the Primer3 software as previously described.[188]
Expression of collagen type I (Col-I), ALP and osteocalcin (OC) was measured by
performing real-time quantitative polymerase chain reaction (RT-qPCR) using a CXF96
PCR system (Bio-Rad, Hercules, CA) with the following primers (synthesized by
Integrated DNA technologies, Coralville, IA): Col-1: forward 5‟-GCA TGT CTG GTT
AGG AGA AAC C-3‟ and reverse 5‟-ATG TAT GCA ATG CTG TTC TTG C-3‟; ALP:
forward 5`CCT TGA AAA ATG CCC TGA AA-3` and reverse 5`-CTT GGA GAG AGC
CAC AAA GG-3; OC: forward 5`-AAA GCC CAG CGA CTC T-3` and reverse 5`-CTA
AAC GGT GGT GCC ATA GAT-3`; S16: forward 5′-AGT CTT CGG ACG CAA GAA
AA-3′ and reverse 5′-AGC CAC CAG AGC TTT TGA GA-3′.[269] The expression ratio
of the gene of interest to that of S16 housekeeping gene was determined using Pfaffl
model[241] and normalized to the first time point.
5.3.8. STATISTICAL ANALYSIS
Data are expressed as means ±standard deviation. All experiments were done in
triplicate. Significant differences between groups were evaluated using a two-way
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ANOVA with replication test followed by a two-tailed Student's t-test. A value of p<0.05
was considered statistically significant.
5.4. RESULTS AND DISCUSSION
5.4.1. CHARACTERIZATION OF MACROMONOMERS
1

H-NMR spectra of star-PEG (m0), SPEGA (G-m2.8), SPEDA (D-m2.9), SPELA

(L-m2.9) and SPECA (C-m2.8) are provided in Figures 5.2.a to 5.2.e, respectively. The
assignment of chemical shifts for PEG macromer in the NMR spectra of lactide chainextended SPEXA was previously described by us.[35] The shifts with peak position at
3.6 and 4.3 ppm in Figure 5.2(a-e) corresponded to methylene protons of PEG attached to
ether and ester groups of HA repeat units, respectively. The shifts with peak position at
4.8-4.9 ppm in Figure 5.2.b corresponded to methylene protons of glycolide; those at 3.7,
4.2 and 4.4 ppm in Figure 5.2.c corresponded to β, α, γ methylene protons of pdioxanone, respectively; those at 1.6 and 5.2 ppm in Figure 5.2.d corresponded to methyl
and methine protons of lactide; and those at 1.4, 1.7, 2.3 and 4.1 ppm in Figure 5.2.e
corresponded to γ, β, α, ε ethylene protons of ε-caprolactone. The shifts with peak
position from 5.85 to 6.55 ppm were attributed to vinyl hydrogens of the Ac as follows:
peak positions in the 5.82-5.87 ppm range corresponded to the trans protons of
unsubstituted carbon in Ac; those in the 6.10-6.20 ppm range corresponded to the protons
bonded to monosubstituted carbon; and those in the 6.40-6.46 ppm range corresponded to
the proton of unsubstituted carbon. The number of HA repeat units per macromonomer
(m) was determined from the ratio of the shifts centered at 4.8-4.9 ppm (glycolide
hydrogens), 3.7, 4.2 and 4.4 ppm (p-dioxanone), 1.6 and 5.2 ppm (lactide) and 1.4, 1.7,
2.3 and 4.1 ppm (ε-caprolactone) to those at 3.6 and 4.3 ppm (PEG). The number of
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Figure 5.2. H-NMR spectra of (a) star PEG, (b) SPEGA (G-m2.8), (c) SPEDA (D-m2.9),
(d) SPELA (L-m2.9) and (e) SPECA (C-m2.8).
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acrylate groups per macromonomer was determined from the ratio of the shifts between
5.85 and 6.55 ppm (acrylate hydrogens) to those at 3.6 and 4.2 ppm (PEG). M n of
SPEGA, SPELA, SPEDA, and SPECA macromonomers depending on HA segment
length was in the range of 5.6-6.5 kDa, 5.8-7.4 kDa, 5.4-6.3 kDa and 5.5-6.4 kDa,
respectively, and the corresponding fraction of acrylated chain-ends was in the range of
0.78-0.87, 0.75-0.86, 0.73-0.82 and 0.75-0.85. Polydispersity of SPEGA, SPELA,
SPEDA, and SPECA macromonomers was in the range of 1.24-1.44, 1.17-1.34, 1.201.35 and 1.22-1.38 respectively.
5.4.2. STRUCTURE FORMATION IN SPEXA PRECURSOR SOLUTIONS
Formation of nanoscale structure by SPEXA macromonomers in aqueous medium
is shown in Figure 5.3. In the absence of HA monomer, the distribution of acrylate
groups attached to SPEXA chain ends was uniform in aqueous medium[60] but the
extension of SPEXA arms with hydrophobic X segments induced aggregation as shown
in Figure 5.3. For SPEGA and SPEDA with n=2, hydrophobic segments were not
sufficiently long to form stable micellar structures. However, SPELA and SPECA
macromonomers (see first column of Figure 5.3), due to higher hydrophobicity of lactide
and ε-caprolactone monomers, formed stable micelles with n=2. All four SPEXA
macromonomers formed stable micelles for n=4 (second column of Figure 5.3). The
aggregate size increased and number density decreased with increasing n from 4 to 8.
According to the theory of micellization in block copolymers in solution, degree of
aggregation increases with increasing block size, driven by the decrease in overall surface
free energy of solvophobic blocks.[270] Cross-sectional view of one of the aggregates
along with its EO beads is shown in Figure 5.4 for different number of HA repeat units.
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Figure 5.3. Evolution of core of the micelles in 20% aqueous solutions of SPEXA. Only
X and Ac (red) beads are shown for clarity. “n” is the number of HA repeat units. G, D, L
and C beads are shown by blue, pink, orange and purple, respectively. The scale bars are
5 nm.
In the images of Figure 5.3, hydrophobic HA segments and hydrophilic EO beads formed
the core and corona of the micelles, respectively. In our previous work, we showed that a
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Figure 5.4. Cross section of the micelles formed in 20% aqueous solutions of SPEXA.
“n” is the number of HA repeat units. SPEGc, EO and Ac beads are shown by yellow,
green and red, respectively. G, D, L and C beads are shown by blue, pink, orange and
purple, respectively. Water beads are not shown for clarity. The scale bars are 2 nm.
change in core size and aggregation number for SPELA micelles is dominated by
interfacial free energy (the product of interfacial tension  and interface area a ).[60]
Due to the presence of hydrophilic EO segments at the interface, the effective interfacial
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tension in SPEXA micelles is different from the interfacial tension between the micelle
core and water,  C W .[249]  can be calculated by minimizing the chemical potential of
the aqueous solution at equilibrium[271]

   C W 


kT  1  Ci N  1
1
3
ln

(Ci  C b )   W EO ( C i2  C 2b )
2 
N
2
4
s  1  Cb


(equation 5.9)

where  C W is interfacial tension between the micelles‟ core and water, k , T , s and N
are Boltzmann constant, absolute temperature, statistical EO segment length, and number
of statistical EO segments on each SPEXA arm. C i and C b are concentrations of EO
segments at the interface and in bulk, respectively. Equation 5.9 implies that an increase
in C i has a negative contribution to interfacial tension. In other words, dense EO
coverage of the interface decreases effective interfacial tension between the hydrophobic
domains and water. According to Figure 5.4, the micelle core size of SPECA
macromonomers with n=8 was similar to that of other monomers even though εcaprolactone was significantly more hydrophobic than the other monomers. This
discrepancy can be explained by higher packing of EO segments in the corona, thus
decreasing the effective interfacial tension of SPECA micelles.
Effect of number of hydrophobic X beads on core diameter of micelles, number of
macromonomers per micelle (aggregation number), number density of micelles, and
fraction of macromonomer free arms is shown in Figures 5.5.a to 5.5.d, respectively.
Assuming there were only X and Ac beads in the core, total number of beads taking part
in core formation per macromonomer equals 4 (n  1) and aggregation number is[60]

n agg 

 Vc
4 (n  1)

(equation 5.10)
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Figure 5.5. Effect of number of degradable HA repeat units on each arm on (a) core
radius (a), aggregation number (b), number density of micelles (c) and free arm fraction
of the micelles (d) in 20% aqueous solutions of SPEXA. Error bars correspond to means
± SD for 5 simulation runs.
where  and Vc are bead number density and micelle core volume, respectively. Core
radius of SPEGA and SPEDA micelles increased from 0 to 22 Ǻ when n increased from 2
to 8. Core radius of SPELA and SPECA micelles increased from 9 and 11 Ǻ to 23 and 24
Ǻ, respectively, with increasing n from 2 to 8. Aggregation number showed an increasing
trend with n after micelle formation (n=2 for L and C and n=4 for G and D). Average
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aggregation number of SPECA increased from 4 to 19 when n increased from 2 to 8
which was the highest aggregation number among the four macromonomers. SPEGA had
the lowest aggregation number, which ranged from 0 to 14 when n increased from 2 to 8.
The increase in SPEXA aggregation number with increasing n is attributed to the increase
in the volume of hydrophobic segments and the decrease in corona thickness of micelles,
leading to an increase in effective interfacial tension between the core and water with
increasing n.[60]
Number density of micelles initially increased with n due to a transition from
uniform distribution of macromonomers in the system to the formation of micelles. The
number density then decreased with n due to the increase in size and aggregation number
of micelles. Figure 5.5.d shows the effect of number of HA monomers on each arm (n) on
the fraction of free arms. For n=0, acrylate groups were uniformly distributed in solution
and fraction of free arms was unity. Fraction of free arms for SPELA decreased from 1 to
0.70, 0.14, 0.05 and zero as n increased from zero to 2, 4, 6 and 8, respectively, whereas
for SPEDA it decreased from 1 to 0.93, 0.23, 0.09 and zero. Fraction of free arms
decreased at a faster rate for SPECA and reached zero for n=6. SPEGA macromonomers
with n≤ 2 did not form micelles and had a free arm fraction of unity, and fraction of
SPEGA free arms decreased to 0.57, 0.18 and 0.04 as n increased from 2 to 4, 6 and 8,
respectively. The slower rate of decrease in fraction of free arms in SPEGA was
consistent with lower hydrophobicity of glycolide compared to the other monomers.
5.4.3. GELATION KINETICS OF SPEXA PRECURSOR SOLUTION
Rate of crosslinking of SPEXA macromonomers in aqueous solution depended on
the proximity of acrylate groups to photo-activated acrylates while the rate of photo-
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activation of acrylates depended on the proximity of initiator molecules to acrylate
groups. Therefore, rate of crosslinking depended on average distance between the
acrylates and initiator molecules. Distribution of photoinitiator beads (pink color) in
SPELA-m3 solution and cross-section of one of the micelle cores are shown in Figures
5.6.a and 5.6.b, respectively. Simulation images indicate that 98% of the photoinitiator
beads partitioned to the hydrophobic core of the micelles in the proximity of acrylates
(see pink beads in Figures 5.6.a and 5.6.b). The simulated fraction of initiators in the
aqueous phase (those not partitioned to the micelles‟ core) in SPELA solutions is shown
in Figure 5.6.c. Fraction of initiators in the aqueous phase decreased from 100% to 7.4,
3.3 and 2% when m increased from 0 to 1, 2 and 3, respectively. Partition of a large
fraction of initiators to the micelles‟ core confined the gelation reaction to the micelle
phase, thus potentially reducing the exposure of encapsulated cells to toxic initiator
molecules. MSCs in 20 wt% SPEXA solutions were exposed to 10 mg/mL photoinitiator
for 10 min, the cells were re-suspended in basal medium (without initiator) and cultured
for 2 days. Figure 5.6.d compares the normalized cell numbers for SPEXA solutions after
exposure to photoinitiator to that in SPEXA-m0 (acrylated star PEG without HA chainextension). Groups included SPEGA (G-m1.6), SPELA (L-m1.7), SPEDA (D-m1.7),
SPECA (C-m1.8) and PEG (m0). The cell number was significantly higher for SPELA
(0.87±0.04) and SPECA (0.84±0.05) solutions compared to SPEXA-m0 (0.77±0.05)
which can be explained by partitioning of initiator molecules to the hydrophobic micelle
phase (see Figure 5.6.c), whereby the exposure of encapsulated cells to initiator
molecules was reduced.
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Figure 5.6. (a) Distribution of photoinitiator molecules in the simulation box in SPELAm3 precursor solution and (b) in the corresponding cross-section of one of the micelles. L
and Ac beads in (a-b) are shown in orange and red, respecctively, while the initiator bead
is in purple. EO and water beads are not shown for clarity. (c) DPD simulation of the
effect of number of degradable lactide monomers per SPELA arm on fraction of initiators
in aqueous solution. (d) Effect of exposure of MSCs to photoinitiator (10 mg/mL) in 20
wt% SPEXA precursor solution on the fraction of viable cells as a function of HA type.
P, G, L, C and D in (d) represent PEG (no HA, control group), SPEXA with glycolide,
lactide, ε-caprolactone and p-dioxanone HA monomer, respectively. “star” indicates a
statistically significant difference between the test group and P. (e) Effect of number of
degradable HA monomers per arm on simulated Ac-Ac running integration number and
(f) experimental gelation time of 20% SPEXA precursor solutions.
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Micelle formation sharply reduced the average inter-acrylate and acrylate-initiator
distance, leading to a significant increase in the rate of initiation and propagation of the
acrylates. To quantify the average inter-acrylate distance (related to crosslinking rate) or
proximity of water beads to ester groups on SPEXA macromonomers (related to
hydrolytic degradation rate), the average number of Ac (or W) beads in a sphere of radius
R around an Ac (or ester) bead or the running integration number of beads “a” around
beads “b”, IN ab (R) was calculated by[248]
R

IN ab ( R)  4 b 0  g ab (r ) r 2 dr

(equation 5.11)

0

where  b 0 is overall number density of type “b” beads and g ab (r ) is radial distribution
function of bead “b” around bead “a”, located at the origin. The running integration
number of Ac-Ac beads in SPELA solutions ( IN Ac  Ac ) at R  rc (the DPD length scale
6.74 Å, see Methods section) initially increased with increasing m from 0 to 2, as shown
in Figure 5.6.e, and then decreased as m increased from 2 to 3. Conversely, a unimodal
increase in IN Ac  Ac was observed for SPEGA, SPECA and SPEDA solutions with
increasing m from 0 to 3. The increase in IN Ac  Ac with m was attributed to a decrease in
average Ac-Ac distance in the micelles‟ core. As the core of the micelles continued to
increase in size and their separation distance continued to increase for m>2, average
distance between the Ac beads began to increase, leading to a decrease in IN Ac  Ac , as
predicted for SPELA in Figure 5.6.c. Furthermore, SPELA and SPECA macromonomers
had higher IN Ac  Ac than SPEGA and SPEDA for m  3 . The predicted IN Ac  Ac values
are related to gelation time of the macromonomers in aqueous solution. Gelation time of
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20 wt% SPEXA solutions was measured with a rheometer as a function of number of HA
monomers per arm and the results are shown in Figure 5.6.f. Gelation times of SPELA
and SPECA precursor solutions were shorter than those of SPEGA and SPEDA, as
predicted by simulation (see Figure 5.6.e). Gelation time of 20 wt% SPEGA, SPEDA,
SPELA and SPECA solutions decreased from 150 s to 61, 64, 28 and 34 s, respectively,
with increasing m from 0 to 3 (see Figure 5.6.f). The initial sharp decrease in gelation
time was attributed to aggregate formation and an increase in IN Ac  Ac . Simulation results
in Figure 5.6.e predict that the IN Ac  Ac value for SPELA should decrease for m>2.
However, a decrease in IN Ac  Ac for SPELA at higher m values was offset by an increase
in residence time of the arms in the micelle core, leading to no change in gelation time.
Residence time of a hydrophobic segment in the micelle core is proportional to[249, 272]

 ~  .n 2 / 3

(equation 5.12)

where  is effective interfacial tension between the hydrophobic domains and water. As a
result, residence time of the unreacted Ac groups in the micelles‟ core increased with n,
which increased the rate of crosslinking, thereby gelation time was reduced. Furthermore,
fraction of bridging arms between micelles increased with increasing residence time,
which in turn increased the extent of physical gelation. Therefore, gelation time of the
macromonomer solutions continued to decrease with increasing n.
5.4.4. DEGRADATION OF SPEXA HYDROGELS
Degradation of SPEXA hydrogels depended on the proximity of water beads to
ester links on HA segments. Local distribution of water beads around hydrophobic cores
of SPEXA-n4 micelles is shown in Figure 5.7.g. Water beads were in close proximity to
G beads in SPEGA solution. The relatively small size of G cores along with lower
117

hydrophobicity of G beads compared to other HA monomers led to a short average
distance between G and W beads. when SPEGA was replaced with SPELA, size of the
micelles‟ core increased and local concentration of W beads around the core decreased
(Figure 5.7.g, see image “L”), thereby increasing the average L-W bead distance. A dip
in the concentration of W beads observed proximal to the micelle core in SPELA was
attributed to the higher hydrophobicity of L beads, compared to G, leading to a higher
packing of EO beads at the core-water interface. Concentration of W beads proximal to
the micelles‟ core increased by exchanging SPELA with SPEDA but core size in SPEDA
was significantly larger than SPEGA. The lowest concentration of W beads at the core
margins was observed for SPECA micelles where the higher hydrophobicity of C cores
compared to other HA monomers overcame the energy of chain extension and forced EO
beads to undergo high-entropy packing at the core-water interface by repelling water
beads from the interfacial layer.
The running integration number of water beads around ester links, IN ester W , for
SPEXA macromononers (data not shown) initially increased with the addition of one
monomer to SPEXA-m0. Then, IN ester W decreased for all SPEXA solutions with m>1
due to increase in micelle size and decrease in total micelle surface area. SPEGA and
SPECA solutions had the highest and lowest IN ester W for all m values, respectively.
However, degradation rate of SPEXA hydrogels depended on the density of ester groups
as well as proximity of ester groups to water beads. Assuming that the formation of
carboxylic acid groups by ester dissociation did not affect hydrolysis rate (this is a good
assumption since degradation was performed in a buffered aqueous medium), the relative
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Figure 5.7. (a) Effect of number of HA monomers per arm (m) on predicted hydrolysis
rate of 20 wt% SPEXA precursor solutions. (b) Effect of HA monomer type on
experimental mass loss of SPEXA hydrogels with incubation time. (c-f) Effect of number
of HA monomers per macromonomner on experimental mass loss of SPELA, SPEGA,
SPEDA and SPECA hydrogels, respectively, with incubation time. (g) Effect of
degradable HA monomer type on distribution of water beads around core of the micelles.
(h) Effect of number of HA monomers per arm on experimentally-measured equilibrium
water content of SPEXA hydrogels. In (g), G, D, L, C, Ac and water beads are shown by
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blue, pink, orange, purple, red and light blue, respectively, and EO beads are not shown
for clarity.
hydrolysis rate (P) at the mesoscale scale, which is proportional to the rate of degradation
at the macroscale, is defined by

P  INesterW  INesterester

(equation 5.13)

In the above equation, INester W and INester ester are proportional to the
concentration of water and ester groups in the micelles, respectively. The simulated
relative hydrolysis rate in the reaction volume for 20 wt% SPEXA macromonomers in
aqueous solution is shown in Figure 5.7.a as a function of m. For all m values, SPEGA
had the highest relative hydrolysis rate followed by SPELA, SPEDA and SPECA.
Relative hydrolysis rate for SPECA and SPEDA solutions increased from zero to 5.2 and
12.5, respectively, with increasing m from zero to 4. Likewise, relative hydrolysis rate of
SPELA and SPEGA solutions increased from zero to 13.4 and 22.5, respectively, with
increasing m from zero to 3 and then decreased to 12.3 and 21.0 with increasing m from
3 to 4. The relatively large difference in predicted relative hydrolysis rates between
SPEXA macromonomers for a given m indicated that hydrolysis was related to
equilibrium water content and concentration of ester groups in the micelles, not to the
bulk water concentrations (the solutions had similar bulk water contents, see Figure
5.7.h). The predicted biphasic hydrolysis rate for SPELA and SPEGA in Figure 5.7.a was
attributed to the low proximity of water to ester beads in larger micelle cores at higher m
values. SPECA with the most hydrophobic micelles had the lowest predicted hydrolysis
rate while SPEGA with the least hydrophobic micelles had the highest hydrolysis rate.
Mass loss of 20 wt% SPELA, SPEGA, SPEDA and SPECA hydrogels with incubation
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time for different m values are shown in Figures 5.7(c-f). SPELA-0L without lactide
chain extension had <5% mass loss after 6 weeks of incubation.
Mass loss of SPELA gels was linear with incubation time for all m values.
SPELA hydrogels lost 6%, 37%, 80% and 100% mass after 4 weeks as m increased from
zero to 0.8, 1.6 and 2.9, respectively. However, SPELA mass loss decreased from 100%
to 87% as m increased from 2.9 to 3.7, which was consistent with the predicted decrease
in SPELA hydrolysis rate for 3 ≤ m ≤ 4 in Figure 5.7.a (brown curve). SPEGA gels had
the fastest degradation rate among HA monomers. The time for complete degradation of
SPEGA gels initially decreased from 8 to 2 days with increasing m from 0.8 to 1.6.
However, SPEGA degradation time increased from 2 to 3 days when m increased from
1.6 to 2.8 mainly due to a transition from surface (controlled by the number of ester
groups) to bulk degradation (domination by water content of the micelles). The difference
in experimental (1.6 < m < 2.8) and simulated (3 < m < 4) transition range for SPEGA
was attributed to the polydispersity of G segments, leading to a wider distribution of
micelle core sizes. Mass loss of SPEDA and SPECA gels after 42 days ranged between
30-39% and 80%-89% respectively. The non-linear degradation trend for SPEDA was
attributed to a wider micelle size distribution, which was not taken into account in the
simulations. The experimentally measured mass losses for SPEXA hydrogels at similar m
values (1.6 ≤ m ≤ 1.8) are compared in Figure 5.6.b. SPEGA and SPELA hydrogels
completely degraded in 3 days and 5 weeks, respectively, whereas SPEDA and SPECA
hydrogels lost 40% and 20% their mass in 6 weeks. Equilibrium water content of SPEXA
hydrogels as a function of m is shown in Figure 5.7.h. The difference in water content of
SPEXA gels was not statistically significant (p values for the difference between water
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contents were >0.17). Therefore, the wide range of degradation rates from a few days to
many months observed for SPEXA gels, as shown in Figure 5.7.b, can only be explained
by differences in equilibrium water content of the micelles with HA type and number of
HA monomers per segment.
5.4.5. OSTEOGENIC DIFFERENTIATION OF MARROW STROMAL CELLS IN
SPEXA HYDROGELS
MSCs were encapsulated in SPEXA gels and the effect of HA monomer type on
osteogenic differentiation of MSCs was evaluated. SPEGA gel due to its relatively fast
degradation (see Figure 5.7.d) was not used for MSC encapsulation. Groups included 20
wt% SPELA (L-m1.7), SPEDA (D-m1.7), SPECA (C-m.18) and PEG (m0). The effect of
HA type on total collagen content with incubation in osteogenic medium is shown in
Figure 5.8.a. Total collagen content of L-m1.7 gel increased from 54 μg/μg DNA at day 7
to 83 and 122 μg/μg DNA at days 14 and 21, respectively. Total collagen content of Lm1.7 gel was significantly higher than those of C-m1.8, D-m1.7 and m0 gels for all
incubation times. The higher secretion of collagen by MSCs seeded in L-m1.7 gels is
attributed to hydrolytic degradation of the matrix concurrent with ECM production. Rate
of ECM production is related to the rate of matrix degradation.[102, 169] ECM
production is limited by free volume when rate of matrix degradation is slower than that
of ECM production. Conversely, ECM production is limited by cell adhesion when rate
of matrix degradation is faster than that of ECM production. ALP activity and extent of
mineralization of MSCs in SPEXA gels are shown in Figures 5.8.b and 5.8.c,
respectively. Consistent with previous results, ALP activity of all groups increased from
day 7 to 14 and then decreased after 28 days with mineralization.[35, 113] At day 14,
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Figure 5.8. (a) Total collagen, (b) ALP activity and (c) alcium content of MSCs
encapsulated in SPEXA hydrogels with incubation time in osteogenicc medium. mRNA
expression of (d) Col-1, (e) ALP and (f) OC of MSCs encapsulated in SPEXA hydrogels
with incubation time in osteogenicc medium. “star” indicates statistically significant
difference (p<0.05) between the test group and all other groups at the same time point.
Error bars correspond to mean ± SD for 3 experiments.
ALP activity of L-m1.7 was significantly higher than the other groups. Calcium content
of all groups had an increasing trend with time. Calcium content of L-m1.7 increased
from 10.3±1.2 to 40.8±8.5 and 224.7±18.5 mg/mg DNA with incubation time from day 7
to 14 and 28. After 28 days, calcium content of L-m1.7 was significantly higher than the
other groups. Furthermore, at day 28, calcium content of D-m1.7 and C-m1.8 was
significantly higher than that of m0 group. It can be inferred from the results that
degradation of SPEXA gels contributed significantly to mineralization with L-m1.7 gel
having 2.3-fold higher mineral deposition compared to non-degradable m0 (PEG gel).
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Higher extent of mineralization of MSCs in degradable gels is consistent with previous
reports. In one study, Human MSCs encapsulated in a hydrolytically degradable PEG
matrix and incubated in osteogenic medium displayed higher cell-cell contact and cell
spreading compared to non-degradable PEG.[30, 273] In another study, mineralization of
osteoblasts increased by three folds with conjugation of lactide segments in PEG
dimethacrylate hydrogels.[101]
mRNA expression levels of Col-1, ALP and OC are shown in Figures 5.8(d-f),
respectively. Col-1 expression for all groups was significantly higher at day 28 compared
to day 7. For example, Col-1 mRNA expression of L-m1.7 increased from 2.9±0.7 to
16.6±1.7 and 45.2±5.0 when incubation time increased from day 7 to 14 and 28. At day
28, Col-1 mRNA expression of L-m1.7 was 2.5 fold higher than PEG gel. ALP mRNA
expression (Figure 5.8.e) showed a trend similar to its bioactivity in Figure 7b. At day 14,
ALP mRNA expression of L-m1.7 was significantly higher than the other gels and 2.2
times higher than PEG gel. OC expression of all groups increased from day 7 to 28 with
L-m1.7 and C-m1.8 gels showing significantly higher OC expression at day 28 compared
to D-m1.7 and PEG gels. Taken together, the findings of this work demonstrate that chain
extension of PEG hydrogels with short HA segments resulted in the formation of micellar
hydrogels that support differentiation and mineralization of MSCs with a wide range of
degradation rates from a few days to many months.
5.5. CONCLUSIONS
Structure formation and gelation kinetics of SPEXA macromonomers in aqueous
solution and degradation of SPEXA gels were investigated by simulation and
experimental measurement. In the absence of HA monomer, distribution of acrylate
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groups was uniform in aqueous solution but the extension of the macromonomer arms
with hydrophobic X segments induced aggregation and micelle formation. Core radius of
SPEGA and SPEDA micelles increased from 0 to 22 Ǻ when number of HA repeating
units per arm (n) increased from 2 to 8 while that of SPELA and SPECA micelles
increased from 9 and 11 Ǻ to 23 and 24 Ǻ, respectively. Aggregation resulted in
partitioning of the polymerization photoinitiator to the micelle phase, which confined the
gelation reaction to the micelle phase, thereby improving viability of encapsulated MSCs.
Micelle formation sharply reduced the average inter-acrylate and acrylate-initiator
separation distance, leading to a significant increase in gelation rates of SPEXA gels. For
example, gelation time of 20 wt% SPEGA, SPEDA, SPELA and SPECA solutions
decreased from 150 s to 61, 64, 28 and 34 s, respectively, with increasing number of HA
monomers per arm (m) from 0 to 3. The simulated hydrolysis rates of SPEXA gels were
strongly dependent on HA type and number of HA repeat units, consistent with
experimentally measured degradation rates. For all HA types, hydrolysis rate of SPEXA
gels was biphasic. For example, as m increased from 0.7 to 1.2, 1.8 and 2.8, mass loss of
SPEGA gels after 2 days increased from 20% to 46% and 80% and then decreased to
66%, respectively. Similarly, as m increased from 0.8 to 1.7, 2.9 and 3.7, mass loss of
SPELA gels after 3 weeks increased from 32% to 50% and 62% and then decreased to
46%. All SPEXA gels had similar initial water contents irrespective of HA type and n. A
biphasic relationship between HA segment length and gel degradation rate indicated a
transition from surface to bulk hydrolysis in the micelle phase. The micellar SPEXA
hydrogels supported osteogenic differentiation, collagen production and mineralization of
MSCs.
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CHAPTER 6
MESOSCALE SIMULATION OF THE EFFECT OF A LACTIDE SEGMENT ON THE
NANOSTRUCTURE OF STAR POLY(ETHYLENE GLYCOL-CO-LACTIDE)-ACRYLATE
MACROMONOMERS IN AQUEOUS SOLUTION

Seyedsina Moeinzadeh and Esmaiel Jabbari, Mesoscale Simulation of the Effect of a
Lactide Segment on the Nanostructure of Star Poly(ethylene glycol-co-lactide)-Acrylate
Macromonomers in Aqueous Solution, Journal of Physical Chemistry B, 2012. 116(5): p.
1536-1543 Reprinted here with permission of publisher.
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6.1. INTRODUCTION
Hydrogels, due to their high water content and high diffusivity of nutrients and
biomolecules, are very attractive as a carrier for delivery of stem cells to the site of defect
in regenerative medicine.[21, 24, 28, 87, 88] After injection and in situ hardening, the
hydrogel matrix guides the development of seeded cell into the desired tissue.[24] In
most in situ applications, the hydrogel should have robust mechanical stability to prevent
deformation and rupture by soft tissue compression or other mechanical loads.[44] In
addition, the hydrogel should be degradable to provide volume for tissue
regeneration.[48] Hydrogels based on small-molecule monomers, due to their potentially
high network density, have excellent structural stability, but viability of the seeded cells
is severely reduced by the diffusion of toxic monomers across the cell membrane.[42]
Naturally based injectable gels have excellent biocompatibility and support cell-matrix
interaction, but they have very low cross-link density and mechanical strength.[31, 274]
Physically cross-linked hydrogels, due to the transient nature of the cross-links, also
suffer from low mechanical strength.[36, 235] There is a need to develop synthetic
biodegradable macromonomers for applications in regenerative medicine with robust
mechanical properties. In that regard, hydrogels based on functionalized poly(ethylene
glycol) (PEG) macromers are inert and nonimmunogenic and have a compressive
modulus exceeding 1 MPa.[169, 275] PEG hydrogels have been used extensively to
investigate the effect of matrix physiochemical, mechanical, and biological factors on cell
function in vitro.[26, 44] To impart degradability to the hydrogels, short degradable
lactide segments can be attached to the PEG macromer by ring opening polymerization
prior to acrylate functionalization to produce a degradable PEG based hydrogel.[136,
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218, 276] However, the hydrophobic lactide segments in the hydrophilic PEG, in addition
to reducing the solubility of the macromonomer in aqueous solution and the water
content of the resulting PEG hydrogel, cause micelle formation.[134, 135] Experimental
results

with

four-arm

star

poly(ethylene

glycol-co-lactide)-acrylate

(SPELA)

macromonomer demonstrate that the hydrogel modulus increases slightly with the
addition of 1−2 lactides per arm followed by a sharp decrease in modulus for higher
lactide segment lengths.[52] The formation of nanostructure by macromonomers in the
hydrogel precursor solution alters the spatial distribution and accessibility of the reactive
functional groups, which in turn affects the rate and extent of cross-linking.[277]
Therefore, a molecular-scale understanding of the factors that affect nanostructure
formation in these mixtures will aid us in designing hydrogels from macromonomers with
improved physical and mechanical properties. Atomistic molecular simulations are
limited to the atomic time and length scales.[278] Mesoscale methods in which the
dynamics of the system is based on course-grained beads made up of a group of atoms
have been developed to simulate the nanostructure of copolymers.[244, 279, 280]
Hoogerbugge and Koelman[243] introduced the dissipative particle dynamics (DPD)
approach, later revised by Espanol and Warren,[242] to simulate the dynamics of soft
spherical beads interacting through pairwise additive force fields. The DPD approach has
been used to simulate the mesoscale dynamics of polymer systems [281-285] after Groot
and Warren related the conservative force terms to the Flory− Huggins interaction
parameter.[58, 80] DPD has been used to simulate the microstructure and microphase
separation for linear and multiarm block copolymer mixtures and solutions.[184, 244,
286-290] The objective of this work was to simulate the nanostructure and micelle
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formation of SPELA macromonomer, a four-arm PEG with short lactide chains
terminated with acrylates. In this work, the effect of the four-arm SPELA lactide segment
length and macromonomer concentration in aqueous solution on micelle formation and
distribution of the acrylate groups will be simulated with DPD. The distribution of the
acrylates, namely free from the micelles, tethered, and trapped in the micelles, provide
information on the crosslinking efficiency of the SPELA macromonomer and then
ultimate modulus of the hydrogel.
6.2. METHODS
6.2.1. THEORY
In DPD simulation, the polymer solution is divided into different beads (set of
atoms) with equal mass and volume. The SPELA macromonomer is synthesized by
ringopening polymerization of lactide monomers initiated by a four-arm star PEG (MW
of 5 kDa), followed by acrylation of the chain ends with acryloyl chloride. Figure 6.1
shows the molecular structure and different bead types on SPELA macromonomer. The
bead types included lactide (L, dark brown), ethylene oxide (EO, green), acrylate (Ac,
red), and star PEG center (SPEGc, light brown). Three water molecules were used for the
solvent bead. The evolution of the position and velocity of all beads is governed by
Newton‟s equation of motion:[242, 243]

d ri
dv
 v i , mi i  f i
dt
dt

(equation 6.1)

where ri , m i , v i and f i are the position vector, mass, velocity vector, and total force
vector acting on bead i respectively. The total force in a cutoff radius (rc) is[242]:
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Figure 6.1. Bead representation of SPELA macromonomer in DPD.

fi 

F
i j

C
ij

 FijD  FijR
(equation 6.2)

where f i is the total force and FijC , FijD , FijR are the conservative, dissipative and random
components of the force respectively. Different parts of the force are given by [242]:

α ij (1  rij ) e ij rij  1
FijC  
rij  1
0

(equation 6.3)

FijD    w D ( rij ) (e ij .v ij ) e ij

(equation 6.4)

FijR   w R ( rij ) ij e ij

(equation 6.5)

where rij and e ij are the magnitude and unit of the vector joining bead i to j ( rij  ri  rj ),
v ij is given by v ij  v i  v j , and αij is a constant that describes the maximum repulsion

between the interacting beads i and j. αij , which is dependent on the characteristics of
the mixture plays a significant role in determining the nanostructure of the equilibrated
130

macromonomer solution. The system contains dissipation as well as total momentum
conservation due to the simultaneous action of FijD and FijR . w D and w R are r-dependant
weight functions for dissipative and random forces respectively, and  ,  are the
magnitude of dissipative and random forces. ij is a random variable with a Gaussian
probability distribution. Espanol and Warren showed that the parameters of the
dissipation and random forces have to satisfy fluctuation-dissipation conditions

w D (rij )  [w R (rij )]2

and

 2  2 k B T  .[242].

The

optimized

weight

function

w D (rij )  (1  rij ) 2 within the cutoff distance for soft chains in aqueous solution was used
in the simulation. [58]
According to the force balance (equation 6.2), the beads on the macromonomer
that are not directly connected move like soft spheres in the solution. However, the
motion of the adjacent beads that are directly connected is constrained by covalent bonds.
Thus, an additional spring force has to be included to simulate the motion of adjacent
beads on the macromonomer chains. The spring force acting on the bonded consecutive
beads of a chain is given by[58]

FiS   C rij

(equation 6.6)

j

where beads j are those that are connected to bead i. A value of 4 was used in the
simulation for spring constant C to properly account for the distance between connected
beads.[244] Due to the domination of repulsive forces between soft spheres in the mean
segment length,[244] the end point distribution of the macromonomer is not very
sensitive to the value of constant C.
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6.2.2. SIMULATION PARAMETERS
The parameters of the conservative force were set by choosing the mapping of
three water molecules per DPD bead in order to simulate the diffusivity and
compressibility of water.[291-293] This mapping made it possible to simulate the
structure of SPELA macromer with small L:EO ratio and one acrylate per arm. All beads
in the simulation system had the same volume of 90 Å3 and the same mass 54 amu. By
choosing the system density ρ = 3rc−3, the DPD fundamental length scale, rc, was 6.46 Å
and the bead−bead interaction parameters were determined by[58]

 ij   ii  3.27ij

(equation 6.7)

where  ij is the Flory-Huggins parameter between beads i and j and  ii is the repulsion
parameter between beads of the same type. To satisfy the compressibility of water, the
mapping of three water molecules per bead led to  ii  78 .[291]. Flory-Huggins
parameters were calculated using:
 ij 

( i   j ) 2 V

(equation 6.8)

RT

where  i and  j are the solubility parameters of beads i and j respectively, V is the bead
molar volume, T is the absolute temperature, and R is the gas constant. The solubility
parameters were calculated via atomistic Molecular Dynamics simulation (Forcite
module in Materials Studio V. 5.5 (Accelrys)) using the COMPASS forcefield which is
an ab initio forcefield optimized for condensed-phase systems[245]. To arrive at the
initial packing for each bead type, 64 beads were simulated in a cubic unit cell with 3D
periodic boundary conditions using the rotational isomeric state (RIS) method,[294]
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subject to equilibration at 298 K. After geometric optimization, the unit cell was
equilibrated by the annealing dynamics simulation method, which included five cycles of
NVT ensemble dynamics between 300 and 800 K to prevent the system from being
trapped in a local minimum. After reaching the lowest energy configuration, 1500 ps of
thermalizing NPT dynamics (1 fs time step) was performed to reach the actual system
temperature and pressure. Next, the cohesive energy density (CED) was determined by
sampling the system and collecting data for 500 ps. The CED was related to the solubility
parameter of bead i, δ i , by
1
2

1
 ΔH v,i 
  (CED) 2
δ i  

 Vm,i 

(equation 6.9)

where H v ,i and Vm, i are the molar enthalpy of vaporization and molar volume of bead i
respectively. The bead−bead repulsion parameters,  ij , calculated from the solubility
parameters using eqs 6.7 and 6.8, are given in Table 6.1.
The initial condition of each simulation was the random distribution of coarsegrained SPELA-nL macromonomers and water beads inside the simulation box with 3D
periodic boundary conditions. The parameter “n” in SPELA-nL is equal to the number of
L beads on each arm of the macromonomer. The total numbers of L and EO beads were
held constant at 32 while n was varied, and the macromer concentration was 30% v/v
unless otherwise specified. The macromonomer was simulated in cubic boxes with
lengths of 30rc, 40rc, and 50rc. The relative distribution and structure of the
macromonomer after equilibration was independent of size of the simulation box. The
simulated root-mean-square radius of gyration (Rg) of the four-arm PEG (MW of 5.9 kDa
with 33 beads on each arm) was 25.4 Å, which was in the theoretical range 21.2−27.8
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Table 6.1. DPD Interaction Parameters (  ij ) Used in the Simulation.

Ac
L
EO
SPEGc
W

Ac

L

EO

SPEGc

W

78.0
83.2
91.9
118.7
98.9

83.2
78.0
86.8
86.3
92.3

91.9
86.8
78.0
93.3
80.5

118.7
86.3
93.3
78.0
115.6

98.9
92.3
80.5
115.6
78.0

Å.[53, 295] Furthermore, the length of the simulation box (197 Å for 30rc) was an order
of magnitude larger than Rg, indicating that the finite size effects may have no effect on
our results.[289] Bead diffusivities reached steady-state values after 150000 time steps.
All simulations ran 200000 times with a dimensionless time step of 0.05. For each
sample, the DPD simulation was repeated five times (with randomly seeded
macromonomers in the simulation box) and the results were reported as the mean ±
standard deviation. All atomistic and mesoscale calculations were performed via the
Amorphous Cell, Forcite, and Mesocite modules of Materials Studio v5.5 (Accelrys, San
Diego, CA).[267]
6.3. RESULTS AND DISCUSSION
6.3.1. EFFECT OF LACTIDE FRACTION
Figure 6.2 shows the effect of the number of lactides on structure formation of
SPELA-nL macromers in water (30% v/v). It should be noted that the W, EO, and SPEGc
beads are not shown in Figure 6.2 for clarity. In the absence of lactide (n = 0), the
acrylates were uniformly distributed over the volume of the simulation box. Addition of
lactide segments (n ≥ 2) to the macromonomer led to the formation of micellar structures.
The hydrophobic lactide and acrylate beads of the arms belonging to different
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Figure 6.2. Evolution of micellar cores for SPELA-nL macromonomers in 30% aqueous
solution. “L” and “Ac” represent lactide and acrylate beads respectively. The other beads
in the image are not shown for clarity.
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macromonomers aggregated and formed the core of the micelles while the hydrophilic
EO segments, facing the aqueous phase, formed the micelle‟s corona. Those arms that are
not part of the hydrophobic core of the micelles are referred to as “free arms”. With
increasing number of lactides per arm, the core size of the micelles increased while the
number of free arms decreased. A cross section of the structures, corresponding to those
in Figure 6.2, is shown in Figure 6.3. With increasing n, more arms of each
macromonomer participated in the formation of the micellar core. Consequently, the core
size increased with n while the corona thickness decreased, as shown in Figure 6.3. At
low n with small hydrophobic domains, the EO segments had an extended conformation
in the aqueous phase at the water−micelle interface. However, as n and the volume of the
hydrophobic domain increased, the EO segments adopted a 2D stretched conformation on
the surface of the micelles. This change in conformation is caused by repulsive
interactions between water and lactide segments at the interface dominating over the
reduction in entropy as the EO segments adopt a 2D conformation on the micelle surface.
The effect of number of lactides on each arm on the core radius and number
density of micelles is shown in Figure 6.4.a. The core size increased with the volume
fraction of lactide segments, while the number density decreased. Although the
aggregation of lactide segments and formation of micelles reduces the total free energy of
the solution, two positive contributions to the free energy controlled the core size and
number density.[296] One factor is the free energy of the water−micelle interface, which
is proportional to the core surface area per macromonomer. The other factor is the steric
repulsive energy between the hydrophilic EO segments positioned at the corona−core
interface of the micelles, which is inversely proportional to the core surface area per
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Figure 6.3. Cross section of the micelles for SPELA-nL macromonomers in 30% aqueous
solution. “L”, “Ac”, “EO”, and “SPEGc” represent lactide, acrylate, ethylene oxide, and
the star PEG core, respectively. The water beads are not shown for clarity.
macromer. The number of EO beads per unit core surface area deceases with increasing
n, leading to a decrease in repulsive energy between the EO segments. At the same time,
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Figure 6.4. The effect of the number of lactide beads on each arm on (a) the micelle core
size and number density and (b) the aggregation number of micelles in 30% aqueous
solution of SPELA-nL macromonomers. n represents the number of lactide beads on each
macromonomer arm, which has a total of 32 L and EO beads. Error bars correspond to
means ± 1 SD for n = 5 simulations.
the EO layer thickness on the core surface decreases with increasing n, thus leading to an
increase in interfacial free energy. Since the core size increased with n (see Figures 6.2
and 6.3), the net effect is the domination of interfacial over repulsive free energy, which
led to the formation of micelles with smaller core surface areas per molecule, larger
cores, and lower number density of micelles. The average number of SPELA
macromonomers in a micelle or aggregation number, n agg , can be calculated by the
following equation, assuming there are only L and Ac beads in the micelle‟s core:
n agg 

 Vc
4 (n  1)

(equation 6.10)

where  and Vc are the bead number density and micelle core volume, respectively.
Figure 4b shows that the aggregation number increased with n. According to Figure
6.4.b, there was a sharp increase in n agg from 3 to 9 when n was raised from 2 to 4. That

138

increase can be related to the transition from macromonomer density fluctuation (size <
Rg) to micelle formation (see Figure 6.2). n agg also increased sharply when n was raised
from 12 to 16, which can be related to the transition from micellar to microphase
separated solution. For the case of SPELA-20L, the small interfacial surface area per
macromonomer could not be achieved for minimization of free energy by spherical
packing, which led to the formation of continuous phases in the simulation box (data not
shown).
6.3.2. EFFECT OF MACROMONOMER CONCENTRATION
The effect of macromonomer concentration on core radius and number density of
micelles for SPELA-4L is shown in Figure 6.5. The core radius slightly increased from
14.9 to 16 Å as the SPELA concentration was increased from 5 to 30%. The ratio of
water to lactide beads was higher for lower SPELA concentrations, resulting in a stronger
repulsive interaction at the micelle−water interface and smaller core size. Since there was
a slight change in core size with concentration, the number density of micelles increased
with increasing macromonomer concentration. In addition, the distribution of acrylates in
the core of the micelles did not change significantly with increasing SPELA
concentration.
6.3.3. INTER-MICELLAR BRIDGING
The cross sections in Figure 6.3 show that the center of the macromonomers
(SPEGc) is positioned in the corona of the micelles. Therefore, the arms can possess three
different conformations, namely, the intermicellar bridges, loops in which at least two
arms of a macromonomer are in the same micelle, and free arms. The three
conformations are shown schematically in Figure 6.6. For SPELA-0L with n = 0, the
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Figure 6.5. The effect of macromonomer concentration on the core size and number
density of the micelles in aqueous solution of SPELA-4L macromonomers. Error bars
correspond to means ± 1 SD for n = 5 simulations.

Figure 6.6. Schematic representation of bridge, loop ,and free arm conformations of
SPELA macromonomers in aqueous solution. “L”, “Ac”, and “EO” represent lactide,
acrylate, and ethylene oxide beads, respectively.
arms are in solution and considered free. For SPELA macromonomer with n > 0,
aggregation of hydrophobic lactide groups and micelle formation results in the creation of
loops and bridges. Assuming ideal solution and connectivity of the macromonomer arms
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does not affect partitioning, the relation between the mole fraction of arms in the micelles
( X ma ) and free arms ( X fa ) at thermodynamic equilibrium is given by[297]
ln 4n agg 
ln X ma 
 0mic   0f

 ln X fa  
4n agg
RT
4n agg

(equation 6.11)

where ( 0mic  0f ) is the standard chemical potential of micellization per arm, n agg is the
aggregation number of macromonomers in a micelle, and R and T are the gas constant
and absolute temperature, respectively. According to Figure 6.5, macromonomer
concentration has a slight effect on micelle core size and thus the aggregation number.
Therefore, on the basis of eq 6.11, the fraction of free arms, X fa , does not change
significantly with an increase in the total macromonomer concentration X T = X ma + X fa
. However, it significantly increases the fraction of arms with bridge and loop
conformation. Therefore, there is a smaller fraction of free arms and larger fraction of
loops and bridges at higher macromonomer concentrations. As the ratio of L to EO
increases at constant X T , the fraction of free arms decreases. The number of bridges per
micelle and the bridge fraction of the arms as a function of n are shown in Figure 6.7. The
number of bridges per micelle continuously increased with n, while the bridge fraction
showed a biphasic behavior. The bridge fraction initially increased when n increased
from 2 to 4, which can be attributed to the decrease in the fraction of free arms from 70 to
14% of total arms. With increasing n to values >4, the intermicellar distance increased
while the length of hydrophilic EO segments connecting the micelles decreased, thus
reducing the probability of bridge formation and the bridge fraction.
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Figure 6.7. The effect of the number of lactide beads on each arm on the number of
bridges per micelle and bridge fraction in 30% aqueous solution of SPELA-nL
macromonomers. Error bars correspond to means ± 1 SD for n = 5 simulations.
The contribution of each bridge to the elastic modulus of the physically formed
network is related to the residence time of the arm in the micelle‟s core, which is
proportional to[249]

 ~ .n 2 / 3

(equation 6.12)

where  is the effective interfacial tension between the micelle‟s core and solution. With
increasing n, the EO segments adopt a thinner interfacial layer on the core surface with
lower entropy, thus increasing the interfacial tension of the micelle−water interface.
Therefore, both n and  increased the residence time of the bridges with increasing
number of lactides per arm. As a result, the contribution of each bridge to the elastic
modulus of the network increased with n [298] even though the fraction and number

142

density of bridges decreased for n > 4. That effect, in turn, reduced the mobility and
accessibility of the reactive acrylate groups with increasing n.
6.3.4. DISTRIBUTION OF REACTIVE ACRYLATE BEADS
The reactivity of an acrylate group in the macromonomer depends on its mobility
and its proximity to other acrylates in the solution. The acrylate mobility, in turn, depends
on the concentration of water in the microenvironment. To quantify the proximity of an
acrylate bead to water beads or other acrylate beads, the average number of water ( n Acw )
or acrylate ( n AcAc ) beads in a sphere of radius R around an acrylate bead or the running
integration number of beads “a” around beads “b”, n a b , was calculated by[248]
R

n a b (R )  4 b 0  g ab (r ) r 2 dr

(equation 6.13)

0

where  b 0 is the overall number density of beads of type „b‟ and

g ab (r) is the radial

distribution function of bead “b” around bead “a” located at the origin. [299] The effect
of the number of lactides in the SPELA macromonomer on n Acw and n AcAc in a radius
of 20 Å is shown in Figure 6.8.a and 6.8.b, respectively. n Acw increased with radial
distance, but the SPELA-0L macromonomer (n = 0) had the highest integration number
with maximum coverage of acrylate groups by water beads. With increasing n and
formation of larger lactide cores, the fraction of hydrophobic acrylates facing water
decreased, leading to a decrease in n Acw . The n Acw value for SPELA-0L at radial
distance rc was an order of magnitude higher than that of SPELA-16L. This large
difference emphasizes the higher accumulation of water beads around acrylates, and
hence higher accessibility to the aqueous phase, for macromonomers with a low number
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Figure 6.8. The running integration numbers for (a) Ac−W beads and (b) Ac−Ac beads of
SPELA-nL macromonomers in 30% aqueous solution.
of lactides. According to Figure 6.8.b, SPELA- 0L with the most uniform distribution of
acrylate beads had the lowest n AcAc . The hydrophilic EO segments in SPELA-0L served
as an energy barrier against the formation of acrylate aggregates; thus, the acrylate local
density was the same as the overall density. Increasing n and the phase separation of
lactide and acrylate beads led to an increase in n AcAc , as shown in Figure 6.8.b. As n
increased from 0 to 2 and 4, the fraction of macromonomer arms incorporated in the
micelles increased from 0 to 30 and 86%, respectively, which led to a higher local density
of acrylates and a decrease in the average Ac−Ac bead distance. With further increase in
n, the local density of acrylates in the micelles‟ core decreased and the intermicellar
distance increased which led to an overall decrease in n AcAc for n > 4. Therefore, n AcAc
reached a maximum value for n = 4.
Figure 6.9 shows the effect of n on the radial distribution of acrylates in the core
of micelles. Due to its hydrophobic nature, there was a high density of acrylate beads in
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Figure 6.9. The distribution of Ac beads in the core of micelles for SPELA-nL
macromonomers in 30% aqueous solution.
the central part of the micelles‟ core. However, a significant fraction of acrylate beads in
micelles with smaller cores, due to volume constraints, were positioned near the surface
layers. For example, in SPELA-4L with relatively smaller core size, 66% of the acrylates
were positioned near the surface layer, away from the core‟s center. The average size of
the micelles‟ core increased with n, which relaxed the volume constraint, thus increasing
the fraction of acrylates in the core‟s inner layers. Therefore, the maximum fraction of Ac
beads for macromonomers with n = 8 and n = 16 were located below the surface layer to
minimize the interfacial free energy, as shown in Figure 6.9. Figure 6.10 shows the
variation of free and tethered fractions of acrylates with the number of lactides in each
arm. All acrylates were distributed uniformly in SPELA-0L. Increasing n led to the
formation of larger micelles and a decrease in the fraction of free arms. The fraction of
free arms decreased dramatically from 0.70 to 0.14 when n was increased from 2 to 4,
which can be explained by a sharp increase in the volume to surface area ratio of the
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Figure 6.10. The effect of the number of lactide beads on each arm on the fraction of Ac
beads on free arms and core surface of the micelles for SPELA-nL macromonomers in
30% aqueous solution. Error bars correspond to means ± 1 SD for n = 5 simulations.
micelles. A 66% increase in the size of the lactide segment of the arms (n changing from
2 to 4) led to a 420% increase in the core volume of the micelles, while the number
density of micelles decreased by only 10%. When n was increased to 8, almost all
acrylates (>99%, see Figure 6.10) became part of the core volume of the micelles. The
reactive acrylate groups on SPELGA macromonomers cross-link by photopolymerization
in aqueous solution and form mechanically robust hydrogel networks.[52] The covalent
cross-links are stronger than the transient physical bridges between micelles. The reaction
between the free acrylates, which are in contact with the aqueous phase, forms
intermolecular cross-links and increases the cross-link density. The reaction between the
acrylates in the micelle‟s core that belong to the same macromonomer (loops) increases
the residence time of the bridges, while the reaction between those acrylates on different
macromonomers (bridges) changes a transient bridge to a permanent cross-link. Since
there is a high fraction of loops in the micelles‟ core (see the bridge fraction in Figure
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6.7), a large fraction of the core acrylates undergo cyclization, which do not contribute to
the elastic modulus of the network.
The effect of the number of lactide beads, n, on the reaction of acrylates and
network formation can be divided into two regimes. SPELA-0L with 100% free acrylates
produces networks with the highest and most uniform cross-link density. For low n
values (n ≤ 4), most of the acrylates are free (see Figure 6.7.a) and the average distance
between the acrylates in the micelles‟ core is relatively small (see Figure 6.3). Therefore,
both free acrylates in the aqueous phase and core acrylates in the micelle phase contribute
to network formation. With increasing n, the Ac−Ac integration number grows, which
increases the rate of propagation reaction between the acrylates, leading to a reduction in
gelation time (formation of infinite network). For n > 4, the fraction of free acrylates is
negligible, so cross-linking is dominated by the reaction between the core acrylates. Since
the solvent concentration in the micelle‟s core is very low, the core acrylates have
significantly low diffusivity compared to free acrylates. Also, the average distance
between the acrylates in the micelles‟ core increases with n. Thus, the rate of crosslinking decreases with increasing n for n > 4, leading to decreasing density of permanent
bridges and lower elastic modulus of the network.
6.4. CONCLUSION
The mesoscale structure of the four-arm star poly(ethylene glycol-co-lactide)acrylate (SPELA) macromonomer in aqueous solution was simulated by dissipative
particle dynamics (DPD). The short lactide segments on each arm led to the formation of
micelles. The micelle size, aggregation number (average number of macromonomers per
micelle), and the number of intermicellar bridges increased with increasing number of
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lactides per arm. Among three possible conformations of the arms (free, loop, and
bridge), the fraction of free arms decreased with increasing n while the fraction of loops
decreased. The fraction of bridges showed a maximum at n = 4. There was a transition
from the uniform distribution of acrylates for n = 0 to nearly complete incorporation in
the micelles for n > 4. For the acrylates incorporated in the micelles, the fraction tethered
to the core surface (those within a volume element facing the aqueous phase) decreased
with increasing n. The average integration number of water beads around the acrylates
was highest for the SPELA-0L (n = 0) and decreased with increasing n. The average
integration number of acrylates around an acrylate had a biphasic behavior with a
maximum at n = 4. The macromer concentration did not have a significant effect on the
distribution of acrylates and the size of the micelles. The results predict that the
conversion of SPELAnL acrylates in the cross-linking reaction decreases with increasing
n, thus reducing the modulus of the hydrogel. The results also predict that there is a tradeoff between the hydrogel modulus and degradation with higher n values favoring
degradation. The predictions of the simulation can be used to design novel PEG-based
hydrogels with robust mechanical properties and the desired degradation rate by changing
the composition of the macromonomer.
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CHAPTER 7
EXPERIMENTAL AND COMPUTATIONAL INVESTIGATION OF THE EFFECT OF
HYDROPHOBICITY ON AGGREGATION AND OSTEOINDUCTIVE POTENTIAL OF BMP2 DERIVED PEPTIDE IN A HYDROGEL MATRIX

Seyedsina Moeinzadeh, Danial Barati, Samaneh K. Sarvestani, Tahereh Karimi and
Esmaiel Jabbari, Experimental and Computational Investigation of the Effect of
Hydrophobicity on Aggregation and Osteoinductive Potential of BMP-2 Derived Peptide
in a Hydrogel Matrix, Tissue Engineering Part A, 2014. Reprinted here with permission
of publisher.
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7.1. INTRODUCTION
A feasible approach to the restoration of injured bone tissue is the use of tissue
engineering strategies to transplant undifferentiated human mesenchymal stem cells
(hMSCs) in a supportive carrier loaded with bone morphogenetic proteins. In particular,
human recombinant bone morphogenetic protein (BMP-2) is used extensively in certain
clinical applications such as spine fusion, sinus augmentation and alveolar ridge
augmentation to accelerate bone regeneration and healing.[62] Due to its short-half-life
and diffusion of the protein away from the site of regeneration, doses much higher than
the endogenous amount are loaded in the implant to induce bone formation.[62, 64] High
doses of BMP-2 protein in vivo cause undesired side effects such as bone overgrowth,
immune response, and tumorigenesis.[65] For example, the probability of an adverse side
effect with the use of BMP-2 in spine fusion may be as high as 40%.[65] Encapsulation
or grafting in nano- and microspheres is used to localize the protein to the site of
regeneration and reduce diffusion,[239, 300, 301] however tumor formation and
inflammatory response persists in some patients.[302]
The side effects of BMP-2 protein stems from its ability to promote cell migration
and vascularization and its involvement in tumor angiogenesis.[303] Therefore, an
attractive approach to reduce the protein‟s side effects in bone tissue engineering is to use
peptides derived from the bioactive domains of BMP-2 and other morphogenetic
proteins.[66] BMP-2 protein is a homodimer of two 114 amino acid residues with two
distinct epitopes. The wrist epitope is assembled around the central α-helix while the
knuckle epitope is located on the two aligned double-stranded β-sheets.[304, 305] It has
been shown that the activity of BMP-2 protein is mainly due to the interaction of the
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knuckle epitope with type II BMP receptor (BMP-II).[304] Multiple peptides derived
from the knuckle epitope of BMP-2 protein have been shown to have osteoinductive
potential.[18, 202] Among those, a peptide corresponding to residues 73-92 (hereinafter
referred to as BMP-2 peptide) showed highest alkaline phosphatase (ALP) and
osteogenic differentiation of MSCs, but the peptide activity was significantly lower than
BMP-2 protein.[66] The higher activity of the protein compared to the BMP-2 peptide
may be due to conformations differences between the native and free states of the peptide
in aqueous medium. Peptides have recently been used to generate tubular, fibrillar,
micellar, or vesicular nanostructures due their amphiphilic nature.[306-309] For example,
peptides with a hydrophilic head and a hydrophobic tail spontaneously self-assemble to
form vesicular structures in aqueous solution.[310] Peptide aggregation may alter the
overall conformation and presentation of the amino acid sequence that interacts with cell
surface receptors which adversely affects the osteoinductive potential of the peptide.
Although the structure and activity of BMP-2 protein has been extensively investigated in
vitro and in vivo, there is limited data on aggregation and nanostructure formation by
osteogenic peptides in aqueous solution and its effect on osteogenesis.
The objective of this work was to investigate the effect of concentration and
hydrophobicity of the BMP-2 peptide on peptide aggregation and differentiation of
hMSCs encapsulated in an inert polyethylene glycol (PEG) hydrogel. To test the effect of
BMP-2 peptide on differentiation, the encapsulated hMSCs were cultured in osteogenic
medium without dexamethasone (DEX). Molecular dynamic simulation was used to
predict the effect of concentration and hydrophobicity on peptide aggregation and critical
micelle concentration (CMC) using a MARTINI coarse-grained force field.[60, 311, 312]
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The peptide concentration was varied by 1000-fold from 0.005 mM to 5 mM with BMP-2
protein as the positive control. Hydrophobicity of the peptide was varied by capping PEG
chain ends with 0-6 lactide monomers. PEG as an inert matrix with tunable properties[51,
52, 113] was used for encapsulation of hMSCs to isolate and investigate the effect of
BMP-2 peptide hydrophobicity on its osteoinductive potential. Experimental and
simulation results revealed that osteoinductive potential of the BMP-2 peptide is
correlated with its CMC and the concentration of free peptide in aqueous medium and not
the total peptide concentration.
7.2. MATERIALS AND METHODS
7.2.1. REAGENTS
Linear polyethylene glycol (PEG) with nominal molecular weight of 3.4 kDa was
purchased from Acros (Pittsburg, PA). Lactide (L) monomer with >99.5% purity was
purchased from Ortec (Easley, SC) and it was dried under vacuum at 40°C for at least 12
h prior to use. 4-(2-hydroxyethoxy)phenyl-(2-hydroxy-2-propyl) ketone (Irgacure-2959)
photoinitiator was obtained from CIBA (Tarrytown, NY). The protected amino acids and
Rink Amide NovaGelTM resin were purchased from EMD Biosciences (San Diego, CA).
Piperidine, calcium hydride, tetrahydrofuran (THF), trimethylsilane (TMS), triethylamine
(TEA), tin (II) 2-ethylhexanoate (TOC), acryloyl chloride (Ac), acrylic acid,
dimethylsulfoxide (DMSO), and ethylenediaminetetraacetic acid disodium salt (EDTA)
were purchased from Sigma-Aldrich (St. Louis, MO). Dichloromethane (DCM, Acros)
was dried by distillation over calcium hydride. Other solvents were obtained from VWR
(Bristol, CT) and used as received. The protected amino acids and Rink Amide NovaGel
resin for peptide synthesis were purchased from EMD Biosciences (San Diego, CA).
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N,N-dimethylformamide (DMF), acetonitrile (MeCN), N,N-diisopropylethylamine
(DIEA),

N,N'-diisopropylcarbodiimide

(DIC),

triisopropylsilane

(TIPS),

N,N-

dimethylaminopyridine (DMAP), hydroxybenzotriazole (HOBt) and trifluoroacetic acid
(TFA) were received from Acros. Dulbecco's phosphate-buffer saline (PBS) and
Dulbecco's Modified Eagle's Medium (DMEM; 4.5 g/L glucose with L-glutamine and
without sodium pyruvate) were received from GIBCO BRL (Grand Island, NY). Fetal
bovine serum (FBS) was purchased from Atlas Biologicals (Fort Collins, CO). TRIzol for
isolation of cellular RNA and trypsin were purchased from Invitrogen (Carlsbad, CA).
Penicillin (PN), streptomycin (SP), fungizone (FG), gentamicin sulfate (GS),
dexamethasone (DEX), ascorbic acid (AA), and ß-sodium glycerophosphate (βGP) were
purchased from Sigma-Aldrich. Quant-it PicoGreen dsDNA reagent kit was obtained
from Invitrogen (Carlsbad, CA). QuantiChrom calcium and alkaline phosphatase (ALP)
assay kits were purchased from Bioassay Systems (Hayward, CA). Human mesenchymal
stem cells (hMSCs), harvested and cultured from normal human bone marrow, were
purchased from Lonza (Allendale, NJ). The cells were tested for purity by high
expression of CD105, CD166, CD29, and CD44 and low expression of CD14, CD34 and
CD45 markers as described by the supplier (Lonza).
7.2.2. SYNTHESIS OF LACTIDE-CAPPED PEG MACROMER
The PEG macromer was capped with short lactide segments (<6 monomers) by
condensation polymerization as we previously described.[35, 52] Briefly, the residual
moisture was removed from the PEG macromer by azeotropic distillation from toluene.
The PEG macromer and lactide monomers were heated to 120°C under dry nitrogen
atmosphere in a reaction flask equipped with an overhead stirrer. After melting, 1 mL of
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TOC catalyst was added and the reaction was allowed to proceed for 8 h at 135°C. After
the reaction, the product was dissolved in DCM and precipitated in ice cold methanol,
followed by precipitation in ether and hexane to remove the unreacted monomer and
PEG. Then, the product was dried in vacuum and stored at -20°C. In the next step, the
lactide-capped PEG was functionalized by reaction with AC using the following
procedure. Equimolar amounts of AC and TEA were added dropwise to a cooled solution
of the capped macromer in DCM and the reaction was allowed to continue for 12 h. After
the reaction, solvent was removed by rotary evaporation and the residue was re-dissolved
in ethyl acetate to precipitate the byproduct triethylamine hydrochloride salt. Next, ethyl
acetate was removed by vacuum distillation and the functionalized macromer was
dissolved in DCM and precipitated twice in ice cold ethyl ether. The product was
dissolved in DMSO, purified by dialysis, freeze dried and stored at -20°C. A similar
procedure was used for functionalization of PEG to produce PEG diacrylate (PEGDA)
macromer. The synthesized macromers were characterized by 1H-NMR (Varian, Palo
Alto, CA) as we previously described.[35] The synthesized macromer is hereinafter
referred to as Ln where “L” stands for lactide-capped PEG macromer and “n” is the
number of lactide monomers per chain end.
7.2.3. BMP-2 peptide synthesis and conjugation to the macromer
The amino acid sequence KIPKA SSVPT ELSAI STLYL (BMP-2 peptide, Figure
7.1.a) was synthesized manually on Rink Amide NovaGelTM resin in the solid phase as
we previously described.[113] The pseudoproline dipeptides (oxazolidine) FmocSer(tBu)-Thr(ΨMe,Mepro)-OH,

Fmoc-Leu-Ser(ΨMe,Mepro)-OH,

and

Fmoc-Ala-

Ser(ΨMe,Mepro)-OH were used in the peptide synthesis to improve the coupling efficiency
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Figure 7.1. Bead representation of the BMP-2 peptide (a) and the peptide/lactide-capped
PEG conjugate (b). Lactide, ethylene oxide and acrylate units in (b) are shown in brown,
green and blue beads respectively. (c) Schematic representation of hMSCs encapsulated
in the PEGDA (blue network) hydrogel matrix for all groups. Experimental groups
included the peptide (shown in red) dissolved in the hydrogel network (d), peptide
covalently attached to the hydrogel network (e), and peptide/lactide-capped PEG
conjugate attached to the hydrogel network (f). The red lines and circles in (d-f) represent
the peptide chain and peptide aggregate, respectively. The lactide-capped PEG macromer
in (f) is shown by brown-green colors.
and product yield.[313] Brieﬂy, the Fmoc-protected amino acid (1 equiv), HOBt (2
equiv) and DIC (1.1 equiv) were added to 100 mg resin swelled in DMF. Next, 0.2 mL of
0.05 M DMAP was added to the mixture and the coupling reaction was allowed to
proceed for 4-6 h at 30°C with orbital shaking. After each coupling reaction, the resin
was tested for the presence of unreacted amines using the Kaiser reagent.[314] The
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coupling reaction was repeated if the test result was positive. Otherwise, the resin was
treated with 20% piperidine in DMF and the next Fmoc-protected amino acid was
coupled. For direct conjugation of BMP-2 peptide to the hydrogel matrix, acrylamideterminated BMP-2 peptide was synthesized by the reaction between N-terminal amine of
the peptide with acrylic acid directly on the resin under reaction conditions used for
amino acid coupling. Acrylamide-terminated cell-adhesive GRGD peptide (Ac-GRGD)
was synthesized using a similar procedure. For conjugation of the peptide to lactidecapped PEG macromer, the amino acid sequence cysteine-glycine-glycine (CGG) was
coupled to the lysine end of the BMP-2 peptide directly on the resin. After coupling the
last amino acid, the peptide was cleaved from the resin by treating with 95% TFA/2.5%
TIPS/2.5% water for 2 h and precipitated in cold ether. The peptide was further purified
by preparative HPLC and characterized by electrospray ionization (ESI) mass
spectrometry as we previously described.[113]
The Michael addition reaction between the cysteine‟s sulfhydryl group on the
peptide and the acrylate on the macromer was used for conjugation, similar to a
procedure we previously described.[315] Figures 7.1.a and 7.1.b show the bead structure
of the BMP-2 peptide and peptide-macromer conjugate, respectively. Blue, brown, and
green beads in Figure 7.1.b represent acrylate, lactide, and ethylene oxide units of the
macromer, respectively. Briefly, a solution of the peptide in sodium borate buffer was
added to the solution of macromer in DMF in a 1:1 molar ratio to terminate on average
one end of the macromer with peptide and leaving the unreacted acrylate-terminated end
for attachment to the hydrogel matrix. The conjugation reaction was allowed to proceed
for 24 h at 30°C. After the reaction, the solution was dialyzed against distilled deionized
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(DI) water to remove the unreacted monomer and peptide, and freeze dried to obtain the
dry peptide-macromer conjugate. The number of peptides per lactide-capped PEG chain
was determined by 1H-NMR as we described previously.[315] The conjugate is
hereinafter referred to as PLn where “P”, “L” and “n” stand for BMP-2 peptide, lactidecapped PEG macromer, and number of lactide monomers per chain end, respectively.
7.2.4. DYNAMIC LIGHT SCATTERING
Dynamic light scattering (DLS) was used to determine CMC of the peptide as
described.[316] Solutions with different concentration of the peptide in PBS were
prepared by sonication for 10 min. A 20 µL aliquot of the peptide solution was used for
DLS measurements on a DynaPro MSX DLS instrument (Wyatt Technology, Santa
Barbara, CA). The intensity of scattered light at 90° angle was collected and averaged
over 50 data points using the DynaPro software (Wyatt Technology). Intersection of the
two linear lines fitted to the data for scattered light intensity at low and high
concentrations was used to define CMC for the peptide as previously described.[317]
7.2.5. CELL ENCAPSULATION AND CULTURE
Prior to cell encapsulation, hMSCs were cultivated at 5000 cells/cm2 in a high
glucose DMEM medium supplemented with 10% FBS, 100 units/mL penicillin and 100
µg/mL streptomycin. The medium was refreshed every 3 days. When the cultivated
hMSC colonies reached approximately 70% confluency, the cells were detached with
0.1% trypsin- 0.03% EDTA and sub-cultivated at 1:3 ratio. According to supplier‟s
instructions (Lonza, Allendale, NJ), all hMSCs used in cell culture experiments were
passaged <5 times. The following procedure was used for encapsulation of hMSCs in
BMP-2 peptide incorporated PEGDA hydrogels by UV polymerization, as shown in
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Figure 7.1.c.[35, 51] First, BMP-2 peptide, with or without conjugation to the lactidecapped macromer, was dissolved in a solution of Irgacure-2959 photoinitiator (1 wt% of
PEGDA) in PBS. Next, 1 wt% Ac-GRGD adhesive peptide was dissolved in a solution of
PEGDA macromer (15 wt%) in PBS to improve cell viability and cell-matrix interaction
after encapsulation. After sterilization by filtration, the initiator and macromer solutions
were mixed by vortexing for 5 min to generate the hydrogel precursor solution. Then,
1x106 hMSCs, suspended in 100 µL PBS, was added to the precursor solution and mixed
gently with a pre-sterilized glass rod. The suspension of cells in the precursor solution
was injected between two sterile microscope glass slides and crosslinked by UV
irradiation with a BLAK-RAY 100-W mercury long wavelength (365 nm) UV lamp
(Model B100-AP; UVP, Upland, CA) as we described previously.[88] The final density
of hMSCs in the gel was 2x106 cells/mL. Experimental groups included peptide dissolved
in PEGDA gel (Figure 7.1.d, peptide in red), peptide covalently attached to PEGDA gel
(Figure 7.1.e), and peptide/lactide-capped PEG conjugate attached to PEGDA gel (Figure
7.1.f). Abbreviations “P” and “cP” denote BMP-2 peptide dissolved in and conjugated to
PEGDA hydrogel, respectively, “PLn” denotes BMP-2 attached to lactide-capped
macromer and dissolved in PEGDA gel, and “cPLn” denotes BMP-2 peptide attached to
lactide-capped macromer and conjugated to PEGDA gel. After removing from the glass
slide and cutting the gel with a cork borer, the disk-shape samples were incubated in
basal medium for 24 h with two medium changes. The medium was then replaced with
osteogenic medium without DEX (50 µg/mL AA and 10 mM βGP) and incubated for 28
days. The cell-encapsulated gels (without BMP-2 peptide) incubated in basal medium and
osteogenic medium without DEX were used as negative controls while those with 0.0004
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mM BMP-2 protein dissolved in the gel (and medium) were used as the positive
control.[318, 319] For the groups with peptide dissolved in the gel, the peptide was also
added to the culture medium for concentration uniformity.
7.2.6. BIOCHEMICAL AND mRNA ANALYSIS
At each time point, the samples were divided in two groups. One group was
homogenized and sonicated to rupture the membrane of the encapsulated cells and expose
the DNA. Double stranded DNA (dsDNA) content of the homogenized samples was
analyzed using the PicoGreen assay as described.[35] Analysis of dsDNA was performed
using a Synergy HT plate reader (Bio-Tek, Winooski, VT) with emission and excitation
wavelength of 485 and 528 nm, respectively. Alkaline phosphatase (ALP) activity of the
samples was measured using the QuantiChrom ALP assay kit on a Synergy HT plate
reader at the wavelength 405 nm as described.[35] The measured intensity was correlated
to ALP activity in IU/L and normalized to cell numbers. Calcium content of the samples,
as a measure of the total mineralized deposit, was measured using the QuantiChrom
Calcium Assay kit as described.[35] The absorbance was measured on a Synergy HT
plate reader at the wavelength of 575 nm. Measured intensities were correlated to the
amount of equivalent Ca2+ using a calibration curve made with calcium chloride solutions
of known concentrations. For mRNA analysis, total cellular RNA was isolated using
TRIzol as described.[113] 250 ng of the extracted total RNA was subjected to cDNA
conversion using Promega reverse transcription system (Madison, WI). The obtained
cDNA was subjected to real-time quantitative polymerase chain reaction (rt-qPCR)
amplification with SYBR green RealMasterMix (Eppendorf, Hamburg, Germany) using
Bio-Rad CXF96 PCR system (Bio-Rad, Hercules, CA) and the appropriate gene specific
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primers. PCR experiments were performed to analyze the differential expression of
osteogenic markers ALP and RunX-2 with time for hMSCs encapsulated in the gels.
Primers for rt-qPCR were designed and selected using the Primer3 web-based software as
described.[188] The following forward and reverse primers were synthesized by
Integrated DNA technologies (Coralville, IA): ALP: forward 5‟-ATG GGA TGG GTG
TCT CCA CA-3‟ and reverse 5‟- CCA CGA AGG GGA ACT TGT C-3‟; RunX-2:
forward 5‟-ATG ACA CTG CCA CCT CTG A-3‟ and reverse 5‟-ATG AAA TGC TTG
GGA ACT GC-3‟; GAPDH: forward 5‟-CAT GAC AAC TTT GGT ATC GTG G-3‟ and
reverse 5‟-CCT GCT TCA CCA CCT TCT TG-3‟.[320] The model of Pfaffl was used to
determine the expression ratio of the gene.[241] The expression of GAPDH
housekeeping gene was used as the reference, and the fold difference in gene expression
was normalized to the first time point.
7.2.7. Statistical analysis
Data are expressed as means ± standard deviation. All experiments were done in
triplicate. Significant differences between groups were evaluated using a two-way
ANOVA with replication test, followed by a two-tailed Students t-test. A value of p <
0.05 was considered statistically significant.
7.2.8. Simulation Method
The atomistic structure of the BMP-2 peptide and lactide-capped PEG macromer
were coarse-grained into different beads (set of atoms) using the MARTINI coarse
graining model.[311, 312] The MARTINI force field has been parameterized and applied
previously to the simulation of proteins, peptides, polymers, and polymer-peptide
conjugates.[321-326] This model is based on the four to one mapping with each bead in
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the coarse-grained model representing four heavy atoms in the atomistic model. The
coarse graining of the peptide and macromer is schematically illustrated in Figure 7.1.a.
There were a total of 16 bead types for the peptide backbone, amino acid side chains,
ethylene oxide repeat unit (EO), acrylate group (Ac) and lactide repeat unit (L). Each
amino acid was coarse grained into a backbone bead and between zero to three side
chain beads, based on the original MARTINI model developed for simulation of
proteins.[311, 312] After coarse graining, the beads were assigned pairwise interactions
that included polar (P), nonpolar (N), apolar (C), and charge (Q) interactions. To
accurately represent its real nature, the interactions were grouped into subtypes based on
the extent of hydrogen bonding or the degree of polarity of the beads. The polar beads
were divided into five subtypes based on the degree of polarity from low (P1) to high
(P5). Apolar beads were divided into five subtypes from high (C1) to low apolar (C5).
The nonpolar as well as charged beads were divided into four subtypes, namely hydrogen
donor, hydrogen acceptor, hydrogen donor and acceptor and incapable of hydrogen
bonding. For example, 4 water molecules were represented by a polar bead with degree
of polarity of 4 or P4. For non-bonded interactions, the following Lennard-Jones potential
function VLJ (r ) was used [312]

  ij 12   ij 6 
VLJ (r )  4 ij      
 r 
 r  

(equation 7.1)

where  ij is the depth of the potential well which is related to the strength of interaction
between beads i and j, and  ij is the minimum distance of approach between beads i and
j. To account for electrostatic interaction between charged beads, the following columbic
function was used [312]
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VEL 

qi q j

(equation 7.2)

4 0 rel rij

where qi and q j are values of the point charges on beads i and j,  0 is the dielectric
constant of free space and  rel is the relative dielectric constant of the medium. To
account for interaction between bonded beads, the following potential functions were
used: harmonic function ( Vb ) for bond length, cosine harmonic function ( Va ) for bond
angle, and dihedral function ( Vd ) for bond torsion [312]

Vb 

1
Kb (rij  db ) 2
2

(equation 7.3)

Va 

1
K a [(cos(ijk )  cos( a )]2
2

(equation 7.4)

Vd  Kd [1  cos(n ijkl  d )]

(equation 7.5)

where K b , K a and K d are force constants for bond stretching, bond angle bending and
bond torsional rotation, respectively. rij ,  ijk and  ijkl represent the distance between
bonded beads i and j, the angle between bonded beads i, j, and k, and the dihedral angle
between beads i, j, k , and l respectively. d b ,  a ,  d and n are the equilibrium bond
length, bond angle, phase angle, and periodicity, respectively. Simulations were
performed under NVT ensemble dynamics. A time step of 10 fs was employed and the
total simulation time was 5 µs. The temperature was held at 37°C using the Nose
thermostat.[327] The simulations were performed in a 200×200×200 Å box with 3D
periodic boundary conditions. To cover a broader range of concentrations, a bigger
400×400×400 Å box was used to simulate the effect of peptide concentration. The
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Mesocite module of Materials Studio (v5.5, Accelrys) was used for the mesoscale
simulations.[267]
For simulations to investigate the interaction of BMP-2 peptide with the cell
membrane, a template membrane with a width of 40 Å was generated using
Dipalmitoylphosphatidylcholine (DPPC) lipid as one face of the simulation box with the
box filled with water. The coarse graining of DPPC has been described elsewhere.[328]
The cell membrane was simulated under NVT ensemble for 100 ns to form the bilayer
structure. After forming the lipid bilayer, the other components of system (peptide or
peptide-macromer conjugate) were added to the simulation box. Next, the interaction
type of all lipid bilayer beads was constrained to P4 type in order to account for the
interaction with water beads. Then, dynamic simulations were run for 5 µs to allow the
formation of peptide or peptide-macromer aggregates in aqueous solution similar to the
simulations without the lipid bilayer membrane. Next, the constraint was removed from
the membrane beads and the pairwise bead interaction potential was changed
accordingly. Finally, the system was simulated for 5 µs similar to that without the lipid
bilayer membrane.
7.3. RESULTS
The average number of lactides per chain end of lactide-capped PEG, average
number of acrylates per chain end, and average number of BMP-2 peptides per conjugate
was determined from the NMR spectra of macromers as we previously described.[35,
315] The number of lactide repeat units per chain end of the lactide-capped PEG
macromer was determined from the ratio of the peaks at 1.6 and 5.2 ppm (lactide
hydrogens) to those at 3.6 and 4.3 ppm (PEG hydrogens).[35] The average number of
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lactide repeat units per chain end for L2, L4 and L6 macromers was 1.9, 3.6 and 5.6
respectively. The number of reactive acrylate groups per chain end was determined from
the ratio of the peaks between 5.85 to 6.55 ppm (acrylate hydrogens) to those at 3.6 and
4.2 ppm (PEG hydrogens).[35] The average number of acrylates per chain end before
peptide conjugation for L0, L2, L4 and L6 macromers was 0.85, 0.85, 0.83 and 0.82,
respectively. The number of peptides in a peptide/lactide-capped PEG conjugate was
determined using the acrylate/PEG molar ratios before and after conjugation as
previously described.[315] The average number of peptides per conjugate for L0, L2, L4
and L6 macromers was 0.57, 0.49, 0.52 and 0.45, respectively. Several studies have
demonstrated that >95% of acrylated PEG/peptide conjugates are integrated in PEGDA
hydrogel network during photo-crosslinking.[113, 329, 330]
Figure 7.2 (a-e) shows the effect of dissolved (not attached to the gel network)
BMP-2 peptide concentration on osteogenic differentiation of hMSCs encapsulated in the
PEGDA hydrogel incubated in osteogenic medium without DEX. Peptide concentration
ranged from 0.00025 mM to 5 mM. Negative and positive control groups were gels
without peptide and with 0.0004 mM BMP-2 protein, respectively. The clinically used
concentration of BMP-2 protein is 1 mg/mL

(~ 0.04 mM) [331] but the typical

concentration used for in vitro 3D experiments is in the 1-10 µg/mL (~0.00004-0.0004
mM) range.[318, 319] In this work, the upper concentration of 0.0004 mM was used to
elucidate the effect of peptide on differentiation of hMSCs. DNA content, ALP activity
and calcium content of the groups are shown at a single time point (7, 14 and 21 days,
respectively) in Figure 7.2(a-c). DNA content of the groups at day 7 did not change
appreciably with peptide concentration (Figure 7.2.a). ALP activity of all groups reached
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Figure 7.2. DNA content (a, day 7), ALP activity (b, day 14), and calcium content (c, day
21) of hMSCs encapsulated in PEGDA hydrogel (15 wt%) and incubated in osteogenic
medium without DEX as a function of dissolved BMP-2 peptide concentration in the
hydrogel matrix. Control groups included hMSCs encapsulated in PEGDA hydrogel (15
wt%) and cultured in osteogenic medium without DEX (OM) and without the BMP-2
peptide (0 mM, negative control) and those cultured in OM with 0.0004 mM BMP-2
protein (0.01 Pr, positive control). Effect of the BMP-2 peptide concentration on ALP (d)
and RunX-2 (e) mRNA marker expression of hMSCs encapsulated in PEGDA hydrogel.
a maximum on day 14 consistent with the biphasic activity of ALP in osteogenic
differentiation of MSCs.[332] ALP activity of the groups at day 14 did not significantly
change when the peptide concentration increased from 0 to 0.00025 and 0.0005 mM
(Figure 7.2.b). The ALP activity of the groups at peptide concentrations above 0.0005
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mM was significantly higher than the ALP activity of the group without peptide (Figure
7.2.b). The ALP activity of groups increased by 1.7 and 2.2 fold when the peptide
concentration increased from 0.0005 mM to 0.0025 and 0.005 mM respectively. The
growth rate of ALP activity of groups decreased with increasing the peptide
concentration above 0.005 mM. A 1000-fold increase in the concentration of peptide in
the gel from 0.005 mM to 5 mM increased ALP activity only by 1.4-fold at day 14
(Figure 7.2.b). ALP activity of hMSCs encapsulated in PEGDA gel with 0.005 mM
BMP-2 peptide was 2.4-fold higher than the gel without peptide (ctrl group in Figure
7.2.b) after 14 days while that with 0.0004 mM BMP-2 protein (same weight
concentration as peptide, 10 µg/mL)

was 7.2-fold higher.

The effect of peptide

concentration on the extent of mineralization of encapsulated hMSCs (Figure 7.2.c), as
measured by calcium content, was consistent with ALP activity. Calcium content of the
gels did not significantly change with the addition of 0.00025 and 0.0005 mM peptide to
the gels. The calcium content increased from 245  50 to 340  40 and 420  50 mg/mg
DNA with increasing the peptide concentration by 5 and 10 folds from 0.0005 to 0.0025
and 0.005 mM respectively, but the calcium content increased at a slower rate from 420

 50 to 700  100 mg/mg DNA with 500-fold increase in peptide concentration from
0.005 mM to 2.5 mM. Further increase in peptide concentration from 2.5 to 5 mM did not
significantly change calcium content. The ALP and RunX-2 mRNA expression as a
function of peptide concentration in Figures 7.2.d and 7.2.e, respectively, were consistent
with ALP activities and calcium contents (Figures 7.2.b and 7.2.c). Notably,
osteoinductive potential of BMP-2 peptide was significantly less than that of BMP-2
protein as the calcium content and ALP mRNA expression of hMSCs cultured with 10 µg
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protein/mL (0.0004 mM) BMP-2 protein were 4-fold and 12-fold higher than those
cultured with the same 10 µg peptide/mL mass concentration of the peptide (0.005 mM) ,
respectively. Furthermore, RunX-2 expression of hMSCs cultured with BMP-2 protein
(0.0004 mM, pink bar in Figure 7.2.e) and those cultured with BMP-2 peptide at highest
concentrations (2.5 and 5 mM, light green and light blue) peaked on day 7 while those
cultured with 0.005-0.5 mM peptide peaked on day 14. To summarize, the results in
Figure 7.2 indicated that the osteoinductive potential of BMP-2 peptide was significantly
less than that of the protein and even 12000-fold higher peptide molar concentrations
could not achieve the osteoinductive potential of BMP-2 protein.
The results in Figure 7.2 prompted us to investigate stability of the peptide in
aqueous solution. The hydrophobicity index for each amino acid, from N-terminus (left
side) to C-terminus (right side) of the BMP-2 peptide, based on the difference in free
energy of the aqueous and condensed phases,[333] is shown in Figure 7.3.a. The positive
and negative indices indicate hydrophobic and hydrophilic residues, respectively. The
distribution of hydrophobicity was not uniform along the peptide chain as the average
hydrophobicity indices on N- (left) and C-terminus (right) sides of the peptide were -0.28
and 0.84, respectively (see the dash lines in Figure 7.3.a). Overall the peptide was
hydrophobic with an average hydrophobicity index of 0.28. The overall hydrophobicity
suggested that the peptides form aggregates in aqueous solution to reduce the overall free
energy. Indeed, molecular dynamic simulations in Figure 7.3.c show that the aggregation
number (number of peptides per aggregate) increased with concentration of the peptide in
aqueous solution. By extrapolating to aggregation number of one in Figure 7.3.c, the
critical micelle concentration (CMC) of 0.040 mM was obtained for the peptide. Similar

167

Figure 7.3. (a) Hydrophobicity index for each amino acid from N-terminus (left side) to
C-terminus (right side) of the BMP-2 peptide. (b) intensity of scattered light as a function
of peptide concentration in aqueous solution. (c) Simulated aggregation number of the
BMP-2 peptide (number of peptides per aggregate) as a function of the peptide
concentration in aqueous solution. (d) density of free BMP-2 peptide and total peptide
density as a function of peptide concentration in aqueous solution.
to surfactants, the peptide is soluble in aqueous solution below CMC but it forms
aggregates in equilibrium with the free peptide in solution above CMC with the
propensity for aggregation increasing with peptide concentration.[334] CMC of the
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peptide was measured by dynamic light scattering from the intersection of the two lines
fitted to the scattered light intensity at high and low concentrations, as shown in Figure
7.3.b. The intensity of scattered light did not change significantly at low concentrations in
the absence of aggregation but it increased exponentially above CMC with aggregation.
The experimentally measured CMC was 0.019 mM which was lower than the predicted
value of 0.04 mM from simulations (Figure 7.3.c). The predicted higher CMC was most
likely due to the error in extrapolating the aggregation number from higher
concentrations to the aggregation of unity at CMC. However, the experimental and
simulated CMCs were within the range of 0.005-0.05 mM which was observed in the cell
studies (Figure 7.2). A lower growth rate of ALP activity and mineralization of hMSCs in
PEGDA gels with peptide concentration when the peptide concentration was in the
0.005-0.05 mM range compared to the 0.0005-0.005 range can be related to the initiation
of aggregation within the former range (see Figure 7.2.b and 7.2.c). The predicted total
and free peptide densities as a function of peptide concentration in solution are compared
in Figure 7.3.d. According to simulation results, the fraction of free peptide above CMC
concentration decreased sharply from 0.54 to 0.16, 0.09 and 0.06 as the peptide
concentration was increased from 0.5 mM to 2.5, 5 and 10 mM, respectively. However,
the decrease in fraction of free peptide was offset by an increase in peptide number
density. Therefore, the density of free peptide in solution increased by 1.9-folds from
0.16x1018 to 0.3x1018/cm3 while the total peptide density increased by 20-folds from 0.28
x1018 to 5.73 x1018/cm3 (Figure 7.3.d). The effect of peptide concentration, added to the
gel and culture medium, on ALP activity (day 14) and calcium content (day 21) of
hMSCs encapsulated in 15% PEGDA gel is shown in Figure 7.2.b and 7.2.c, respectively.
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Note that concentration scale in the figures is logarithmic. As the total peptide
concentration was increased by 10-folds from 0.5 to 5 mM in a range well above CMC,
ALP activity and calcium content increased by 1.1 and 1.2 folds, respectively, while the
free peptide concentration increased by 1.6-fold from 0.26 to 0.42 mM (see Figure 7.4).
Therefore, the data suggests a better correlation between osteogenic activity and the free
peptide concentration. Further, the significantly lower osteogenic activity of the peptide
compared to BMP-2 protein even at 12000-fold higher concentration, can be partially
(see other effects due to peptide interaction with the cell membrane) explained by
aggregation in aqueous solution.
The effect of peptide hydrophobicity and its conjugation to the PEGDA network
on DNA content, ALP activity and calcium content of the encapsulated hMSCs is shown
in Figures 7.5.a to 7.5.c, respectively. Groups included gels incubated in basal medium
(BM), osteogenic medium without DEX (OM), OM with peptide conjugated to the gel
(cP), OM with peptide dissolved in the gel (P), OM with peptide/lactide-capped PEG
macromer with zero (cPL0), 2 (cPL2), 4 (cPL4), and 6 (cPL6) lactides conjugated to the
gel. DNA content of hMSCs cultured in BM increased with incubation time while those
incubated in OM decreased, with or without peptide (Figure 7.5.a). The increase in DNA
content in BM indicated that hMSCs were able to grow in the encapsulating PEG matrix
but DNA content decreased with incubation time as the encapsulated cells underwent
differentiation in osteogenic medium consistent with previous reports.[252, 253]
Addition of BMP-2 peptide, peptide hydrophobicity, or peptide conjugation to the PEG
matrix did not have a significant effect on cell number with incubation time.
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Figure 7.4. ALP activity (b, day 14), and calcium content (c, day 21) of hMSCs
encapsulated in PEGDA hydrogel (15 wt%) and incubated in osteogenic medium without
DEX as a function of dissolved BMP-2 peptide concentration in the hydrogel matrix.
Control groups included hMSCs encapsulated in PEGDA hydrogel (15 wt%) and
cultured in osteogenic medium without DEX (OM) and without the BMP-2 peptide (0
mM, negative control) and those cultured in OM with 0.0004 mM BMP-2 protein (0.01
Pr, positive control).
ALP activity of the encapsulated hMSCs cultured in BM did not change with
incubation time while those cultured in OM, with or without peptide, peaked on day 14.
The addition of BMP-2 peptide to the culture medium significantly increased the peak
ALP activity on day 14, as shown by one star in Figure 7.5.b. Further, the group with
BMP-2 peptide dissolved in the medium (P) had significantly higher ALP activity on day
14 compared to those groups in which the peptide was conjugated to the PEG gel (cP,
cPL0, cPL2, cPL4, cPL6), as shown by two stars in Figure 7.5.b. This is consistent with
the fact that BMP-2 protein is associated with the soluble, not the insoluble fraction of the
bone matrix.[335] Further, ALP activity for cPL0 group (peptide-PEG conjugate attached
to the gel) was 3000  450 IU/mg DNA which was higher than that for cP group (peptide
attached to the gel) with 2200  260 IU/mg DNA. Notably, ALP activity of the
encapsulated hMSCs decreased when the PEG chain conjugated to the peptide was
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Figure 7.5. DNA content (a), ALP activity (b), and calcium content (c) of hMSCs
encapsulated in PEGDA hydrogel and incubated in basal medium (BM, control group),
osteogenic medium without DEX (OM, control group), OM with the BMP-2 peptide
covalently attached to the hydrogel network (cP), OM with BMP-2 peptide dissolved in
the hydrogel (P), OM with peptide/lactide-capped PEG conjugate with zero (cPL0), 2
(cPL2), 4(cPL4) and 6 (cPL6) lactide units, attached to the hydrogel network. One star
indicates a statistically significant difference (p<0.05) between the test and OM groups at
each time point. Two stars indicates a statically significant difference between the test
and all other groups at each time point. Error bars correspond to means±1 SD for n=3.
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capped with a hydrophobic lactide segment (cPL2, cPL4 and CPL6 groups). However,
the lactide segment length did not significantly change the peak ALP activity of hMSCs.
The extent of mineralization of hMSCs, as measured by calcium content, did not
change with incubation time in BM but it increased in all OM groups (with or without
peptide), as shown in Figure 7.5.c. The addition of BMP-2 peptide to the gel (P group,
Figure 7.5.c) significantly increased calcium content compared to that without peptide
(OM medium, Figure 7.5.c). Consistent with ALP results, the calcium content of hMSCs
cultured in the gel with dissolved peptide (P group) was 680  40 mg/mg DNA which
was significantly higher than that conjugated to the gel (cP group, 370  50 mg/mg
DNA), as shown by two stars in Figure 7.5.c. Extension of the peptide with a PEG chain
increased the calcium content of hMSCs from 370  50 to 500  40 mg/mg DNA at day
28. However, extension of the peptide with a lactide-capped PEG chain (lactide segment
length of two, cPL2) significantly reduced calcium content at day 28 compared to PEGextended peptide. The length of the lactide segment in lactide-capped PEG conjugated
peptide did not affect calcium content of hMSCs.
We hypothesized that the lower osteoinductive potential of the peptide groups
conjugated to PEG or lactide-capped PEG was due to increased aggregation. The images
in Figure 7.6 show the simulated equilibrium structure of BMP-2 peptide or
peptide/lactide-capped PEG conjugates in aqueous solution (15 wt%). The blue and
brown beads are for acrylate and lactide units, respectively, and ethylene oxide beads are
not shown for clarity. Images 7.6.a to 7.6.g correspond to acrylate-terminated (blue
beads) PEG, lactide-capped PEG (2 lactides, L2), PL0, PL2, PL4 and PL6, respectively.
The acrylate-terminated PEG chains without lactide were uniformly distributed in the
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Figure 7.6. Evolution of the BMP-2 peptide aggregates in PEGDA hydrogel (15 wt%)
without the peptide or lactide-capped PEG macromer (a, control), with lactide-capped
PEG macromer (b, control, L0 group), the peptide (c, P group), the peptide-PEG
conjugate (d, PL0 group), the peptide/lactide-capped PEG conjugate with 2 (e, PL2
group), 4 (f, PL4 group), and 6 (g, PL6 group) lactides. The blue and brown beads
correspond to acrylate and lactide beads, respectively. Ethylene oxide and water beads
are not shown for clarity.
simulated aqueous solution, as shown by the acrylate beads in Figure 7.6.a. PEG chains
capped with lactide and terminated with an acrylate group formed micellar structures 1-3
nm in size as shown in Figure 7.6.b,[35, 51] with lactide and ethylene oxide beads
forming the core and corona of the micelles, respectively. The acrylate-terminated
peptide without (Figure 7.6.c) or with conjugation to PEG (Figure 7.6.d) formed
irregularly-shaped aggregates (Figures 7.6.c,d) due to its amphiphilic nature. In the
peptide case, hydrophobic side chains of the amino acids formed the core of the
aggregates while ethylene oxide beads covered surface of the aggregates with hydrophilic
amino acids (polar and charged) positioned at the core-corona interface (Figure 7.6.d).
The size of the aggregates increased when the peptide-PEG macromer was capped with 2,
4 and 6 lactide units as shown in Figures 7.6.e, 7.6.f and 7.6.g, respectively, and the
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number density of the aggregates decreased with increasing lactide segment length. The
cross sections of one of the aggregates in the simulations of Figure 7.6 are shown in
Figure 7.7 with green beads representing ethylene oxide (EO) units. The cross sections in
Figure 7.7 show that the aggregates in aqueous solution are covered with ethylene oxide
units of PEG to reduce the interfacial free energy between the aqueous phase and
hydrophobic structures, thus stabilizing the aggregates. Notably, thickness of the EO
layer increased with aggregate size.
The average aggregation number (nagg) and fraction of the free peptide (P) and
peptide conjugated to lactide-capped PEG (cPL0, cPL2, cPL4 and cPL6) are shown in
Figure 7.7.h. Due to PEG hydrophilicity, nagg decreased from 3.4 to 3.0 and aggregate
distribution narrowed with conjugation of the peptide to PEG (cP). The nagg increased
from 3 to 3.9, 5.8 and 7.7 as the PEG macromer in peptide-PEG conjugate was capped
with 2 (cPL2), 4 (cPL4) and 6 (cPL6) lactides, respectively. The nagg increased from 3.4
to 4.3, 6.6 and 11.1 when the peptide was directly conjugated to lactide without PEG with
segment length of 2, 4, and 6, respectively. On the other hand, the fraction of free peptide
in solution increased from 0.06 to 0.1 with conjugation of the peptide to PEG (cP).
Further, the fraction of free peptide decreased from 0.1 to 0.04, 0.03 and 0.02 for cPL2,
cPL4 and cPL6, respectively.
To quantify the proximity of different beads, the average number of “b” beads in
a sphere of radius R around bead “a” or the running integration number of beads “b”
around bead “a”, IN ab (R) , was calculated by[35, 51]
R

IN ab ( R)  4 b 0  g ab (r ) r 2 dr

(equation 7.6)

0
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Figure 7.7. Cross-section of one of the BMP-2 peptide aggregates in Figure 5 with green
beads representing ethylene oxide units. Images (a-g) correspond to aggregates without
the peptide or lactide-capped PEG macromer (a), with lactide-capped PEG macromer (b),
the peptide (c), peptide-PEG conjugate (d), peptide/lactide-capped PEG conjugate with 2
(e), 4 (f), and 6 (g) lactides. Water beads are not shown for clarity. (h) Simulated average
aggregation number and the fraction of free peptide (h) and the water-amino acid
integration number for lysine (charged), serine (uncharged but polar), and isoleucine
(nonpolar) (i) for the peptide only (P), peptide-PEG conjugate attached to the hydrogel
network (cPL0), peptide/lactide-capped PEG conjugate attached to the gel network with 2
(cPL2), 4 (cPL4), and 6 (cPL6) lactide units. Error bars correspond to means ± SD for 5
simulation runs.
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where  b 0 is the overall number density of “b” beads and g ab (r ) is the radial distribution
function of bead “b” around bead “a”, located at the origin. The integration numbers
between water and amino acids lysine (K), serine (S) and isoleucine (I) representing
charged, polar and hydrophobic amino acids, respectively, are shown in Figure 7.7.i.
Isoleucine with lowest INAA-w (green curve in Figure 7.7.i) was confined to the center of
the aggregates while lysine with highest INAA-W was situated on the aggregate surface in
proximity to the PEG layer (see Figures 7.7.b-g). The simulation results in Figure 7.7
indicated that, due to peptide aggregation, the encapsulated hMSCs may interact with the
PEG layer on the surface of peptide-PEG aggregates or amino acids different from the
BMP-2 peptide sequence, leading to a lower osteoinductive potential of the lactidecapped PEG conjugated peptide.
The effect of peptide aggregation on interaction of the peptide with the cell
membrane was simulated by molecular dynamics and the results are shown in Figure 7.8.
When a single peptide (not an aggregate) or a single peptide-PEG conjugate was in
contact with the cell membrane, the distance between the center of masses of the peptide
and cell membrane did not change significantly. However, when an aggregate of the
BMP-2 peptides (P, upper left and right images) or an aggregate of the peptide-PEG
conjugates (PL0, lower left and right images) were in contact with the cell membrane,
higher energetic interaction, penetration of the peptide and pore formation in the
membrane was observed. However, conjugation of the peptide to PEG (PL0) reduced the
attractive interaction between the conjugate and cell membrane and the extent of pore
formation. Notably, covalent attachment of the peptide-PEG conjugate to the hydrogel
network eliminated pore formation in the cell membrane.
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Figure 7.8. Effect of an aggregate of the BMP-2 peptide (top images) and an aggregate of
the peptide-PEG conjugate (bottom images) on energetic interaction, penetration of the
peptide and pore formation in the cell membrane. The water beads are not shown for
clarity. The images on the left and right show the side and top views of the membrane,
respectively. In the top view, all membrane beads are shown in gray for clarity.
7.4. DISCUSSION
Aside from cost efficiency, osteogenic peptides are less likely to lose their activity
by denaturation than their corresponding protein. Therefore, a wider range of methods
can be used for incorporation of osteogenic peptides in engineered scaffolds. Li and
collaborators measured osteoinductivity of the BMP-2 peptide loaded in nano-hydroxy
apatite/collagen/poly(L-lactic acid) scaffolds by implantation in a rat calvarial
defect.[336] They reported that 3 mg of the BMP-2 peptide loaded in the scaffold had
osteoinductive potential similar to 1 µg of BMP-2 protein, indicating that 3000-fold
higher BMP-2 peptide concentrations are required to achieve the same activity as the
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protein. Our results demonstrate that although the addition of the BMP-2 peptide
significantly increased osteoinductive potential, but the level of activity was much less
than that of BMP-2 protein even at 12000-fold higher molar concentrations (1000-fold
higher mass concentrations). Further, the expression of RunX-2, a marker for the onset of
osteogenic differentiation, was delayed with the BMP-2 peptide compared to BMP-2
protein (Figure 7.2.e). One factor that can lower osteoinductive potential of the peptide is
aggregation in aqueous solution. The peptide is derived from BMP-2 protein based on its
ability to differentiate MSCs to the osteogenic lineage without consideration for its
stability in aqueous solution. Hydrophobicity index analysis of each amino acid indicated
that the peptide is amphiphilic with an overall positive index of hydrophobicity.
Therefore, the peptide tends to form aggregates above its CMC in aqueous solution to
reduce the interfacial free energy. The BMP-2 peptide concentration range of 0.000250.005 mM was below the peptide‟s CMC concentration of 0.019 mM (or 0.040 mM
based on the simulation results). Therefore, based on the experimental and simulated
values for CMC, the peptides in cell encapsulation experiments with 0.00025-0.005 mM
concentrations were most likely not aggregated. Above CMC concentration, the fraction
of free peptide decreased with increasing peptide concentration but the free peptide
density in the hydrogel slightly increased which could explain the slight increase in
osteoinductive potential with increasing peptide concentration in Figure 7.2. Therefore,
the experimental and computational results indicate that osteoinductive potential of the
BMP-2 peptide is related to the density of free non-aggregated peptide in aqueous
solution, not the overall concentration. Further, simulation results show that the amino
acids in the peptide aggregates facing the aqueous phase may be different from those of
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the free peptide (Figure 7.7.i) which may lead to non-specific interaction of the
aggregates with cell surface receptors. In addition, simulation results in Figure 7.8 show
that the peptide aggregates (P) had a higher energy of interaction with the cell membrane
than the free peptide, leading to undesired pore formation on the membrane and reduced
peptide activity. When the peptide was conjugated to PEG (PL0), the peptide aggregates
were shielded from the cell membrane by surface-bound PEG chains, which slightly
increased peptide activity. This is consistent with previous results that palmitoylation of
pro-apoptotic peptides can affect micelle stability and cell uptake.[337]
The results show that there was higher osteogenic differentiation of encapsulated
hMSCs when the BMP-2 peptide was dissolved in the hydrogel matrix as compared to
conjugated peptide (Figure 7.5) which was similar to the previously reported lower
activity of BMP-2 protein attached to immobilized heparin.[338] Conjugation of the
peptide to the hydrophilic PEGDA matrix decreased the degree of freedom of the peptide
beads, which decreased aggregation and increased the free peptide density. Further
capping the PEG chain with hydrophobic lactide units increased aggregation number of
the conjugated peptide which can be explained by a decrease in CMC. The free energy of
micelle formation is related to CMC by [334, 339]
0
Gmic
 RT ln(CMC )

(equation 7.7)

where R and T are the gas constant and absolute temperature respectively and G 0mic is
the difference in free energy of the peptide between the dissolved and aggregated states.
CMC and G 0mic increased with conjugation of the peptide to hydrophilic PEG, leading to
an increase in free peptide concentration and higher osteoinductive potential of the PEGconjugated peptide (cPL0) compared to cP. However, the addition of hydrophobic lactide
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units to the PEG-peptide conjugate offset the positive effect of PEG conjugation to the
peptide, leading to an insignificant change in osteoinductive potential of cPL2, cPL4 and
cPL6 groups compared to cPL0.
7.5. CONCLUSION
In this work, the effect of concentration and hydrophobicity of the BMP-2
peptide, from residues 73-92 of the knuckle epitope of BMP-2 protein, on differentiation
of hMSCs encapsulated in PEGDA hydrogel was investigated experimentally and by
molecular dynamic simulation. The encapsulated cells were cultured in osteogenic
medium without DEX supplemented with the BMP-2 peptide. The index of
hydrophobicity of the peptide was varied by conjugation to a lactide-capped PEG chain
with 0-6 lactide units. The BMP-2 peptide dissolved in the hydrogel had significantly
higher osteoinductive potential than the attached peptide consistent with the fact that
BMP-2 protein is associated with the soluble not the insoluble fraction of the bone
matrix. The osteoinductive potential of the BMP-2 peptide was significantly less than the
protein even at 12000-fold higher molar concentrations which was explained by peptide
aggregation in aqueous solution. Based on simulation results, the fraction of free peptide
in solution decreased while the concentration of free peptide increased slightly with
1000-fold increase in peptide concentration in aqueous solution, which reduced
osteoinductive potential of the peptide. A decrease in the index of hydrophobicity of the
peptide by conjugation to PEG increased CMC which increased osteoinductive potential
of the peptide. Conversely, an increase in the index of hydrophobicity of the peptide by
conjugation to lactide-capped PEG reduced CMC which reduced the peptide
osteoinductive

potential.

Experimental

and
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simulation

results

indicated

that

osteoinductive potential of the BMP-2 peptide should be correlated with its
hydrophobicity index, CMC concentration in aqueous medium, and the concentration of
free peptide in solution, not the total peptide concentration.
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CHAPTER 8
CONCLUDING REMARKS

This work showed that hydrogels based on star PEG macromonomers chain extended
with short hydroxyl acid segments (SPEXA) with a wide range of degradation rate,
gelation kinetics and mechanical properties are potential candidates for delivery of stem
cells to the site of regeneration in tissue engineering. Although SPEXA hydrogels were
applied in this work for osteogenic differentiation and mineralization of MSCs, these gels
can be utilized for a wide range of applications including vasculogenic differentiation of
endothelial progenitor cells or chondrocyte implantation in cartilage regeneration.
Further, results of this work demonstrated that the nano-scale characteristics of the
hydrogels‟ precursor solutions, predicted via meso-scale molecular simulation methods,
can be utilized for anticipating the hydrogels‟ macroscopic properties including
degradation rate, gelation kinetics and stiffness. In addition, experimental and simulation
results revealed that activity of a model osteo-inductive peptide in PEG based hydrogels
is correlated with the free peptide concentration in aqueous medium and not the total
concentration. To continue this work it is necessary to study the effect of concentration
and hydrophobicity of other osteo-inductive peptides on the activity of peptides and
interaction of peptides with cell-surface receptors.
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